var title_f25_60_26560="Honeycomb cysts in IPF CT";
var content_f25_60_26560=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F82237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F82237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Honeycomb cysts in IPF/UIP",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 283px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEbAXcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5+8VeIdaTxPrCprGoqq3kwAFy4AG8+9QfbfFv/Pzr3/fyaqXiz/katZ/6/Zv/AEM16zDESqsWIB44oA80+1+L/wDn41//AL7mqSGXxpM6pDJ4ikdjhVRpiSfavXNN064v5o4bUNK7HCgLnJr6A+HPw9t9Bihv9TXzdUK52nlYvb3PvTA+Of8AhH/iiRkaR41/8Brr/Cj/AIR/4o/9Ajxr/wCA11/hX6E0UgPz2/4R/wCKP/QI8a/+A11/hR/wj/xR/wCgR41/8Brr/Cv0JooA/Pb/AIR/4o/9Ajxr/wCA11/hR/wj/wAUf+gR41/8Brr/AAr9CaKAPz2/4R/4o/8AQI8a/wDgNdf4Uf8ACP8AxR/6BHjX/wABrr/Cv0JooA/Pb/hH/ij/ANAjxr/4DXX+FH/CP/FH/oEeNf8AwGuv8K/QmigD89v+Ef8Aij/0CPGv/gNdf4Uf8I/8Uf8AoEeNf/Aa6/wr9CaKAPz2/wCEf+KP/QI8a/8AgNdf4Uf8I/8AFH/oEeNf/Aa6/wAK/QmigD89v+Ef+KP/AECPGv8A4DXX+FH/AAj/AMUf+gR41/8AAa6/wr9CaKAPz2/4R/4o/wDQI8a/+A11/hR/wj/xR/6BHjX/AMBrr/Cv0JooA/Pb/hH/AIo/9Ajxr/4DXX+FH/CP/FH/AKBHjX/wGuv8K/QmigD89v8AhH/ij/0CPGv/AIDXX+FH/CP/ABR/6BHjX/wGuv8ACv0JooA/Pb/hH/ij/wBAjxr/AOA11/hR/wAI/wDFH/oEeNf/AAGuv8K/QmigD89v+Ef+KP8A0CPGv/gNdf4Uf8I/8Uf+gR41/wDAa6/wr9CaKAPz2/4R/wCKP/QI8a/+A11/hR/wj/xR/wCgR41/8Brr/Cv0JooA/Pb/AIR/4o/9Ajxr/wCA11/hR/wj/wAUf+gR41/8Brr/AAr9CaKAPz2/4R/4o/8AQI8a/wDgNdf4Uf8ACP8AxR/6BHjX/wABrr/Cv0JooA/Pb/hH/ij/ANAjxr/4DXX+FH/CP/FH/oEeNf8AwGuv8K/QmigD89v+Ef8Aij/0CPGv/gNdf4Uf8I/8Uf8AoEeNf/Aa6/wr9CaKAPz2/wCEf+KP/QI8a/8AgNdf4VWvdO+ItgAb6z8W2wPQzRXKZ/MV+iVQXtpb31s0F5Ck0LdUcZBoA/OT7T4w/wCe/iD0+/NTft3i3/n613/v5NX1/wCPvhMsqPeeHyxOSzW5/hH+z6/SvFdW02e3LIbd43XgqwIY/h1FMDyn7f4s/wCfvXf+/kv+NRy6v4mh/wBdqGsx/wC9NKP616NtO0KMqw/Wub8UIBZPhGDBx85OcikA34Za/rE3jfTUl1bUHQ+ZlWuXIP7p+2aKzPhb/wAj3pn/AG1/9FPRQBleLP8AkatZ/wCv2b/0M17XpNhJdvDDAskskjAKsa5LH0A9a8U8Wf8AI1az/wBfs3/oZr7r+EXg1NF0qDUr5Fa+njBQY/1Snkf8C96ANL4eeCrfw3ZxzzgSaiy5LEf6sEdB/Wu0oooAKKKKACiiigAooqtf39rYReZeTpEmcZP+FAFmmyyRwpvldUX1Y4FcZrPju2SPy9G23E5OCzjAX3xxmuN1zWReRPJcasJrvzABCoKqi9xinYD1OXX9KiaYPfQAxDLfOP09aybfx7oM4Oy4k4OOUrzHTNNk8QW/2WARCRSWBPV/bNYN9ZXGm3jQ3ULQyg8KT1HtRYR7ifHGhC3843TBc4x5Zz+Vami6zZ6xAJbKTcMZweo/CvnlHn3h8xbTxhj0rb8M6lLp+pQSmQwqJAX2HqPSiwHvlFZug6mNVtXnARQHIAVs8ds+laVIYUUUUAFFFFABRRRQAUUUUAFFFFAFXU76PTrN7mcMY1IBC9eTiqF14k0+3R2MmcDK/wC17CqfxBCnw5KX+6rAnmvOLa5R4Y925DGmFkIzkfSmkI7nTPHlncSmO7VYDuxuJ49qn13xfDZWTPaBJLhXA2t0x615nPfNZu0LW42PyzsnOPWt6LQLa20n+1J7kKjRbomc58xu3y9adgOqj8XXH2JbqXT9sGPvkkBvpVfR/GVxqN5LHHbR7S2F3ttVR7nFcv4evI7y+jivrxYrZuAGJ2/QDtWZ4rP9m67PZQrILNhlGjbBZfrRYD2yK6hdxGJYzLtztU5qevCtN8YTWaW8ECfLG3LOMyH0Ga7OL4giAxi6h8xpTuCpwUHvSsB6FRWXpOsw39vFI8b2zSnCCXA3/wC6e9alIYUUUUAFFFFABXH+N/Ath4lieaNRbamBlJ143H0b1FdhRQB8e+MNCn0e8eKWN4J4yRIrDk+49j1zXAeJYsaeW4O5l5z196+2fHPhC08UWQDqkd7F/qpSP0b1FfKXxT8O3WhySW91BtPmKBgcDmmB5x8Lf+R70z/tr/6Keij4W/8AI96Z/wBtf/RT0UgMrxZ/yNWs/wDX7N/6Ga/SqyfzLS3ZVAUoD9OK/NXxZ/yNWs/9fs3/AKGa/SjTAF021CjAES4/KgCzRRRQAUUUUAJjGfeoL69t7GFpbqZI1AzyeTUOsaraaRbefeyBFJwo7sa8W8Va42o3s84csxbIjyeB6U0gO88XeMpLEiLTJLaQSLuVw2WH4Vw914hbUrc/2m0T8/64N+8X2A6Vyz3KyBWdDG/ZieKjn8tnjIVeepHQUxD2mZpJHj3SfNwx4OO1R3MsrTl3ALvzzxmm3JMMpEb8AfeB4pkbLLKn2reVX7pX0oAvQxXKwLcROYkJwWD4I9cUjyR3EoR5nfy+DM5PT8al1S5t3jitrBXkgiGVZx82T1qhKQ0SZB255A60ATCENKFR9/PbjI7V0i6PaLYRTRanA12w/eWpU7l/HpXNhUVUeORxIM71x+WKs2F7JCMBRtYdzzigD3XwVZJY6NFFblWtyoYHq249QTW/XiGlaxc28dubO5lXEgMo3HDDPAxXtkMglhjkXo6hh+NJjH0UUUgCiiigAooooAKKKKACiiigCjrWmxatp0tnOWVHwcqcEEdK8xvPC2q6eLmSQg2i/u0Kn5j7n2r1yue8bz2cWjst67rk5jCtjLe9NAeYX9w0WnwNeXK3LA7QSRuA9GrL1PXZLhf9LcMLePy4FzwoqrcupuJPKaOYsCTx096Ymjx3dvJLDqdkZ4k3C3YHe/sKYjKHnSz7lkOzqxH8Irt/BcMniS6itJsvDEp8u4PJUDtjvXET3D/ZUihUAtkFU6k+9dZ4c1SXwxPHOyqLUQiRvQueo+tAEep6Pcwa08axRtbKzDzQwHQ9cU3VL2TzoHhMd2LdAp2IFJH9ao6/4ifV7yW6hgit0foFJz71X8NtGusxNdM2AQygDIbPr7UAdX4MvLm/1qG1dnCopl/eZZYwOcj0r1fTNQF0sD2pae0k3ATNwSR3we1ce+taV4dRoWsk+3zL8zA8MD71zuta7cx6hp9xbRtbRKo2ASEjpQB7Ba3UN0rNA4baSpHcGpq4DwbrUmsy38RkC3EsJ2bMDacdeK7DRhdxWEMOpSI92owWX+Iev1qRl+iiigAooooAK82+PWh2uq+Bbi4lQC5tZI3jfv8AfHH0r0muO+Li7vh/qnGSAhx6/OKAPhT4W/8AI96Z/wBtf/RT0UfC3/ke9M/7a/8Aop6KAMrxZ/yNWs/9fs3/AKGa/SbSedKsznOYU5/AV+bPiz/katZ/6/Zv/QzX6R6Gc6Lp5He3j/8AQRQBeooooAKgvbmOztZJ5fuoOnrU9eaeOdZu2uJrUMu2GTiEDnGOGJ796EBX8RpPq+rGeS9t9kIGEEnCd8Vw2vWjSXcksW3evzHDdfpTjcTwQzPEuWc7mLDOap3MV6ZIppWWHzRuUnIXFUIhjT7QYoVQB2PPPWotQRbeRrfByvyt7Gnlc3Mb5IIYHI+7xWjLot1frNqELLNbhsuE5K0AZEcP7hGR8M2coRnHvTGiRQPnORwRV+DTZ5Lp4VSQSDkgj7o9TVeaNLW92l/MKd1OQaAIruNo3BhVwuODnrUsMBNiZjcIsm7HkkfMfemSOwkwXbn1HShsxqSsmGPbGaAJIFQPH5/mbAfn9avXl1bXN0v2e3VY4xhRjkj/AGqqlAyx7CQQPnY96jR2GQHAQnGcc0AejfDDR7TU5rue5jDCBlKgdMnJr1muO+F8dvHocnkypJIXHmbRjHHFdjSYwooopAFFFFABRRRQAUUUUAFFFFADZZFiieRzhEUsT7CvH/HOurrTSNBGRbqu1N38Yz1PpXpfi2Uw+Hrxw5T5cEg4JB4IrwkKss/lvKywsTkZ4A96aEZr20wuXSNRt2buD2qCHdDMGhyrYxyORWnIga5MtrIUjB2gscfnUMkssE+WiSRieW9fpTAqrE7SrPAA0uc+mK6Tx3YW1toGlm18z7JcfMxLEkz4+YA+nTiubCi5uGVj5Wfuseh9q77WNKng03TNJdibeBRdGTHHzDp+lAHERWE0unCQQGMA43t0NXNEt2vIL0xoZbizQEeX0YeldRoOnjVLqW0MmNKiQmV24Kj29apXmp2lo39m+FoTbwox3uTuM3vz/KgAsorjUbgSx2hupGwiJKMlfen+I7f/AInMFlOTDFbQq8itxliOcV2vhVYprOI3Fq1uLJwrTh8eY/UcDtXK+N5pdZ1qQ2wUQx/KJdgGT6Z70AX/AIeabanUp9R0+8WGOEFZEkOCR3P0ruNKuhM7v9qWVp5CiSqRwByPw7V5dobNZstncxKUZxIzquMj0Pt7V0+kWL27eZBDK7Syg+WfuouRggdqAO+tb6Oe6nthuEkJCsW4DH2q5XI39/Pa3l2yNZSTeaqxq4PD44FdRZyma2jdwBJgbwOgbvipGTUUUUAA781yPxYyPAGqsPvKqkfXcK66uT+KwB+H+sBunlDn0+Yc0AfB/wALf+R70z/tr/6Keij4W/8AI96Z/wBtf/RT0UAZXiz/AJGrWf8Ar9m/9DNfpD4dbf4f0xuObaM8f7or83vFn/I1az/1+zf+hmv0d8LZ/wCEZ0nIwfskX/oIoA1KKKKAIrncUCKVBYgEH071iakugRTSteiEyKgBXknb6ACkmu7XVJbtE8+NkhcLKpwrfT3rxq9u54pXSNnfnAkc5YfjTSEej/ZvC4invLCcW+1GUxlSck9CAefyrzO9lFw7hY3xGMu5yOPp2qv9rMl1EzSEspxvJ+6a6u28SaZBp1xb6np0cvmgo0ycu3uaYHFRSgTIrOFgDDLYzit3UNVaeBLWwPl2/Rni+Xf9cVmajZaY6LPotxKCTh0mAXB9qqKslqwMj/MozgfxUAazW2qS+WYhMzzkIkkbYL9sE1VXTEtrqW3vpFt7lSVKt/CfQ11ng3xTbaSsFtfQK8EjhvMzlkP0rpvEngax1pZtU0ty8848wDf8rk989qAPIrX/AEi8WIhnLNsU9z9KfKyWV7JDcQDCnYdw+ZamvrO60jUDb3VvJDImcA8c+oNUZI5JWzK5ZmOcnk5oA9H8J6N4b1zT3jhvZ4ryIfvN5VcD1GeorG1XwjNYMJIL22vLR32h43DEfXFUdFjj0eCSW9gneSZCm2NsFSemfaux+G1j9pZYWkiNvbnzXiK5LE8D8BigDvPDGlppGjW9sAvmBcyMP4jWrRRUjCiiigAooooAKKKKACijnI9KKACiiigDC8amIeHp/tC7oSRv5wcdzXhN/lpysTAW5HyepFe6eOIDceHp1EYkxjI9B3NeCXsMkTA+UyqWIUkdaaEVEeQ8I3yqcgY61LMJElAmLBsZwDTIWEcw8xFlRTkqTjPtU5gMjNdpiJAQQBz+FMCzoMdne69YWdxFN5csq5APOK9v8Y6I1/oxjs3WB41CknP3B2ryrwdHFP4y0tpPmYyZJIxkgHt+Fek/EXVJrW2hs7dwpuM7z3wO1IDy65W6sbOYWrzJbtmNi3/LSmeHrF45R5CNNdEfuFAyPcn6V2knhC41Xw7b3Xm4mb5yucAL6VjwQWZuGkjuJbWztF2qyE7ixGG5HbOaYGyL2WWyh0W2mleWM7XucfunPqWqxolla5/s66nW8Kvu+TkA59RXILq8TQTadbeaqZykgPX61dtryx8JPHdC6ee8cZKg/Iv+9QB6pPpNlEqyNiKGMfMDjFcXbePNOgvHhXTHiRZNqtu689c1yWseN73WYmhupI1iRvMXyPusPeq94ix6bFJNtIf5mUdvSiwHqVn4tsJtSktpLbyVX5zK2CGPtXQpdNI8b5RICCSWP3vQj0r5wOpSm8jKy7VVvlT1Fet+Dry7vtEZLl1QsdsKucNjucUrAd8pDAMpBBGQRS1UtnjtUgtXkZn24ViPvf8A16t0hh361yvxSIHw/wBb3f8APA/jyK6quX+J4z8Ptd5x/ox/mKAPgv4W/wDI96Z/21/9FPRR8Lf+R70z/tr/AOinooAyvFn/ACNWs/8AX7N/6Ga/Rrwg27wpo5xj/RIv/QRX5y+LP+Rq1n/r9m/9DNfov4JyfB+i56/Y4v8A0EUAbVV7/wAr7HIJygiIw299o6+tWK8Z+NOs3M2orpMUm21iQSOqH75Pr9KAO71PUEvbE2eieVPaqpScq2Cg9h3/AAryHWNLVZpnsmZ7ZTjLHBz6VB4C1uXTNfg8qby1nPkne3Cg96m8YreQajcfZ3c2m/JKcqx9c1QjKnhcYjOFB5JphIk2x7uny5NaNo3lojMQ8kgwF7H3FNisXaSRmKhgchWOMGgDOmtJbecJcKQD0A70ydmyit5nPALHkV1t/Bc3NjGJ2imdBwm4DH41L4RtdIupZbTXQVMoIRwfuEdOlAHJCMKPNIzjofeuv+Hfia+0rVI7SV2exmbJjb+HP8S0zxnoEWhLAlkWmtJBuWQHOT6cVh+H5UTWrVrhi0QbGOhB7UAfQer6Pp+sQiPUrWK4UA7Sy8rn0PauU/4Vxp8LLJaTSCVG3LvAIx2FSeGPEN03ijV9H1NstAvmo56AccflXZQSpPCskZDIw4NLYZxd3oXmPPHqGoRtdSkFFVRwAOmK3/DmjR6VE5R2YyADBXGMVduLO0Nwt1JDF5wI/eMOfzqzFKky7onDrnGR60APooopAFFFFABRRRQAUUUYGQe9ABRRRQAUUUUAUNema30W9mRkBjiLfOuRwPSvENWsrmayjuY1Y2jMWRx/e7iveLy3ju7Sa2mGYpUKMPY1l2PhuwtNMtrEIzwwFmXcepPXNNMD59kgJdjsyR1wKRVumt5Tax+fbgjdgZ216P4i8HXW26eztyzMxcMh42f4+1cVHYTm7jsYhI0znAQcAn0piOq+EthHc6/LcXMLSNbRZidxwjZ7e+Ca6f4j2CXN1p8ihmlBO4D+7xzXQ+FNGTQ9IjtgD5r/ALyUk5+YjkZ9BXOfE/UHtLdLO2JF1fDasn9xR1H45pdQMm+8TrPpEuj6OryRoMSzrztTv0rkdT1a1ltbaw06IIkRIkkJ+8TULuthbPaWrtEGGJtvVz3H0rKlkjh0yVnjKtn5Tjr9aYEmq6taQRra2aiKWPiRx8241ixSmaV5rpywAwQf0qkG+95Y+Zvmzjk1JcGKS52W7ThBjmRQOfegCW2mkimdkkVkbjkdq2Zr95XaIEvE2OM859qwIWWCYySxq+zomeG+tPKStbNcvEY0Zh8uSAfp7UAb+m/6Bcy3bRxSrtziVdwU/wCNaPh/W7ye9RhchAmXTn9BXLx3TmLG8qig5QdCKNNnLXgJwFY8AdqAPdfDV/qdxq0Au2kuInHmnHIjyMDNdxE/mJu2leSMHrXiXhLWJdI1CHz5MgMWYk5AU9jXskOqWc9tb3EU6tDcMEjYA8segpMC5XNfEkD/AIQHXsgkfZXyPXiulrnPiON3gLXx/wBOch/8dpDPgb4W/wDI96Z/21/9FPRR8Lf+R70z/tr/AOinooAyvFn/ACNWs/8AX7N/6Ga/RbwOc+D9G/69I/8A0EV+dPiz/katZ/6/Zv8A0M1+ivgfP/CHaNkYItUGPwoA3K8z+KXhGLVLiG7tz5MzAiSXdwcdBivRrt2S2kKHEhUhPr2rjvGNwINOtrqVFNsxxKrE/M/8OPxpoDgPDXhM6XqMF/rU0UcNv++SEgMZcduOlXtMMfivWbzTrUeXazMX94x1qh4k1WK4QRz2cdu+cbo3JJ/A1zmg6lPomtNPYuVUKQT3ORTEddrnw6vdMiN5pdz9rji6ID8yVxyvLbyf6ZL8xPO6rh1+/tvMdZ5W35Jyx5+oqnHdnUyZLlV3MDtOOhFAFhWhZleSWdYmbHJ5I9angWF5WW0uAi54804Jrn4by7gDKVUk8HcM4+lSoPNlDeXJnudpx/KgDt7S3uvs28atanAwUaUdPQZrUey8KXV3byfaGtbuMAyeWu5GP1zXBG0MseNoABycDmolVju+VwD0UA9utAH0AulWokk1bR44p7ueLbvLcP75qPwRDqtvZ3UWrQLCBLmIBs5B6/h0rybQdT12x8tdOa6FqzAhVGUr2TwzqFzeW8kOoRlLyDbvyMZDZwf0pMDWmjEsbI3QjFLEixoqKAAB2GKdRSGFFFFABRRRQAUUUUAFFFFABRRRQAUhOMUtFABRRRQAABQABgDtWdHounx6ib1LdBcdjjgH1A9a0aKAGbWV2YMzbsfKTwv0rg9d02y1TWtSuBPNPc2sR/dbcqvHY5rs9YvRp2l3V2RnyYy341wXw68210bU9YvWZkuJDz2APVj7CmhHn+oWu3yyJF8yQZK+3+Nc1rNzi6WMMTHGMBe1e2jRPCZia8uL+KUH5/3co6+w61554yj0G8O/RjNFL/FuUACmBwoklHCsp3cAYxzRJG8UxikcJJkblPNOktnTbnc5B4OPvGnTLK2oCS4hYu2A6sCCaQDBHs/eJlh33Gllv5LhRGXzFH8qoP6Uy5KiVldG2dkB6VNHOogQQ2yo7fK0pOcD6UATQxCODac75Dyp6gVt6XpKwwefIHM0jBIjj5FJ9axxc/ZbaSKGLzHmAHmk8j6Vb0m0ubwNCb3y7gHcIi3DGmBd8trPUntGu45ZGXlkbIB716Z8PbiLT7CKK7XIklHzHlVPY57V5toHh65vdWCNsRg2SSO/vXa+IoriGKG1hUrtYblQYBPrQB6+CCMg5B71g/EAbvA2vD/pyl/9BNaulqy6ZaB87hEuc/Ss3x0u7wXroyR/oUp4/wBw1Iz8/wD4W/8AI96Z/wBtf/RT0UfC3/ke9M/7a/8Aop6KAMrxZ/yNWs/9fs3/AKGa/RTwLz4P0jPX7OtfnX4s/wCRq1n/AK/Zv/QzX6H/AA9dX8GaVsYMFi259CCRigDR1K8a2urYFVMBJLkqSR9K5PWbiTUpLyyL28sMamVV8s/KQMj8a7DVrme2tg1vCJSW2sCcYB71Q1m4sdJsp726hMjwpyEXlsjpTEeKWo36ibnW7W5VGX5McAnNXtYg0l9LSWJhDOD8yH749MUniDxJca1GFaMW8Lrtjh2DKj61z1mYHlH2ublQVORmmBbXC5WeEyROuGdBlsVSngWG3zbqrhcnk9R2rZ0HxRp2hxzQy2El3yRvLfw/QisjU2sZpWmsRNErknyi+evpQBgxSO90DKfl3Zb2rdbxJqr23kRXaiFOApiXOPyzWY1uyEDZnI+bFTJbK12pT+Icbu1AFq11K/tJ0kif96TuDOg5/DFdXpfjzVlnMdzFazBcZ/cIMfkK586bd3V1BC2SFGweoFdhoHw8vryYXFxNHDAOAQcsaAPQvCuvWOr26qiRRTjgoABk+oroQAGLADJ6nHWuW8PeCbLRbpbiO6upnU5xIRjP4CuqqRhRSd+nFLQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFc94t8U2nh23/AHgaa7dcxwJ1PufQUAY/xN1mKO1i0WN/9Ju2UMo5wma4bxpf3tvANEkmNvBaALtQECbjPOPrVLw3c6v4h8bjU4rZbyeJi7LJny4we34dqj8dT3VxrV7LMiiR2+VQeOABxVCOc060mubh0som+RdzAtgfhmoBKS7nID5+6RSTSTywquQrx9ADge/NQwMSSHU7h0PrQBde8a3tgsUJediS8h+6B22jtWfPfSCWGWTzJJc5znmrcMLyERh9rsMgdj+NRTRq/krHxg8gD7x+vYUADyoxd3j+bGV9D61FbeWZkdo8452P0+lPnYMFGNsqnDseh9ABUTgWshaOTzWHzZI4HtQA+co8zScgngL2FLBbjzzJOnnc9Q5HH1FVHlknk2sy7m5GO9WV/dzLF5hztywHRaAPQtJ8T/8ACPW0E81rGyyArFJuzj60tn4tu5dQVrlFmtJGyygDOfY4rmtJTTLmwuI9TuJtsRHlgYwvrjitzw1pJm1eAQqZ7ZpAyeXyQvv70Ae1eHZLibRreS7GJGyQMdFydo/LFReL1RvCmsiUMU+xzbgpwSNh6GtWMbY1UAgAADNZniwA+FtYB6fY5v8A0A1Iz8+Phb/yPemf9tf/AEU9FHwt/wCR70z/ALa/+inooAyvFn/I1az/ANfs3/oZr9D/AIfPv8Iaf14Vl/JjX54eLP8AkatZ/wCv2b/0M1+hnw5Up4QslPUFx1z/ABmgDeu38qMyMflHauauNRm1bQJ5Ut5GY5SSKAZcelReP9XewtyiKzDbubBxx0ry5fEmqabKbnTXbzP7hPy/iO9NIQ/xDbSPtZIrhIYwFBlXGW7iufaz23JUq2QMncO/tXS3WuXGpQCTUNqyn5nVRhQfXHrWZfXJCpJOMFkJKjG4D60wOeEUyXj/AGoN5Lc9OvvUkjbZ1EcZEXYc/nWraP8Aa4fmcKjjA8w54p1pZQylw2pW0aj+F25NAGUy4dg7kvjKe4ptnfXtjdLcWbJkgoTJGGAz9atTmG3U+WTLKrn5j0Ipi3aSwFHVtjHJA6ZoAgl1G9SXzRMS5PLDjFdDpvijV7W3VUvJl3jGVc9fXrWCYY5oyEcAjkhuKLOUW+RHyVBzkUAddP4m1u2khV9UunJUMSshxXsfhO5mvfDtjc3MnmSyx7i34187eYsyK247j1JHSvWPh54strfRYrHU98HkDakhU4K0mB6PRXP2ni3Sbm+Fsk5UscI7DCsfSugpDCiiuB8c+NL7QNSFpbWkDKyZV5Ccn6YoA76ivHLf4o6omVktLeVj0LZX+VXbT4pXLTbLmwtwv+w5zTsB6tRXLeG/Gum63M0ALW1wOAsnAY+xrqaQBRRWfqms2Glui31wsTMNwBBORQBoUVyLfELQVuTGbh/KA/1uw4z6Y61f03xhoWo3Ytra/jMzHCKwK7/pmgDfooooAKKKKACvLPFXgzVtb8UXc8Q2wMRtkeTgLgcAV6nRQBjeHtGtfDekJb26BmHMkgX5nPvXM+PJvD11b/Y3u7K2vd27zGTJQd+nf6139eG/FfSXs/EXmISIbhfMz6deP0poDmtT06O3Qvb39tqETcHyVxt+uaxJCwj2OSJM8lRjApYWa3myrHcMkDHWmXN200hd5NxbggJimIrvJJkIr/KO1OjmnjXZjCtwSe/09qWIhMsV/dt3Jp0OHmUkM8IHQHFICMqCQijcMgbj604xuWaNWTCHkZ60t2lvujkt3dQOqMaZbwzTOZoox5YY7n9KAJJo4IkV4H3FuoIxgjtVy0czxfZ/KALc7ieR+NV47OJoGZ7q33HoAe9aGnPooeOLU7q+jHRmiUEUwIPIjkLxq+0Djf71678KY5LKzVFQSl225xyvv9K83N5omk6k0FjHPfR7hteddv8AKvTvCPiW1gvLS2e1SBrr5SVb7vHGaAO5azkk1JLmW4by4xhIkyBk9z61H4mx/wAI3quen2SX/wBANaVZ3iMZ8PamPW1l/wDQTUjPz0+Fv/I96Z/21/8ART0UfC3/AJHvTP8Atr/6KeigDK8Wf8jVrP8A1+zf+hmv0I+Gef8AhDrTII+eX/0Y1fnv4s/5GrWf+v2b/wBDNfoH8Km3eDLfPUTTA/8AfxqAKHxBZRO6yHrGMbu30rj7jStLbSQbO/LX6keZFNhQ3+7616B4o0+3vdZiS+kYQSRHaAcEsATxXlJZEnaOaPMgfaJTjAH+NUhCOwFowIzMvBVuOKzEhyRI54LbQT0Ga6rUorMaVEzuq3aH5x3KnoaxY4DKfs9sjyW7MAVYZ+bsaAMeV/JZQQAyuQT7VRdyrmRF3r13VvXWhXX2hopA5dBkqw4IrNuXGlSL5Xyk/JIuPXtQBRjLCOSWRcxHpjqDU4nknhRIokMag8hcfnVfzw8hMEWMnBBFOljkEpcBt/XAFADUOGAETZzgmnTQzRkuAwU8jd3+lSKhcA7WDd+K1Y7WM2Ya6uMYHyLjOaAKUDgxFSEJZQNvfNXYdQvdosrmVzC543/wfSotL06JpjPJJkAnHOMe9X7fRDcyyrFcBiOfMYcH6UARQyyhHiWQMiHjnlq6/wALeOL7S0jt79FuLLcFDZ+aMeg9am8FeC4biV5bucM207UHr6muS1zSrrRtTmsro4US5Vj91l9aAPftO1C11G3SaznSVGGeDyPqO1effGTSbq5isb61jeRIsxOEXcRnofpXnVncT2Uztb3BSQHKlGxjBr0rwv8AESKZTHrJCvkBXjGfzFKwHkUlvKhKlWBXueKdGkhkztJkByQK95ln8I35aScaZI/U+Yi7j+fWpbHS/CrTpdWVtpZlX5ldNuRRcDzfwl4R1PVTFclDa227KzMcE+uB1Ne1KNqhck4GMmhWDqGUhlPQg5BpaQwrxb4nRX0PiWWSdZBbSYMLtyvAHSvaajuIIriMx3ESSxnqrrkUAfL0iMW9mPOO9NG9ZCoXIHevcde+HWl36vJYFrK5Y53AllP/AAE9K4rV/h5rNlJtsYheRnrKrAYH+6TmquIx/C3iy/0C9zE/mWr43wtyG/wNe2+G9ai1zT1uY0Mb9GjJyR/9avn280S+tJ1idJBOT9wg5rv/AANoGupd28jTS2dvGAXLnlx6AUmB6zRRRSGFFFFABWR4ltdLlshPrEKSxQHcoYZycdPetevO/jZO8Xh60VJChefqPYUAeSarHEby6e3liSPeTGoOCBnpWVGkaPi53IxHSMdRSdCHc7hnPHcVHLukZ3jBI7c9KoRJLJbQybSjuy8qrjGarXF/EApa1ZPMY4CgkA4zk+lAWadcsm5oxkn0FVzL5hH3snpjvSAvQ3QSONo22lj0Izg1DdXbXMpSWQgr/dG0GpbIQ3LJarGxkdvlK9SadrOnS6dfGCfBcqDgds9jQBVaAxQwybgoI4zzUbKkqNLPKFCfcA/iNPKtHGQUw3Ur6UkHEwdz8q8r7GgDb0NbdI1m1MPlvnh28cCtT7WZL6GeFjkN8oXtWQkxvp1MsQmIHygHH8qs2Lul08v2NlReNmTmmB7n4D1ufU2uIbmXzNgDKW+8RXQ68M6HqIwDm3k4P+6a89+FV5uvJBsEcTrsQE5PXNei6uM6Tej/AKYP/wCgml1Gfnd8Lf8Ake9M/wC2v/op6KPhb/yPemf9tf8A0U9FIDK8Wf8AI1az/wBfs3/oZr9APhPn/hDYsgg/aJ/x/eNX5/8Aiz/katZ/6/Zv/QzX398JCf8AhDlz2up//RhoA2PFFibi2iuI5zDJbkkEDOcjGP1rm4PBsZtYjPLvLuJGJGNq9xXfMqsMMAR6EVx/xLvZNN0QSWztFJIfLJHTGKaEcZr+o2TTzKAjyR/IpHYD+dcufEt5Gjs8cflbsqygA/lWPcyzpIt5E6+W2Qw7j3rFkvnM8gEpYdfm6UwN2/12dnEjSMBnIw3JqvNqrSbnuIomjYfeK96yvmlQjbgEgjjrVxrBmgEs6rHCvDc9TQAw3Zkk3QIoXvVhbuUqrKVDKeR3NZ4RfLJhbIz8p9KnSFkjUMmGI3H3pAWxdSv87fKP9mo3vJJDGgAGOQw6mmPLH5e7BXttpYoHaIER/Iec9CR7UwJ4b9mcI6hgvdjg1fbW3Z4I4Y1WMfe2n7/1rDZCGB25fPbtUy26B2KkJg4Kk8/hQB1PhrxHNpuuxSo5YM2Cu7gCux+J89lrdnYPCokuVGflfGBXmBeNR5xRI5AQAB1NW7W4+0rNsfG05wT09qALKWsNzKkFtExuAM7i2BxUMdx9nkkMW1yRtYFelNZro/v7eM/LwWXtTnjaOJZmQoWP3W4Le9AE6rDtE77zjh1B5X0rc03U3sbbfpdsHVl2SeYN3PtXPxOoy6AhgRx65rfsL29jt5BDmCEfeAXINAHY+AdXne4Ky3AW3c4MUh6Mf7vpzXoteWeFNTaGDyYQEldtzyMmc+n0r1GMkxIWOSVGTjFJjHUUUUgCiiigA7570UUUAFFRXSu1tKsJxIVIXnHOK5jQNXe1vU0zUXdX28NIuFz/ALxoA6yisq/8QaZp+oQ2V7ciG4mICBlIBz79K1aACvJ/jVdtPb28UILwxkklRkE969H13WbLRLGS5vpVVVBITPzN7AV4J4n8Ty6zcPJIgjjkOY0U4wO1NCOYYiKJXRlxIOQOo+tRphIgU2spPQ9jUl5avDMpJUBxlQT1qOWH5R5ZAPdTTAmfUbqLzYkl2qRt+6DuGKzIuJw8uGUdVxirBj3HAZRIDhgTUZj3szKCzHjr0pAdN4Phii1C51GUiO2s4zJGxGQ0g6LXOTXx1PVZrqdiTK5IHp9Ku3OpSJoUejJGv2YyiWTaefM6c1n2dois3kyZYc4JGBQBYldihjVVJPBJHzfnTPszvZSsqKYkwGY9RUFyjkfNHtBGd+epq1JM0kFqDGUjiOSoOd31oA6/w3ZHTNH+2WVpHf3HQqRuMf8AtVTuZp3haYtskJO4entWBHfXVrfPLZySRrIORniumfWkurKzjuIlWZGy7BcB+eOKYHZ/CfTJTcpcEbGjXLk9Wr1HVf8AkGXn/XF/5GuX+HUMM1vcahAX/eOYyp6DHPFdVqP/ACD7rJwPKb+VJjPzr+Fv/I96Z/21/wDRT0UfC3/ke9M/7a/+inopAZXiz/katZ/6/Zv/AEM19+fCIg+DxgY/0qb/ANCr4D8Wf8jVrP8A1+zf+hmvvn4Ptnwk4yDi6l6fWgDuK4D4vxTy6XZiAbh5nK4z26139Yfi+283R5JUDb4TvGwZJoQHzRd3UsN3IjMoJIBBXim3VmsTDaoYkb1x0rf1+wtory4YGScMQV3rj61ilCNzJ8qg457CqEVTvWEtJ36beMVaiWaW2S2CvJubcNxzzVQhQ2WYvu6kdqmt7qe0niuYWIdH3ICOM0gK/lPGScBdp6epq200hMYf5t3B9KNWuXv7hpWjCs/JCdM/hUNvA+cspAC5xnrQBbntGicxuBv4PJ7VpatOZ4bBI4o08qMRfIfvH1PvVLzmRGEmOn3n5I/Gq8LmXDFyPm6CmBbt/LhAdoPMIPAJxRNLHKh8q3zI7c4NVpXdY/lkyCcfN1p4BA3RuUlHoeM0AS+X58xyMFQO2afbNFFM58suG6gcVPavbbk2TFW2kuG9faq0eZH3CQjscjrQBaG+HMcbsNwyRnginL5jYLZZFHy7znFOjjhlJ8yYrJj5cdDSAFXAUghfvEGgAiuC86BEViSATt4r0L/hIrVdKhs2sYpGUYlaNe3vXCJISAzShXbgAKOKuW08lvIkKsGib7+R1oA3dBnEmolbTebZ24B+8DXs0YIjQHJIAHNeefDbTfMlkupIgIl5U46tXotJgFFFFIYUUUUAFFFFABXIeLNIe7uGmS5i+TaVgP3izHH/AOquvrgvEuqWuma3LdTLvuAyLs3YAUEHNNAdEdAtr3TrWDWIxdSQY2yP978TW0oCqABgDgCuJuviXoUDsuZWZewWrXhzx3pmtXhtQr20zH92H53/AOFAHnnxVt72PxQ8s0Lm2lICsclSuMYrgp7S5MwjgjkeNQcDGSB/9avf/G/iK10t47O5hjkLoXzIuQOccV5xfajp2oa7FBcSDT/MXCzJ8qHjofrTEcZYWBuEkzOhdVyPmziqckHDhiQ/b0P41q+IRaWE8tvYxMkYOGfHJ+ntWcFeXZFMxWEDdhun4e9AFWQtNAiyFVaPoR60+E+RHKrxHzHwFbOKZIYZZWXa0cXbP3q1b5rU6ba/O0zvksz8GPHpigDFVZRMqRx5JPORkk13nhn4dX2ozrJqVvJbWJUsZgwXj+f6VyVnfSWT/abQqzA4A64HrXp+g/FqyubMafrts1uzR+X5yNkNxjpgYpAec+LmsotQaz08lobf92pJyXx3NY2HcCN28sDuvU1u+IbFYLt7u0fz7eRsqwXkD3FU0t555BMFwH6cZzTAfBbSeXBH9nJj/wCezcD866PRNLj1WYRwpvdWC4Tkr749KzoIZrVTAZWZSNwB5AP0r0j4R6EVxqbpJEwBUsOBIf8ACgDvfDelLo2lraqxb5ixJ9TWhdjdaTD1Qj9KlqO5XfbyqCVJQjI6jipGfnP8Lf8Ake9M/wC2v/op6KPhb/yPemf9tf8A0U9FAGV4s/5GrWf+v2b/ANDNfe3wc/5FaXpn7S5r4J8Wf8jVrP8A1+zf+hmvvT4Ntu8MzeonP8hTA72kdQ6MrfdYYNLRSA8k8T+G10+K5k37ooicFuSN3Iryq8bBYEEjOPavpDxZpbXVlNLAwjYIWYnnOBxxXgradPLePAjJJIWLnIC/hVCMW4ki2oI4jg/ex3PtVyO4W8jS0kRImQ5Dnr9Kq3WYlJ2YdDg98VDaP5shL7S5HpigDY07Qbpi8sE0Dggkor5LVE9rOpAlgkhI6tjrTrb7RCpfcVKkYMXBro449Sg0m6nuoi0N0mxDPyVH95fQ0AcqYHEa4+aIgneev4iohD5sTbG+7zwOlWd687G3ITtIz1zUasYmHkrsYcYFAEcYLQNNgnBx070sTqu52fPH6+lLul3Mqqm1juP1pjmJF8wcspyyjpQBrWOjzXUUt0yqlpGRuckZB7Cku/IQqY1KYGQx6E+9VXu3ktm2Mygkbh2rQDQCwC+UJDjJfd2oApkCW0EiKS3cDpVjToctxjaRhj2/CpNNxcTRR28RcgYIJwPzrtLHwhfi1M7RJDAuZMFxzQBxCbSu0AAKcAn1rS0q3eS5AEgdycDJ71Wl3K8rfLtXJ6fer0H4baVHd3P22SLAhA+UjIYkcflQB3+h2ZsNJtrZlVXRBvC9M96vUUVIwooooAKKKKACiiqOsapaaRZNdX0gSMcAd2PoKAK/ijVo9G0ea5d9shBSP/eI4r5/1q7uL/UDJPL5xc5JBzmuk8X+K5NfTEibLWOTciZ6D39a5FnXKmcgIAcFeKpCIUiLzOfm4k4TsRXVfDiI/wDCZWG+ZSDuJBxxjtXJmchwYs7vrT9Cu5rXVEvYyAYpA6++DyKAPRPjdFMuqWk6o3leRt344zuPFeeW08ckaw3oxs5jk6lK7b4keKbfxDp1lDAXjccsmeCa8+maa3CgwFm6blHagDVuk+3GPeoZQMCbcBkfSpdJ021knuUvrjFtHGdspHR8cDFY05B2rC5STqATxmm/bpUjZLjJdiCHHJFAFVllkM0WVIBxvI5I9vSh1lkjijVCABWs0VvJysG95FG6bcd35Ui25+ZoHGwHgtwR+FAGbFGHlKxgoVGHxUMUG+N5LhVUIfv9h7V1lhpqzWd1PdbFQKBgONznP6Vz95cRSKkQGIkcAR46j39aANfwrqSWWpLPehZrAKA8ajLOPQCtDWtXsZNXj/siEwQP84RhhRXLzI0cRncYR8hFTipNIia7VQ4zg8hudtAHdeFtImvtZtWmIlSaQlgP4Vr2+3t4raBIbdBHEnRV6CuF+FFoPsU906EMDsQ9sd/6V39JjCkf7rfSloPSkB+cfwt/5HvTP+2v/op6KPhb/wAj3pn/AG1/9FPRQBleLP8AkatZ/wCv2b/0M194fBbI8NzjOf3wP0yor4P8Wf8AI1az/wBfs3/oZr7s+CbBtCvAM5EqZ/74FMD0WiiikBFdQi4tZYWxiRCv0yK+efEumT6dqMkU3mPJGxwrDgDsa+i653xh4ah16zYKVhucY8zHJHoaaA+d0HmRyEoIweuepNNs7fz3EUMbSyMcKFGcVuajpzaZdeTcASvGfm29CKs+EIbmTVohpyiJ3kJB747imI7HR/Duj+FtGS712VZLp18xIwc4Pbp1rhPEXiB9XvHl2mKJeI1B4x9K2/iRMl5qSyW5WSGFdoyckVxdzDHvim3MTjAVcHFAEMUbsWYvgZyMCp7VJi6uCDhjnIzxVuMtHB8sSnj+Kui8IWE9zZX0KwbRIm45/hxzxQBzlhbC7u4LSE5uJm2KB0JJpt5YJp2oz2VzbzxXCnDK54PvU2jXjWGrW97b26mSzfdhm5fBrY8X6vB4h1f7XPAYCYlGBz096AMu109Z7Vmil6nAQdSKY0cccpt4xIoUfNu6k11PgDR7a/1mCRpiLeH52VhjJHb/AOvWDrt1Amv3JiQkGZwox2z0oA3rG+0w+GYrYK6XsU6zGRR94DtUniHWbq8uYo4Z5DGE3eX/AA9K5WHzPnMYyW46cD8Ku20ym4PDkIoBKnFAEU0Zl8nyVYM/y8DOK958K6YukaHbWqtubbvdvVjya8z8CaUupa3EwH7iAb3V+civYhgAAdKTAKKKKQwooooAKKKKAI7meK2gknuHWOGNdzM3QCvEvFmuT6xqE/ny/uVOLdF+5j1+tew+ICF0O/LIJB5LZU9+K+fdXUCXcrbYzzjP3KaEUZpBErowRmTtnkiq1vJJLJ5ckfyLycUsjQ5c8u+M5FS6aX8qaVF3BeMnuaYDL1zBGjx4EjnGD2FQmF57U7yDzltpxVe5LXD9A2ew6Zq35vkafBbxQsZCPmJH8vagAEc1yqyJhktxzxS2s00e/wC7hhn5uat2lzjTrmBAyCQYfZ3x610/hnwza6j4G1XVbuQrJCriI5AxgZ5oA4k38MqL9qiVSGIDKAKr3qrEYsPkMOPcVlFPnjQSbwwBzVk/aAm0sHhLYOTyDSAs288sbs/zGNP7h5P0rUt43uQ9xHbeZCg2MCOnv9av6z4XuNF0S01AzJc2dwMhh1U+mKytHN0be4kVisTclD3pgUrqYx3zR+RFECB8wPOKkjeBZ2MTSSsWGFYdalaWGdjHcQlZSQAcg8VPcWK6eytDLHKX5PHSgC3FpIZTOkkewjmJWBwa6bw34TvruSNNgWOT5iTwW96zvC9pAlreTXy5ZVyir1kyOv4V614HtXlsbO+mlmykPlIjnjGetAG/o2nQ6Vp0VpbrhEHPOcnvV2iipGB+uKKKKAPzj+Fv/I96Z/21/wDRT0UfC3/ke9M/7a/+inooAyvFn/I1az/1+zf+hmvuj4Ik/wBi3oyOJI+PT92K+F/Fn/I1az/1+zf+hmvun4JEf2NfD0eLj/tmKAPSKKKPSgAopAckjBGO/rS0Acd408MLeq19YxBrgDEkY48wf41yPgfQ5XuZL7aIhFuUKXAK9RXr9c/rPh9Li4N1aKqS4IdBwJP/AK9O4jxfXbC70/UJLXzRIrZw2AciqthY+bJJAhHmKu5UIyWPeu1bTBqcM9qsFylxavtWIpyB7U/wlovlag2o6i5tHgOIEPG/HXOaYHM6ToN7fRb5gILf7pkccCux8FXMEMWozMPNdY/J+XGMDjNP8Va0dTsvNgjKvbtzEOhPrmvPdOumnmlkm3xvu5VTwRQBFe28AupDDlSMnPvnpVbzPMgjy3yk4Ld6m1eab+1YDbDKEbV46irUNnKt4mYwkR55XIzQBraPLPYI+JMKEwpJ5I9azL3T7x5Xngjd4wQxcLkLnrk12VpYTalo8ksYjkmjHQLt+SodKmltGl0xwGiuFw5x09MfnQBxCMI5pdkgbcPlz3NaGlW3nTbZVbeeyjk1uad4Za5uZojZsxQ5Vwvauo8KeFJ7fWBqF4rRxR8JE/JJ9RQBveC9BTR9PEj5a5nAZiRjaOy10VFFSMKKKKACiiigAooooA5/xvcyQaNtTO2Vtj49K8U12EIscUGG3/O2Owr3LxdCkvh+7Lkjy13gj1FeCXVzm79XwVPHBpoRlRRGC5TahkU9R3xWy+ppBbmytLcQRMMyKedzeuahBUK7BDHJj5XPas8G5k3KRHJgct6UwGx2oa5CxRmRic4BpJbOaO9nlRyu3kA84rrfhzZSXHii3fyi9tHG5nYDgYU4/Wue1e7S41W+aKTYCWCovTOaAMr7UQ2C37xvvbRjNdFpHiMRaBqGjvIFhmQkDtmsFBaCMi6VklOAGAyaiaxS2EiqW2sOCeM0AUILZ4XMuwOE4O0cYqwgVj5TRIVc8ccgetXZL37NaPEluCGxj5qrWlwWuogrKJS2RleMUgNrVblreGK2W6lks0UbIj0Vsc1lpdyvc25uXxCrY2DstNvrmWG4dN0ZyQCrLnFDOGyoj3KDy4HQUwLN5ZSRTPIkRCsQY1fg12EcA1fTYNhG62QM+QFAb2Pf6VUtRN/ZkFzKn2vYNgBGSM12/hbw81/4chtZVeMPcGVpo/4Rj7hoAb4U8MPc3HnyxbYiVLPu447Ad816ciLGgRFCovAA4AqGxtY7KzitoBiONdoqepYwooH5Ud6ACmTbvKfZndjjFPoJA5JwKAPzj+Fv/I96Z/21/wDRT0UfC3/ke9M/7a/+inooAyvFn/I1az/1+zf+hmvuP4Ftu0rUhknDwnn/AK5ivhzxZ/yNWs/9fs3/AKGa+2/gVI39jaqQQp3w4J6fcoA9WpOc9OPWoIbmNnERkDS4yan75oAXnPFQTXMVu0azyBWc4XIPJqemuqEhnVSR0J7UAOopu4ZXGTnoRTqAIzBGZRLsAkH8QGCfrWDr2mPO4vIoDM3QwNj8xXQ5GcZGcZxSg56UAcNcWDQ27GPTWjmB3P5oBDL6DBNc9Z+CL6W/hu40WKOUnfE2RgV6VqGm/a3VlneLDbiByDVu1h+z26Rby+0Y3HrTuI851v4fs11BJp80fmIAoVifl/TpWrJ4babSIo53H2m2ONqcjmr/AIki1bz0TR42ChcmTIyTnpyavHSZp4lae4ZZyBvKn86AOPnkWCOZVZoNqmIPGMhiOcH0rG8LJMt2LyS4aZySBsXfu59q7rT/AAlFa3U7vdPcQSHd5cgzg1v2lja2ShbS3iiA6bFxRcCaAloYyRglQSMY7U+iikMKKKKACiiigAooooAKKKKAGyoJYnjb7rAg14Pr2j31rrM8DQqnl5/et8odfUZ6171WX4g0W21uz8i5BDrzG46qf8PammB85ajGoILPkg9FOc1DBEk0hiCtGhbHmbu/uK7jxP4VudHYkW0bRkj98v3Dn+Rrnf7PuYJQyxLjG4qf4/pTEXrW4bw/PHFbTuikjzpAThwe1Z2uWsq6rNdWUEfkM26PjqPU1anjk1G+2m3dMrtxt6U7xFHdRWUUwtJVjt4xGzEEZx3oAwGlkkic3Nunnr90KOT9at+HYZb2K5nvoHKRqTHvHy59Kz0vYmk3OSWHRsdq2rfU4ZdJMF1cbULkptXH8qAMO4hlM7okcZQHLAHn8KZFDGNVhXYFwAwP9DXQaRc6UZ7me9DmOFMKFOCx7HOKxrieLUZ/Mt7dlOdoAPJ96ALet2Vrd6x59vDLEXAH7tSQDitXTdEnWN0gSW5L8HCfc/KrdvpAt7FIrNrh71fmlLNuX6DFek/DazngtpZZbd4w/V36sfSgDO8F+GtUiRGutsNuP4ZE+Zh9O1eiQxRwRiOFAiDsBT6KkYUUUUAFFFJnr7UAKKjuFRoHEjBUxyScYqSqmrSww6bcyXTrHbohaR26KoHJNAH53fC3/ke9M/7a/wDop6KPhb/yPemf9tf/AEU9FAGV4s/5GrWf+v2b/wBDNfbHwBw2lakSRgNEP/Ha+J/Fn/I1az/1+zf+hmvsX4BG4ks9REJj2Axk7/6UAe1KqZ3BV3dM45pec8gfnVdbnYzLPgMo3ZHTFOjuY5FBD7c9A3GaAJ6CAaPxoHPSgAAooooATapIbAyOhpaRVC5x3OaWgAooooABnJ44+tFFFADI4xGzbeFJzj3pzAnGDjnnjrS55xzRQAUUUUAFFGMke1FABRRRQAUUUUAHXpRTdu1cRgDnvTqACiiigBrosilZFVlPZhkVzl74RtJr0XEMhi7+WV3DPt6V0tFAHmup6FqlkZHgtTJ1y8ZBwPWuQS+vkmNreRzyRMx4uB8jD3r3mqep6ZZ6pbmC/t0mjPY5B/Mc07isfOd/o7XV2ZLdbUQO20IpOAfarKaYiu6NbYMShWQfdJr2m38C+H7aTfb2Rj53YEjEA/iasWfhPSbS4aZIXZ2JY73JBz7UXA8SXSZLi2uDJbqkR4XBwKt+HfBzXYUw20xYcKwBCj8a9yGk2HkND9lj8puStWreGO2hWKBAka9FHai4WOa8F+E4fD0DNuaSeUDcG5211IGBgcCm7x5mzBJxknHAp1IYUUUGgAopCMA7evvSHdgYxnvkUAOopq7wPn2k+1RzSvHIqrC7qerLjigBs1z5Lnev7sdwefyr52/aU+LN3pMUfh/w7dCGW6jb7Y5QGSNc42YOcbh39K9K+N/ji08HeCruYXUUGszRkWUUgyzv9B2r4K1S+udSv57y+uJLi5mYtJLI2WY+5oA6D4W/8j3pn/bX/wBFPRR8Lf8Ake9M/wC2v/op6KAMrxZ/yNWs/wDX7N/6Ga9N8CfGs+E1uCuhPcyyAAML4xhce3lnNdXrngHw1NrWoSSabl3uJGY+fLySx/2qo/8ACvfDH/QM/wDJiX/4qgDZb9qcuuJPB+4FcH/iZ9f/ACDSL+1FCiBR4LJx0LarnH/kGsf/AIV74Y/6Bn/kxL/8VR/wr3wx/wBAz/yYl/8AiqAOiX9q8AY/4QvP/cV/+00o/axAGB4KAHtqv/2muc/4V74Y/wCgZ/5MS/8AxVH/AAr3wx/0DP8AyYl/+KoA6T/hrL/qS/8Ayq//AGmj/hrL/qS//Kr/APaa5v8A4V74Y/6Bn/kxL/8AFUf8K98Mf9Az/wAmJf8A4qgDpP8AhrL/AKkv/wAqv/2mj/hrL/qS/wDyq/8A2mub/wCFe+GP+gZ/5MS//FUf8K98Mf8AQM/8mJf/AIqgDpP+Gsv+pL/8qv8A9po/4ay/6kv/AMqv/wBprm/+Fe+GP+gZ/wCTEv8A8VR/wr3wx/0DP/JiX/4qgDpP+Gsv+pL/APKr/wDaaP8AhrL/AKkv/wAqv/2mub/4V74Y/wCgZ/5MS/8AxVH/AAr3wx/0DP8AyYl/+KoA6T/hrL/qS/8Ayq//AGmj/hrL/qS//Kr/APaa5v8A4V74Y/6Bn/kxL/8AFUf8K98Mf9Az/wAmJf8A4qgDpP8AhrL/AKkv/wAqv/2mj/hrL/qS/wDyq/8A2mub/wCFe+GP+gZ/5MS//FUf8K98Mf8AQM/8mJf/AIqgDpP+Gsv+pL/8qv8A9po/4ay/6kv/AMqv/wBprm/+Fe+GP+gZ/wCTEv8A8VR/wr3wx/0DP/JiX/4qgDpP+Gsv+pL/APKr/wDaaP8AhrL/AKkv/wAqv/2mub/4V74Y/wCgZ/5MS/8AxVH/AAr3wx/0DP8AyYl/+KoA6T/hrL/qS/8Ayq//AGmj/hrL/qS//Kr/APaa5v8A4V74Y/6Bn/kxL/8AFUf8K98Mf9Az/wAmJf8A4qgDpP8AhrL/AKkv/wAqv/2mj/hrL/qS/wDyq/8A2mub/wCFe+GP+gZ/5MS//FUf8K98Mf8AQM/8mJf/AIqgDpP+Gsv+pL/8qv8A9po/4ay/6kv/AMqv/wBprm/+Fe+GP+gZ/wCTEv8A8VR/wr3wx/0DP/JiX/4qgDpP+Gsv+pL/APKr/wDaaP8AhrL/AKkv/wAqv/2mub/4V74Y/wCgZ/5MS/8AxVH/AAr3wx/0DP8AyYl/+KoA6T/hrL/qS/8Ayq//AGmj/hrL/qS//Kr/APaa5v8A4V74Y/6Bn/kxL/8AFUf8K98Mf9Az/wAmJf8A4qgDpP8AhrL/AKkv/wAqv/2mj/hrL/qS/wDyq/8A2mub/wCFe+GP+gZ/5MS//FUf8K98Mf8AQM/8mJf/AIqgDpP+Gsv+pL/8qv8A9po/4ay/6kv/AMqv/wBprm/+Fe+GP+gZ/wCTEv8A8VR/wr3wx/0DP/JiX/4qgDpP+Gsv+pL/APKr/wDaaP8AhrL/AKkv/wAqv/2mub/4V74Y/wCgZ/5MS/8AxVH/AAr3wx/0DP8AyYl/+KoA6T/hrL/qS/8Ayq//AGmk/wCGsRnP/CF8/wDYV/8AtNc5/wAK98Mf9Az/AMmJf/iqP+Fe+GP+gZ/5MS//ABVAHRn9rHIwPBhHuNV/+01Ev7Vrj/mUWYe+qD/4zWD/AMK98Mf9Az/yYl/+Ko/4V74Y/wCgZ/5MS/8AxVAHRP8AtXq4w3grI6/8hX/7TVaX9qq4ZsxeF3jXP3RqKn+cNY3/AAr3wx/0DP8AyYl/+Ko/4V74Y/6Bn/kxL/8AFUAeQ+OfFup+M/EFzqusTySyOxESMQRFHk7UGABwOM45xXPV7/8A8K98Mf8AQM/8mJf/AIqj/hXvhj/oGf8AkxL/APFUAeVfC3/ke9M/7a/+inor3DwZ4G8O2viWzmt9O2SrvwfPkOMow7tRQB//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Idiopathic pulmonary fibrosis/usual interstitial pneumonia with bilateral, small subpleural honeycomb cysts which are separated by normal parenchyma. The anterior segmental bronchus of the left upper lobe is slightly dilated, consistent with mild traction bronchiectasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26560=[""].join("\n");
var outline_f25_60_26560=null;
var title_f25_60_26561="Nalidixic acid: International drug information";
var content_f25_60_26561=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nalidixic acid: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4151607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acido Nalidissico (IT);",
"     </li>",
"     <li>",
"      Acido Nalidixico Prodes (ES);",
"     </li>",
"     <li>",
"      Betaxina (IT);",
"     </li>",
"     <li>",
"      Dixiben (IT);",
"     </li>",
"     <li>",
"      Enexina (IT);",
"     </li>",
"     <li>",
"      Enterodix (IN);",
"     </li>",
"     <li>",
"      Entolon (JP);",
"     </li>",
"     <li>",
"      Eucistin (IT);",
"     </li>",
"     <li>",
"      Gramoneg (IN);",
"     </li>",
"     <li>",
"      Innoxalon (JP);",
"     </li>",
"     <li>",
"      Jicsron (JP);",
"     </li>",
"     <li>",
"      Kusnarin (JP);",
"     </li>",
"     <li>",
"      Mictral (GB);",
"     </li>",
"     <li>",
"      Nalidix (AR);",
"     </li>",
"     <li>",
"      Nalidixin (CZ, IT);",
"     </li>",
"     <li>",
"      Nalidixol (ES);",
"     </li>",
"     <li>",
"      Naligram (IT);",
"     </li>",
"     <li>",
"      Nalissina (IT);",
"     </li>",
"     <li>",
"      Nalitucsan (JP);",
"     </li>",
"     <li>",
"      Nalixan (FI);",
"     </li>",
"     <li>",
"      Narigix (JP);",
"     </li>",
"     <li>",
"      Neg-gram (IT);",
"     </li>",
"     <li>",
"      Negadix (IN);",
"     </li>",
"     <li>",
"      Negram (AU, FR, GB, IE, NL, NO);",
"     </li>",
"     <li>",
"      Nevigramon (HU, PL);",
"     </li>",
"     <li>",
"      Nicelate (JP);",
"     </li>",
"     <li>",
"      Nogermin (ES);",
"     </li>",
"     <li>",
"      Poleon (JP);",
"     </li>",
"     <li>",
"      Renogram (HR);",
"     </li>",
"     <li>",
"      Sicmylon (JP);",
"     </li>",
"     <li>",
"      Specifin (IT);",
"     </li>",
"     <li>",
"      Unaserus (JP);",
"     </li>",
"     <li>",
"      Uralgin (IT);",
"     </li>",
"     <li>",
"      Uri-Flor (IT);",
"     </li>",
"     <li>",
"      Uriben (GB);",
"     </li>",
"     <li>",
"      Uriclar (IT);",
"     </li>",
"     <li>",
"      Urisco (IT);",
"     </li>",
"     <li>",
"      Urodixin (IT);",
"     </li>",
"     <li>",
"      Urogram (HR, IT);",
"     </li>",
"     <li>",
"      Uronax (IT);",
"     </li>",
"     <li>",
"      Uroneg (IT);",
"     </li>",
"     <li>",
"      Wintomilon (PT);",
"     </li>",
"     <li>",
"      Wintomylon (AR, BR);",
"     </li>",
"     <li>",
"      Wintron (JP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F4151608\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Nalidixinic Acid",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F4151609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Quinolone",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F4151610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of urinary tract infections",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F4151612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children 3 months to 12 years: 55 mg/kg/day divided every 6 hours; suppressive therapy is 30 mg/kg/day divided every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults: 1 g 4 times/day for 2 weeks; then suppressive therapy of 500 mg 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing comments in renal impairment:",
"     </b>",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;50 mL/minute: Avoid use",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F4151613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Suspension, oral: 250 mg/5 mL (473 mL) [raspberry flavor] [Not available in the U.S.]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Tablet: 500 mg [Not available in the U.S.]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10512 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-5A6B11C91F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26561=[""].join("\n");
var outline_f25_60_26561=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151607\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151608\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151609\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151610\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151612\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821094\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151613\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10512\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10512|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_60_26562="Posterior blepharitis";
var content_f25_60_26562=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Posterior blepharitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lower eyelid with characteristic posterior lid inflammation and oily white plugs visible at the meibomian gland openings.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26562=[""].join("\n");
var outline_f25_60_26562=null;
var title_f25_60_26563="Normal human metamyelocyte";
var content_f25_60_26563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F59197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F59197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal human metamyelocyte",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral blood smear shows a normal human metamyelocyte. The cytoplasm resembles the mature neutrophil and band forms; granules are small, fine blue-black or grey, and dispersed homogeneously throughout the cytoplasm. The nucleus is indented like a bean and the nuclear chromatin is coarse, clumped, and condensed peripherally.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Baehner, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26563=[""].join("\n");
var outline_f25_60_26563=null;
var title_f25_60_26564="Human chorionic gonadotropin: Drug information";
var content_f25_60_26564=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Human chorionic gonadotropin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?31/15/31988?source=see_link\">",
"    see \"Human chorionic gonadotropin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/25/33171?source=see_link\">",
"    see \"Human chorionic gonadotropin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F151099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Novarel&reg;;",
"     </li>",
"     <li>",
"      Pregnyl&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F151100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Chorionic Gonadotropin for Injection;",
"     </li>",
"     <li>",
"      Pregnyl&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F151114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Gonadotropin;",
"     </li>",
"     <li>",
"      Ovulation Stimulator",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F151101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Induction of ovulation:",
"     </b>",
"     Females: I.M.: 5000-10,000 units 1 day following last dose of menotropins",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Spermatogenesis induction associated with hypogonadotropic hypogonadism:",
"     </b>",
"     Males: Treatment regimens vary (range: 1000-2000 units 2-3 times a week). Administer hCG until serum testosterone levels are normal (may require 2-3 months of therapy), then may add follitropin alfa or menopausal gonadotropin if needed to induce spermatogenesis; continue hCG at the dose required to maintain testosterone levels.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F151109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/25/33171?source=see_link\">",
"      see \"Human chorionic gonadotropin: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Various regimens:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prepubertal cryptorchidism:",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4000 units 3 times/week for 3 weeks",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5000 units every second day for 4 injections",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 units 3 times/week for 4-6 weeks",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 injections of 500-1000 units given over 6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Hypogonadotropic hypogonadism:",
"     </b>",
"     Males: I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     500-1000 units 3 times/week for 3 weeks, followed by the same dose twice weekly for 3 weeks",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     4000 units 3 times/week for 6-9 months, then reduce dosage to 2000 units 3 times/week for additional 3 months",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F151102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F151085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 10,000 units",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Novarel&reg;: 10,000 units [contains benzyl alcohol (in diluent)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pregnyl&reg;: 10,000 units [contains benzyl alcohol (in diluent)]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F151072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F151088\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.M. administration only",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F151087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Induces ovulation and pregnancy in anovulatory, infertile females; treatment of hypogonadotropic hypogonadism, prepubertal cryptorchidism; spermatogenesis induction with follitropin alfa",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F151112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Frequency not always defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Depression, fatigue, headache, irritability, restlessness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Gynecomastia, precocious puberty",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction, pain at injection site",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity reaction (local or systemic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Arterial thrombus, ovarian cyst rupture, ovarian hyperstimulation syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F151091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to chorionic gonadotropin or any component of the formulation; precocious puberty; prostatic carcinoma or similar neoplasms; pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F151076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use with caution in patients with asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cryptorchidism: May induce precocious puberty in children being treated for cryptorchidism; discontinue if signs of precocious puberty occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Migraine: Use with caution in patients with a history of migraines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Obesity:",
"     <b>",
"      Not",
"     </b>",
"     effective in the treatment of obesity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorders: Use with caution in patients with a history of seizure disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children &lt;4 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ovulation induction: Appropriate use: These medications should only be used by physicians who are thoroughly familiar with infertility problems and their management. May cause ovarian hyperstimulation syndrome (OHSS); characterized by severe ovarian enlargement, abdominal pain/distention, nausea, vomiting, diarrhea, dyspnea, and oliguria, and may be accompanied by ascites, pleural effusion, hypovolemia, electrolyte imbalance, hemoperitoneum, and thromboembolic events. If severe hyperstimulation occurs, stop treatment and hospitalize patient. This syndrome develops rapidly with 24 hours to several days and generally occurs during the 7-10 days immediately following treatment. Ovarian enlargement may be accompanied by abdominal distention or abdominal pain and generally regresses without treatment within 2-3 weeks. If ovaries are abnormally enlarged on the last day of treatment, withhold hCG to reduce the risk of OHSS. In association with and separate from OHSS, thromboembolic events have been reported. May result from the use of these medications; advise patients of the potential risk of multiple births before starting the treatment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299037\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F151080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F151082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2998838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Teratogenic effects (forelimb, CNS) have been noted in animal studies at doses intended to induce superovulation (used in combination with gonadotropin). Testicular tumors in otherwise healthy men have been reported when treating secondary infertility.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F151104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F151092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Chorionic Gonadotropin Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10000 unit (1): $220.85",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Novarel Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10000 unit (1): $221.09",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Pregnyl Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10000 unit (1): $83.48",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F2998840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Male: Serum testosterone levels, semen analysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Female: Ultrasound and/or estradiol levels to assess follicle development; ultrasound to assess number and size of follicles; ovulation (basal body temperature, serum progestin level, menstruation, sonography)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F151086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Depends on application and methodology; &lt;3 mIU/mL (SI: &lt;3 units/L) usually normal (nonpregnant)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F151093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Choragon (MX);",
"     </li>",
"     <li>",
"      Choriomon (MX);",
"     </li>",
"     <li>",
"      Pregnyl (MX)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F151075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Luteinizing hormone obtained from the urine of pregnant women. Stimulates production of gonadal steroid hormones by causing production of androgen by the testes; as a substitute for luteinizing hormone (LH) to stimulate ovulation",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F151090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Biphasic: Initial: 11 hours; Terminal: 23 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Association of Clinical Endocrinologists, &ldquo;American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Hypogonadism in Adult Male Patients &minus; 2002 Update,&rdquo;",
"      <i>",
"       Endocr Pract",
"      </i>",
"      , 2002, 8(6):440-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/60/26564/abstract-text/15260010/pubmed\" id=\"15260010\" target=\"_blank\">",
"        15260010",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9249 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.96.59.103-08F48505D8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26564=[""].join("\n");
var outline_f25_60_26564=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151099\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151100\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151114\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151101\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151109\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151102\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682640\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682641\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151085\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151072\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151088\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151087\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151112\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151091\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151076\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299037\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151080\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151082\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2998838\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151104\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151092\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2998840\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151086\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151093\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151075\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151090\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9249\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9249|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/15/31988?source=related_link\">",
"      Human chorionic gonadotropin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/25/33171?source=related_link\">",
"      Human chorionic gonadotropin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_60_26565="Ethics in the intensive care unit: Informed consent";
var content_f25_60_26565=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ethics in the intensive care unit: Informed consent",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/60/26565/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/60/26565/contributors\">",
"     John A Kellum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/60/26565/contributors\">",
"     Douglas B White, MD, MAS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/60/26565/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/60/26565/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/60/26565/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/60/26565/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/60/26565/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Informed consent is a process of communication between a clinician and a patient or surrogate decision-maker that results in the patient agreeing to undergo a specific medical intervention. Consent for specific aspects of medical treatment is a relatively new concept in medical ethics, having evolved over the last century. Society previously accepted the notion that clinicians had the detailed technical knowledge required to make medical decisions on behalf of the patient and that clinicians were guided by an overriding desire to do the right thing (ie, beneficence). Most clinicians and patients believed that medical decisions should be made by the clinician without participation from the patient, thereby sparing the patient and family from the burdens associated with these difficult choices. This paternalism emphasized beneficence to the exclusion of autonomy and failed to consider that biases are unavoidable and clinicians are not always able to determine what is in their patients' best interests [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acceptance of paternalistic clinician beneficence was replaced by an emphasis on patient autonomy during the mid-1980&rsquo;s. This was probably the consequence of two main factors: society began to embrace the idea of patient autonomy and the assumption of clinician beneficence began to be questioned once it was recognized that the economic pressures exerted upon clinicians by outside forces can be great. Clinicians began to act as impartial agents for their patients who, in the extreme, were considered clients with the power to choose any therapy they desired. Giving advice was considered taboo by some who argued that this was equivalent to exerting inappropriate influence on the patient or family. Patients or family members were often made to feel that they have to \"make the decision\" regarding whether to attempt resuscitation. A common scenario was one in which poorly informed patients were confronted with an open-ended request to tell the medical team what \"they want to have done.\" Often their response was to have \"everything done\" and this was accepted by the clinician as a request for cardiopulmonary resuscitation even if the clinician thought it would be a mistake.",
"   </p>",
"   <p>",
"    Although autonomy is still emphasized in many ways, it is increasingly recognized that overemphasis of autonomy deprives patients of expert advice and may cause the clinician to abandon his or her responsibility to protect the patient against inappropriate therapy. As a result, the pendulum has begun to swing back from absolute autonomy toward a more balanced approach. This has been termed &ldquo;enhanced autonomy&rdquo; or the &ldquo;fiduciary role&rdquo;, but in reality it is recognition that an approach based solely upon one principle (such as autonomy) is no better than one based solely on another (eg, beneficence) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ethical issues related to informed consent in the intensive care unit (ICU) are reviewed here. Our emphasis is on informed consent for a medical intervention. Although most principles also apply to informed consent for participation in clinical research, this area is vastly more complex and is beyond the scope of our review. Ethical issues related to withholding life support, withdrawing life support, and requests for futile or inappropriate therapy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32887?source=see_link\">",
"     \"Ethics in the intensive care unit: Withholding and withdrawing life-support\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24934?source=see_link\">",
"     \"Ethics in the intensive care unit: Responding to requests for futile or potentially inappropriate therapies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4863473\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR INFORMED CONSENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generally speaking, all invasive procedures require informed consent. Those that are considered routine ICU procedures (eg, central line insertion) may be covered by a &ldquo;blanket consent&rdquo;, which broadly covers almost everything a doctor or hospital might do without mentioning anything specific [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/6\">",
"     6",
"    </a>",
"    ]. Blanket consent is typically obtained from the patient or a surrogate decision-maker upon admission to the hospital or ICU. It is the responsibility of individual units and institutions to establish guidelines for which procedures require formal written informed consent and which are covered by the blanket consent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/7\">",
"     7",
"    </a>",
"    ]. An exception to the requirement for informed consent occurs when an emergent, life-saving procedure is required (eg, endotracheal intubation).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6538198\">",
"    <span class=\"h1\">",
"     PROCESS OF INFORMED CONSENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician who will perform the intervention should obtain informed consent from either the patient or a surrogate decision-maker. Informed consent consists of providing information about the intervention, ensuring adequate understanding of the information, and then obtaining permission to perform the intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Provide information",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is generally accepted that informed consent should include a description of the following: the intervention (including the personnel who will be participating), the potential benefits and risks of the intervention, and the potential benefits and risks of any alternative courses of action (including no intervention). This information should be communicated concisely and using terminology that the patient or surrogate can understand.",
"   </p>",
"   <p>",
"    There is no single widely accepted standard for how much detail should be provided in the informed consent process. The goal is to be informative, but communicating every detail is neither possible nor practical. This is particularly relevant to communicating the risks of an intervention; generally speaking, adverse events that are either frequent or severe should be described.",
"   </p>",
"   <p>",
"    Concern for the quality of informed consent has increased in recent years [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/8\">",
"     8",
"    </a>",
"    ]. One study of informed consent in cardiology found that current consent forms were complex, incomplete, and unreadable for the average patient [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/9\">",
"     9",
"    </a>",
"    ]. Another study of patients providing informed consent for elective cardiac catheterization found that 88 percent of the patients had mistaken beliefs about the benefits of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/10\">",
"     10",
"    </a>",
"    ]. Reducing the amount of information conveyed while focusing on how and when the information is delivered, and perhaps using newer technology to improve traditional consent discussions, has the potential to &ldquo;move informed consent away from a meaningless piece of required paperwork and toward a focus on patient autonomy and well-being&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The law provides three different standards by which the adequacy of the information provided may be judged: the professional community standard, the reasonable person standard, and the subjective standard. It is often useful to consider if the information provided would pass all three standards if judged by an outside observer:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The professional community standard compares the information provided with that provided by other physicians who are faced with the same or a very similar clinical situation. Such comparisons had previously been made to physicians in the local community; however, these standards are increasingly being established by national professional organizations.",
"     </li>",
"     <li>",
"      The reasonable person standard compares the information provided with that desired by a well-reasoning individual who is free of mental or physical illness and who has no conflicting interests in the outcome of the case. This standard varies based upon a number of factors, such as the cultural and educational background of the individual receiving the information.",
"     </li>",
"     <li>",
"      The subjective standard requires the clinician to use experience and judgment to decide what information is required. This standard allows information to be tailored to a specific clinical situation by the clinician; however, it is subject to criticism by those who, on retrospective review, believe that the information provided was inadequate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While it is important that the pertinent medical information be provided to the patient or surrogate when obtaining informed consent, it is equally important that the clinician encourage and listen carefully to the questions and opinions of the patient or surrogate. Occasionally, patients or their surrogate will ask the clinician how many similar interventions he or she has performed and their success rate. Such questions should be answered truthfully. Complete and open communication between the clinician and the patient or surrogate promotes trust and cooperation.",
"   </p>",
"   <p>",
"    Clinicians with potential financial conflicts of interest should disclose those conflicts to the patient or surrogate. As an example, a clinician who is seeking permission to use a medical device on a patient and owns the patent for the device (or stock in the company that makes it) should disclose the financial relationship. Failure to disclose such conflicts of interest leaves the clinician susceptible to accusations of impropriety.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Assess comprehension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician must ensure that the information that was provided was understood by the patient or surrogate. A useful technique to assess understanding is to ask the patient or surrogate to summarize the information that has been conveyed and to clarify any misunderstandings that occur with the patient (or surrogate).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4863423\">",
"    <span class=\"h2\">",
"     Obtaining the consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the appropriate information has been provided, questions have been answered, and comprehension has been confirmed, the clinician should ask the patient or surrogate whether they grant permission for the intervention to be performed. Patients or surrogates usually ask for the clinician&rsquo;s opinion before giving final consent, in which case the clinician should render their opinion regarding the proper course of action. Decisions of this magnitude are best made jointly by those who have in-depth knowledge of the patient's values and wishes, and those who understand the pertinent medical issues [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/11\">",
"     11",
"    </a>",
"    ]. A set of facts should not be presented to the patient or surrogate without professional input and advice. The emphasis on patient autonomy has created the temptation for clinicians to shift the burden of decision-making entirely to patients or surrogates; we believe that this is an incorrect approach and that obtaining informed consent requires both the clinician and the patient or surrogate.",
"   </p>",
"   <p>",
"    A number of improvements in the informed consent process are under investigation. A systematic review identified 44 controlled trials of a wide range of interventions designed to improve patient comprehension in informed consent for medical and surgical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/12\">",
"     12",
"    </a>",
"    ]. The main lessons from these studies are: (1) more is not always better, (2) discussions should take place well before the decision to undertake the intervention, and (3) informing patients using a variety of methods will improve the quality of the discussion with the physician [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/8,12\">",
"     8,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Occasionally, the decision made by a surrogate that seems contrary to the patient&rsquo;s best interests",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the clinician&rsquo;s expectation. In such cases, the clinician must be certain that no outside influences have caused the surrogate to deviate from the patient's true wishes. This can be difficult to assess and requires that the clinician explore the motivation for the surrogate&rsquo;s decision. As an example, the clinician might say, &ldquo;can you tell me a little about why you believe that your father would not want the procedure?&rdquo; Ongoing communication with family members usually allows clinicians to identify situations in which the patient's well-being is not the surrogate's primary concern. In such cases, clinicians will need to involve the hospital ethics committee and, in extreme cases, involve legal action to ensure that the patient&rsquo;s best interests are the primary driver of clinical decision making.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4863481\">",
"    <span class=\"h2\">",
"     Documentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should carefully document any informed consent discussions, regardless of whether consent was ultimately obtained. Documentation should include the date and time of the conversation, the identity of individuals who participated in the discussion, and the benefits and risks of the intervention and alternative interventions that were described. Finally, the clinician should document that the patient or surrogate understood the information, was given the opportunity to ask questions, and either agreed to proceed with the intervention or declined the intervention. If the patient declined the intervention, it should also be documented that the risks of not undergoing the intervention were described. If the intervention is performed without informed consent due to an emergent situation, the precise circumstances for the intervention should be documented in detail.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     INCAPACITATED PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who lack the capacity to make an informed decision are unable to participate in medical decision-making because they cannot understand the choices available or the potential consequences of their medical decisions [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/13\">",
"     13",
"    </a>",
"    ]. Such patients are frequently called incompetent but, strictly speaking, incompetence is a legal term and patients can only be deemed incompetent by the legal system. The incapacity to make informed decisions may not be obvious and psychiatric consultation should be sought if there is uncertainty.",
"   </p>",
"   <p>",
"    Although we strive to respect patient autonomy even if their capacity to make an informed decision becomes impaired, we can only truly do so when the patient has already made a choice. Written advanced directives may be available for this purpose. However, in the absence of an advanced directive, ethicists, caregivers, and the legal system all mandate that the medical team and persons who are most acquainted with the patient (eg, family) attempt to construct the patient's judgment by analyzing their prior statements, values, and beliefs. Although the goal is to determine what the patient would say if they were able to do so, this \"substituted judgment\" does not actually preserve patient autonomy, but rather serves to allow for decisions that are &ldquo;authentic&rdquo; to the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/14\">",
"     14",
"    </a>",
"    ]. Importantly, the evidence suggests that &gt;90 percent of patients prefer family members to work with the clinician to make medical decisions for them if they are ever incapacitated [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26565/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to recognize that patients without the capacity to make an informed decision may regain capacity as their illness improves and the effects of medications wears off. Thus, patients who have been deemed incapable of making informed decisions should be reassessed daily. Once the patient regains the capacity to make decisions, his or her wishes supersede the wishes of any surrogate or family members.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4863455\">",
"    <span class=\"h1\">",
"     FOREIGN LANGUAGE SPEAKERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Informed consent should be obtained in the patient&rsquo;s native language using an interpreter, preferably one who is familiar with medical terminology. This is necessary to insure that the patient understands the information being conveyed by the clinician and is able to ask questions in the way that he or she intends. Family members should not be used to interpret information because they may filter the information in order to protect the patient and this may impede the patient&rsquo;s ability to make an informed judgment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6537804\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Informed consent is a process of communication between a clinician and a patient or surrogate decision-maker that results in the patient agreeing to undergo a specific medical intervention. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All invasive procedures require informed consent, although those that are considered routine intensive care unit (ICU) procedures may be covered by the &ldquo;blanket consent&rdquo; that is typically obtained at the time of admission. It is the responsibility of individual units and institutions to establish guidelines for which procedures require formal written informed consent and which are covered by the blanket consent. An exception to the requirement for informed consent occurs when an emergent, life-saving procedure is required. (See",
"      <a class=\"local\" href=\"#H4863473\">",
"       'Indications for informed consent'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Informed consent consists of providing information about the intervention, ensuring adequate understanding of the information, and then obtaining permission to perform the intervention. Clinicians should carefully document any informed consent discussions, regardless of whether consent was ultimately obtained. (See",
"      <a class=\"local\" href=\"#H6538198\">",
"       'Process of informed consent'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who lack the capacity to make an informed decision (eg, due to the critical illness or medications) are unable to participate in medical decision-making because they cannot understand the choices available or the potential consequences of their medical decisions. Patients do not lose their autonomy if their capacity to make an informed decision becomes impaired. Instead, the medical team and persons who are most acquainted with the patient (eg, family) must attempt to reconstruct the patient's judgment by analyzing their prior statements, values, and beliefs. This is referred to as \"substituted judgment.\" (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Incapacitated patients'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2065118\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Michael Dacey, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/1\">",
"      Schneiderman LJ, Kaplan RM, Pearlman RA, Teetzel H. Do physicians' own preferences for life-sustaining treatment influence their perceptions of patients' preferences? J Clin Ethics 1993; 4:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/2\">",
"      Burstin HR, Lipsitz SR, Brennan TA. Socioeconomic status and risk for substandard medical care. JAMA 1992; 268:2383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/3\">",
"      Blendon RJ, Aiken LH, Freeman HE, Corey CR. Access to medical care for black and white Americans. A matter of continuing concern. JAMA 1989; 261:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/4\">",
"      Quill TE, Brody H. Physician recommendations and patient autonomy: finding a balance between physician power and patient choice. Ann Intern Med 1996; 125:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/5\">",
"      Prendergast TJ. Resolving conflicts surrounding end-of-life care. New Horiz 1997; 5:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/6\">",
"      Davis N, Pohlman A, Gehlbach B, et al. Improving the process of informed consent in the critically ill. JAMA 2003; 289:1963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/7\">",
"      Schweickert W, Hall J. Informed consent in the intensive care unit: ensuring understanding in a complex environment. Curr Opin Crit Care 2005; 11:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/8\">",
"      Schenker Y, Meisel A. Informed consent in clinical care: practical considerations in the effort to achieve ethical goals. JAMA 2011; 305:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/9\">",
"      Terranova G, Ferro M, Carpeggiani C, et al. Low quality and lack of clarity of current informed consent forms in cardiology: how to improve them. JACC Cardiovasc Imaging 2012; 5:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/10\">",
"      Rothberg MB, Sivalingam SK, Ashraf J, et al. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med 2010; 153:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/11\">",
"      Arnold RM, Kellum J. Moral justifications for surrogate decision making in the intensive care unit: implications and limitations. Crit Care Med 2003; 31:S347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/12\">",
"      Schenker Y, Fernandez A, Sudore R, Schillinger D. Interventions to improve patient comprehension in informed consent for medical and surgical procedures: a systematic review. Med Decis Making 2011; 31:151.",
"     </a>",
"    </li>",
"    <li>",
"     Devita M, Grenvik A. Foregoing life-sustaining therapy in intensive care. In: Textbook of Critical Care, Ayres S, Grenvik A, Holbrook P, Shoemaker W (Eds), WB Saunders, Philadelphia 1995. p.1802.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/14\">",
"      Brudney D. Choosing for another: beyond autonomy and best interests. Hastings Cent Rep 2009; 39:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26565/abstract/15\">",
"      Puchalski CM, Zhong Z, Jacobs MM, et al. Patients who want their family and physician to make resuscitation decisions for them: observations from SUPPORT and HELP. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Hospitalized Elderly Longitudinal Project. J Am Geriatr Soc 2000; 48:S84.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1621 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-8F853297CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26565=[""].join("\n");
var outline_f25_60_26565=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6537804\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4863473\">",
"      INDICATIONS FOR INFORMED CONSENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6538198\">",
"      PROCESS OF INFORMED CONSENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Provide information",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Assess comprehension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4863423\">",
"      Obtaining the consent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4863481\">",
"      Documentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      INCAPACITATED PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4863455\">",
"      FOREIGN LANGUAGE SPEAKERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6537804\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2065118\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24934?source=related_link\">",
"      Ethics in the intensive care unit: Responding to requests for futile or potentially inappropriate therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32887?source=related_link\">",
"      Ethics in the intensive care unit: Withholding and withdrawing life-support",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_60_26566="Collateral circulation lower extremity";
var content_f25_60_26566=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F72956&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F72956&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    Collateral circulation lower extremity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 691px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26566=[""].join("\n");
var outline_f25_60_26566=null;
var title_f25_60_26567="Rosiglitazone and glimepiride: Drug information";
var content_f25_60_26567=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Rosiglitazone and glimepiride: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?1/38/1638?source=see_link\">",
"    see \"Rosiglitazone and glimepiride: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2529528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Avandaryl&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F11245467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Avandaryl&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F2529532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidiabetic Agent, Sulfonylurea;",
"     </li>",
"     <li>",
"      Antidiabetic Agent, Thiazolidinedione",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F2529946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Type 2 diabetes mellitus:",
"     </b>",
"     Oral: Initial: Rosiglitazone 4 mg and glimepiride 1 mg once daily",
"     <b>",
"      or",
"     </b>",
"     rosiglitazone 4 mg and glimepiride 2 mg once daily (for patients previously treated with sulfonylurea or thiazolidinedione monotherapy)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Patients switching from combination rosiglitazone and glimepiride as separate tablets: Use current dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Titration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     <i>",
"      Dose adjustment in patients previously on sulfonylurea monotherapy:",
"     </i>",
"     May take 2 weeks to observe decreased blood glucose and 2-3 months to see full effects of rosiglitazone component. If not adequately controlled after 8-12 weeks, increase daily dose of rosiglitazone component.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Dose adjustment in patients previously on thiazolidinedione monotherapy:",
"     </i>",
"     If not adequately controlled after 1-2 weeks, increase daily dose of glimepiride component in &le;2 mg increments in 1-2 week intervals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Maximum dose:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     U.S. labeling: Rosiglitazone 8 mg and glimepiride 4 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Canadian labeling: Rosiglitazone 4 mg and glimepiride 4 mg once daily",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F2529947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">",
"     Rosiglitazone 4 mg and glimepiride 1 mg once daily. Carefully titrate dose.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F2529948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rosiglitazone 4 mg and glimepiride 1 mg once daily. Carefully titrate dose.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F2529949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rosiglitazone 4 mg and glimepiride 1 mg once daily. Carefully titrate dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ALT &le;2.5 times ULN: Use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ALT &gt;2.5 times ULN: Do not initiate therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ALT &gt;3 times ULN or jaundice: Discontinue.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2529955\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Avandaryl&reg; 4 mg/1 mg: Rosiglitazone maleate 4 mg and glimepiride 1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Avandaryl&reg; 4 mg/2 mg: Rosiglitazone maleate 4 mg and glimepiride 2 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Avandaryl&reg; 4 mg/4 mg: Rosiglitazone maleate 4 mg and glimepiride 4 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Avandaryl&reg; 8 mg/2 mg: Rosiglitazone maleate 8 mg and glimepiride 2 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Avandaryl&reg; 8 mg/4 mg: Rosiglitazone maleate 8 mg and glimepiride 4 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F2529530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11245585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;\">",
"     As a requirement of the REMS program, the prescribing and dispensing of any rosiglitazone-containing medication in the U.S. requires physician and patient enrollment in the Avandia-Rosiglitazone Medicines Access Program&trade;. Complete program details are available at www.avandia.com or by calling the program Coordinating Center at 800-282-6342.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Health Canada requires written informed consent for new and current patients receiving rosiglitazone.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM143421.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM143421.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F2529951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be administered with the first meal of the day.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F2529535\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of type 2 diabetes mellitus (noninsulin dependent, NIDDM) as an adjunct to diet and exercise",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5174561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F2529929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Percentages below refer to combination Avandaryl&reg;. Also see individual agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Edema (3%), hypertension (2% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (3% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Hypoglycemia (4% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Nasopharyngitis (4% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): CHF, weight gain",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2529924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     NYHA Class III/IV heart failure (initiation of therapy)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Hypersensitivity to rosiglitazone, glimepiride, other sulfonamides, or any component of the formulation; any stage of heart failure (eg, NYHA Class I, II, III, IV); serious hepatic impairment; diabetic ketoacidosis (with or without coma); pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2529925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular mortality: Product labeling states oral hypoglycemic drugs may be associated with an increased cardiovascular mortality as compared to treatment with diet alone or diet plus insulin. Data to support this association are limited, and several studies, including a large prospective trial (UKPDS) have not supported an association.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fractures: Increased incidence of bone fractures in females treated with rosiglitazone observed during analysis of long-term trial; majority of fractures occurred in the upper arm, hand and foot (differing from the hip or spine fractures usually associated with postmenopausal osteoporosis). Consider risk of fracture prior to initiation and during use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Heart failure/cardiac effects:",
"     <b>",
"      [U.S. Boxed Warning]: Thiazolidinediones, including rosiglitazone, may cause or exacerbate congestive heart failure;",
"     </b>",
"     closely monitor for signs and symptoms of congestive heart failure (eg, rapid weight gain, dyspnea, edema), particularly after initiation or dose increases. Not recommended for use in any patient with symptomatic heart failure. In the U.S., initiation of therapy is contraindicated in patients with NYHA class III or IV heart failure; in Canada, use is contraindicated in patients with any stage of heart failure (NYHA I, II, III, IV). Use with caution in patients with edema; may increase plasma volume and/or cause fluid retention. A higher frequency of cardiovascular events has been noted in patients with NYHA class I or II heart failure treated with rosiglitazone. Use may also be associated with an increased risk of angina and MI. Use with caution in patients at risk for cardiovascular events and monitor closely. Discontinue if any deterioration in cardiac status occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic effects: Rosiglitazone may decrease hemoglobin, hematocrit, and/or WBC count (slight); effects may be related to increased plasma volume and/or dose-related. Use with caution in patients with anemia; may reduce hemoglobin and hematocrit.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoglycemia: All sulfonylurea drugs are capable of producing severe hypoglycemia. Hypoglycemia is more likely to occur when caloric intake is deficient, after severe or prolonged exercise, when ethanol is ingested, or when more than one glucose-lowering drug is used. It is also more likely in elderly patients, malnourished patients and in patients with impaired renal or hepatic function; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfonamide allergy: Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). A risk of cross-reaction exists in patients with allergy to any of these compounds; avoid use when previous reaction has been severe. Use in patients with sulfonamide allergy is specifically contraindicated in Canadian labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Weight gain: Dose-related weight gain observed with rosiglitazone use; mechanism unknown but likely associated with fluid retention and fat accumulation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes, type 1: Mechanism of rosiglitazone requires the presence of insulin; therefore, use in type 1 diabetes (insulin dependent, IDDM) or diabetic ketoacidosis is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glucose-6-phosphate dehydrogenase (G6PD) deficiency: Patients with G6PD deficiency may be at an increased risk of sulfonylurea-induced hemolytic anemia; however, cases have also been described in patients without G6PD deficiency during postmarketing surveillance. Use with caution and consider a nonsulfonylurea alternative in patients with G6PD deficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use rosiglitazone with caution in patients with elevated transaminases (AST or ALT); do not initiate in patients with active liver disease of ALT &gt;2.5 times the upper limit of normal (ULN) at baseline; evaluate patients with ALT &le;2.5 times ULN at baseline or during therapy for cause of enzyme elevation. During therapy, if ALT &gt;3 times ULN, reevaluate levels promptly and discontinue if elevation persists or if jaundice occurs at any time during use. Idiosyncratic hepatotoxicity has been reported with another thiazolidinedione agent (troglitazone); avoid use in patients who previously experienced jaundice during troglitazone therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Macular edema/diabetic retinopathy: Use rosiglitazone with caution in patients with pre-existing macular edema or diabetic retinopathy; postmarketing reports of new-onset or worsening diabetic macular edema with decreased visual acuity has been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Stress-related states: It may be necessary to discontinue therapy and administer insulin if the patient is exposed to stress (fever, trauma, infection, surgery).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoglycemic agents: Combination therapy with other hypoglycemic agents may increase risk for hypoglycemic events; dose reduction with the concomitant agent may be warranted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Insulin: Avoid use of rosiglitazone with insulin due to an increased risk of edema, congestive heart failure, and myocardial ischemic events.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Nitrates: Concomitant use of rosiglitazone with nitrates is not recommended. An increased risk of myocardial ischemia has been observed in nitrate users versus non-nitrate users in clinical studies.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Metformin/sulfonylureas (Canadian labeling; not in U.S. labeling): Rosiglitazone may be added to metformin or a sulfonylurea (if metformin is contraindicated or not tolerated) if glycemic control is inadequate. The use of triple therapy (rosiglitazone in combination with metformin and a sulfonylurea) is not indicated due to increased risks of congestive heart failure and fluid retention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Premenopausal/anovulatory females: Use rosiglitazone with caution in premenopausal, anovulatory women; may result in a resumption of ovulation, increasing the risk of pregnancy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; REMS program:",
"     <b>",
"      [U.S. Boxed Warning]: Due to cardiovascular risks, rosiglitazone-containing medications are only available through the Avandia-Rosiglitazone Medicines Access Program&trade;.",
"     </b>",
"     Patients and prescribers must be registered with and meet conditions of the program. Call 1-800-282-6342 or visit www.avandia.com for more information.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Secondary failure: Loss of efficacy may be observed following prolonged use as a result of the progression of type 2 diabetes mellitus which results in continued beta cell destruction. In patients who were previously responding to sulfonylurea therapy, consider additional factors which may be contributing to decreased efficacy (eg, inappropriate dose, nonadherence to diet and exercise regimen). If no contributing factors can be identified, consider discontinuing use of the sulfonylurea due to secondary failure of treatment.  Additional antidiabetic therapy (eg, insulin) will be required.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F2529934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F2529933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): Sulfonylureas may enhance the adverse/toxic effect of Alcohol (Ethyl). A flushing reaction may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May enhance the hypoglycemic effect of Sulfonylureas. Cardioselective beta-blockers (eg, acebutolol, atenolol, metoprolol, and penbutolol) may be safer than nonselective beta-blockers. All beta-blockers appear to mask tachycardia as an initial symptom of hypoglycemia. Ophthalmic beta-blockers are probably associated with lower risk than systemic agents.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the absorption of Antidiabetic Agents (Thiazolidinedione).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloramphenicol: May decrease the metabolism of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May increase the serum concentration of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colesevelam: May decrease the serum concentration of Glimepiride. Management: Administer glimepiride at least 4 hours prior to colesevelam.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyclic Antidepressants: May enhance the hypoglycemic effect of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Inducers (Strong): May increase the metabolism of CYP2C8 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Inhibitors (Moderate): May decrease the metabolism of CYP2C8 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Inhibitors (Strong): May decrease the metabolism of CYP2C8 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Substrates: CYP2C8 Inhibitors (Moderate) may decrease the metabolism of CYP2C8 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inducers (Strong): May increase the metabolism of CYP2C9 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Moderate): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Strong): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP2C8 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fibric Acid Derivatives: May enhance the hypoglycemic effect of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May increase the serum concentration of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gemfibrozil: May decrease the metabolism of Antidiabetic Agents (Thiazolidinedione). Management: Limit pioglitazone maximum adult dose to 15 mg/day, and consider dose reduction of rosiglitazone, when used in combination with gemfibrozil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     GLP-1 Agonists: May enhance the hypoglycemic effect of Sulfonylureas. Management: Consider sulfonylurea dose reductions when used in combination with GLP-1 agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypoglycemic Properties): May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: May enhance the adverse/toxic effect of other Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Insulin: May enhance the fluid-retaining effect of Antidiabetic Agents (Thiazolidinedione).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: May diminish the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Luteinizing Hormone-Releasing Hormone Analogs: May diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP2C8 Substrates. Management: Use CYP2C8 substrates at the lowest recommended dose, and monitor closely for adverse effects (including myopathy), during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP2C9 Substrates. Management: Use CYP2C9 substrates at the lowest recommended dose, and monitor closely for adverse effects, during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: May enhance the hypoglycemic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pregabalin: May enhance the fluid-retaining effect of Antidiabetic Agents (Thiazolidinedione).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May decrease the protein binding of Sulfonylureas. Probenecid may increase the serum concentration of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: May enhance the hypoglycemic effect of Sulfonylureas. This appears to be particularly concerning early in the course of combination therapy. Quinolone Antibiotics may diminish the hypoglycemic effect of Sulfonylureas. With longer-term combination, there is a greater risk of hyperglycemia.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ranitidine: May increase the serum concentration of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifampin: May increase the metabolism of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifampin: May increase the metabolism of Antidiabetic Agents (Thiazolidinedione).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Hypoglycemic Agents. Management: Consider increased monitoring of glycemic control with concomitant use of a hypoglycemic agent and an SSRI. Dosage adjustments of the hypoglycemic agent may be necessary upon SSRI initiation or discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatropin: May diminish the hypoglycemic effect of Antidiabetic Agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonamide Derivatives: May enhance the hypoglycemic effect of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trimethoprim: May decrease the metabolism of Antidiabetic Agents (Thiazolidinedione).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vasodilators (Organic Nitrates): May enhance the adverse/toxic effect of Rosiglitazone. Specifically, a greater risk of myocardial ischemia was reported for users of this combination in a meta-analysis. Management: Consider alternatives to this combination when possible.  Rosiglitazone prescribing information states that the combination of rosiglitazone and a nitrate is not recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Sulfonylureas may enhance the anticoagulant effect of Vitamin K Antagonists. Vitamin K Antagonists may enhance the hypoglycemic effect of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: May increase the serum concentration of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F2529937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ethanol: Caution with ethanol (may cause hypoglycemia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: Caution with alfalfa, aloe, bilberry, bitter melon, burdock, celery, damiana, fenugreek, garcinia, garlic, ginger, ginseng (American), gymnema, marshmallow, stinging nettle (may cause hypoglycemia).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F2529679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2529680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted with this combination; therefore, rosiglitazone/glimepiride is classified as pregnancy category C. See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F2529922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F2529923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F2529950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken with the first main meal of the day. Dietary modification based on ADA recommendations is a part of therapy. Decreases blood glucose concentration. Hypoglycemia may occur. Must be able to recognize symptoms of hypoglycemia (palpitations, sweaty palms, lightheadedness).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Avandaryl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-1 mg (30): $156.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-2 mg (30): $156.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-4 mg (30): $156.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8-2 mg (30): $269.45",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8-4 mg (30): $269.45",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F2529953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hemoglobin A",
"     <sub>",
"      1c",
"     </sub>",
"     , fasting serum glucose; signs and symptoms of fluid retention or heart failure, blood pressure; liver enzymes (prior to initiation of therapy, then periodically thereafter); ophthalmic exams. Evaluate patients with ALT &le;2.5 times ULN at baseline or during therapy for cause of enzyme elevation. Patients with an elevation in ALT &gt;3 times ULN should be rechecked as soon as possible. If the ALT levels remain &gt;3 times ULN, therapy should be discontinued. Signs and symptoms of hypoglycemia (fatigue, excessive hunger, profuse sweating, numbness of extremities).",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F2529942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Recommendations for glycemic control in nonpregnant adults with diabetes (ADA, 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     : &lt;7% (a more aggressive [&lt;6.5%] or less aggressive [&lt;8%] Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     goal may be targeted based on patient-specific characteristics)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Preprandial capillary plasma glucose: 70-130 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Peak postprandial capillary blood glucose: &lt;180 mg/dL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Avaglim (AT, BE, BG, CH, CZ, DE, DK, ES, FI, FR, GB, GR, HN, IE, IT, NL, NO, PT, RU, SE, TR);",
"     </li>",
"     <li>",
"      Avandaryl (ID, PH);",
"     </li>",
"     <li>",
"      Enselin-2G (IN);",
"     </li>",
"     <li>",
"      Grexa Plus (PE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F2529940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rosiglitazone is a thiazolidinedione antidiabetic agent that lowers blood glucose by improving target cell response to insulin, without increasing pancreatic insulin secretion. It has a mechanism of action that is dependent on the presence of insulin for activity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glimepiride stimulates insulin release from the pancreatic beta cells; reduces glucose output from the liver; insulin sensitivity is increased at peripheral target sites.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F2529943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Diabetes Association, &ldquo;Standards of Medical Care in Diabetes Mellitus -- 2012,&rdquo;",
"      <i>",
"       Diabetes Care",
"      </i>",
"      , 2012, 35(Suppl 1):11-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/60/26567/abstract-text/22187469/pubmed\" id=\"22187469\" target=\"_blank\">",
"        22187469",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gerstein HC, Yusuf S, Bosch J, et al, &ldquo;Effect Of Rosiglitazone On The Frequency Of Diabetes In Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose: A Randomized Controlled Trial. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication)Trial Investigators,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2006,368(9541):2096-105.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/60/26567/abstract-text/16997664/pubmed\" id=\"16997664\" target=\"_blank\">",
"        16997664",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kahn SE, Haffner SM, Heise MA, et al, &ldquo;Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006:355(23):2427-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/60/26567/abstract-text/17145742/pubmed\" id=\"17145742\" target=\"_blank\">",
"        17145742",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lago RM, Singh PP, and Nesto RW, &ldquo;Congestive Heart Failure and Cardiovascular Death in Patients With Prediabetes and Type 2 Diabetes Given Thiazolidinediones: A Meta-Analysis of Randomized Clinical Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2007, 370(9593):1129-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/60/26567/abstract-text/17905165/pubmed\" id=\"17905165\" target=\"_blank\">",
"        17905165",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nissen SE, Wolski K, &ldquo;Effects Of Rosiglitazone On The Risk of Myocardial Infarction and Death From Cardiovascular Causes,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2007. Available at file://content.nejm.org/cgi/content/full/NEJMoa072761",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/60/26567/abstract-text/17517853/pubmed\" id=\"17517853\" target=\"_blank\">",
"        17517853",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Qaseem A, Humphrey LL, Sweet DE, et al,&ldquo;Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline from the American College of Physicians,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2012, 156(3):218-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/60/26567/abstract-text/22312141/pubmed\" id=\"22312141\" target=\"_blank\">",
"        22312141",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Singh S, Loke YK, and Furberg CD, &ldquo;Long-Term Risk of Cardiovascular Events With Rosiglitazone,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2007, 298(10):1189-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?25/60/26567/abstract-text/17848653/pubmed\" id=\"17848653\" target=\"_blank\">",
"        17848653",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10272 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-2ED33AB258-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26567=[""].join("\n");
var outline_f25_60_26567=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709406\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529528\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11245467\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529532\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529946\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529947\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529948\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529949\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529955\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529530\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11245585\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874985\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529951\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529535\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5174561\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529929\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529924\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529925\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529934\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529933\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529937\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529679\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529680\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529922\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529923\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529950\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422175\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529953\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529942\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539970\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529940\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529943\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10272\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10272|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/38/1638?source=related_link\">",
"      Rosiglitazone and glimepiride: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_60_26568="Cervicogenic headache";
var content_f25_60_26568=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cervicogenic headache",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/60/26568/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/60/26568/contributors\">",
"     David M Biondi, DO",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/60/26568/contributors\">",
"     Zahid H Bajwa, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/60/26568/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/60/26568/contributors\">",
"     Jerry W Swanson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/60/26568/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/60/26568/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/60/26568/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neck pain and cervical muscle tenderness are common and prominent symptoms of primary headache disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/1\">",
"     1",
"    </a>",
"    ]. Conversely, it is plausible that head pain can be referred from bony structures or soft tissues of the neck, a condition called cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/2\">",
"     2",
"    </a>",
"    ]. Nevertheless, there has been debate regarding the existence of cervicogenic headache as a distinct clinical disorder, as well as its underlying pathophysiology and source of pain [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/3-7\">",
"     3-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the definition, etiology, diagnosis, and treatment of cervicogenic headache.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is evidence that headache can be caused by referred pain from the upper cervical joints [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The anatomic locus for cervicogenic headache is the trigeminocervical nucleus in the upper cervical spinal cord, where sensory nerve fibers in the descending tract of the trigeminal nerve (trigeminal nucleus caudalis) are believed to interact with sensory fibers from the upper cervical roots (",
"    <a class=\"graphic graphic_figure graphicRef81107 \" href=\"UTD.htm?41/36/42563\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/8\">",
"     8",
"    </a>",
"    ]. This functional intersection of upper cervical and trigeminal sensory pathways is thought to allow the bidirectional transmission of pain signals between the neck and the trigeminal sensory receptive fields of the face and head.",
"   </p>",
"   <p>",
"    The first three cervical spinal nerves and their rami are the primary peripheral nerve structures that can refer pain to the head (",
"    <a class=\"graphic graphic_figure graphicRef58357 \" href=\"UTD.htm?1/0/1029\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The C1 spinal nerve (suboccipital nerve) innervates the atlanto-occipital joint. Pathology or injury affecting this joint is a potential source for pain that is referred to the occipital region of the head.",
"     </li>",
"     <li>",
"      The C2 spinal nerve and its dorsal root ganglion have a close proximity to the lateral capsule of the atlanto-axial (C1-2) zygapophyseal joint and innervate the atlanto-axial and C2-3 zygapophyseal joints. Trauma to, or pathologic changes around, these joints can be a source of referred head pain.",
"     </li>",
"     <li>",
"      The third occipital nerve (dorsal ramus C3) has a close anatomic proximity to, and innervates, the C2-3 zygapophyseal joint. Pain from the C2-3 zygapophyseal joint is referred to the occipital, frontotemporal and periorbital regions of the head (\"third occipital headache\").",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Involvement of the C2-3 zygapophyseal joint is the most frequent source of cervicogenic headache, accounting for up to 70 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6,9-13\">",
"     6,9-13",
"    </a>",
"    ]. The evidence implicating this joint as the source of cervicogenic headache is derived from studies of patients with a history of neck injury or trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6\">",
"     6",
"    </a>",
"    ]. As an example, one series of 100 patients who had chronic neck pain following whiplash found that the prevalence of third occipital headache was 27 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Involvement of the atlanto-axial joint is probably the second most common source of cervicogenic headache, but the true frequency is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6,11\">",
"     6,11",
"    </a>",
"    ]. Uncommon sources of cervicogenic headache include the C3-4 zygapophyseal joint, upper cervical intervertebral discs, and lower cervical zygapophyseal joints [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/10,14,15\">",
"     10,14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Available data suggest that the prevalence of cervicogenic headache in the general population is 0.4 to 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. However, there have been no rigorous, large scale epidemiologic studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DEFINITION AND CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no global consensus regarding the definition of cervicogenic headache, but two conflicting viewpoints are widely recognized [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One approach employs a definition that relies on clinical features, as proposed in 1983 with introduction of the term \"cervicogenic headache\" [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/2\">",
"       2",
"      </a>",
"      ]. In this sense, cervicogenic headache is said to be characterized by unilateral head pain of fluctuating intensity that is increased by movement of the head and radiates from occipital to frontal regions [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/2,3,21,22\">",
"       2,3,21,22",
"      </a>",
"      ]. The headache is precipitated by neck movement or sustained awkward head positioning. The headache does not shift from side to side. The pain is typically nonthrobbing, nonlancinating, of moderate to severe intensity, and of variable duration. Patients with cervicogenic headache may have restricted neck range of motion, and may have ipsilateral neck, shoulder, or arm pain.",
"      <br/>",
"      <br/>",
"      One problem with this definition is that the proposed clinical features of cervicogenic headache overlap with those commonly associated with primary headache disorders such as tension-type headache, migraine without aura, and hemicrania continua. As a result, distinguishing cervicogenic headache from other headache types can be difficult, and the validity of proposed diagnostic criteria has been challenged. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnostic criteria'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Another approach ignores clinical features of cervicogenic headache and relies instead on establishing the diagnosis by demonstrating a cervical source of head pain and confirming the diagnosis by anesthetic blocks that pinpoint sources of pain in the upper cervical joints [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic anesthetic blockade'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anesthetic blockade of the lateral atlanto-axial joint, the C2-3 zygapophyseal joint,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the C3-4 zygapophyseal joint can be used to confirm the diagnosis of cervicogenic headache. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Diagnostic anesthetic blockade'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Some investigators believe that the diagnosis of cervicogenic headache can be made in certain cases without doing an anesthetic procedure, if the diagnosis is based on a careful history, physical examination, and a complete neurologic assessment. Limited evidence suggests that the presence of a combination of physical measures &mdash; palpably painful upper cervical joints, restricted range of neck extension, and muscle impairment characterized by reduced electromyographic activity in the deep neck flexors &mdash; can distinguish cervicogenic headache from migraine and tension-type headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/23\">",
"     23",
"    </a>",
"    ]. However, the diagnostic utility of this method has not been validated, and its use requires specialized skills and equipment.",
"   </p>",
"   <p>",
"    Others argue that cervicogenic headache cannot be diagnosed on clinical grounds alone since the definitive criterion is complete relief of pain after controlled anesthetic blocks of cervical structures or their nerve supply [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/24\">",
"     24",
"    </a>",
"    ]. In support of the latter viewpoint, a study that evaluated 71 patients with chronic neck pain and headache found no distinguishing features on history or examination that confirmed a definitive diagnosis of third occipital headache before nerve blocks [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since accurate diagnosis of cervicogenic headache is a prerequisite to appropriate treatment, we suggest that the diagnosis should be confirmed by controlled anesthetic blocks of cervical structures or their nerve supply. These blocks should be performed by an experienced specialist &ndash; where available &ndash; as discussed below. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Diagnostic anesthetic blockade'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Other headache etiologies should be pursued if the response to diagnostic blockade is incomplete.",
"   </p>",
"   <p>",
"    Imaging with plain films, cervical spine MRI, and CT myelography cannot confirm the diagnosis of cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Imaging is primarily used to search for secondary causes of pain that may require surgery or other, more aggressive forms of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic criteria for cervicogenic headache have been proposed by two groups: the Cervicogenic Headache International Study Group (CHISG) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/22\">",
"     22",
"    </a>",
"    ] and the International Headache Society (IHS) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although these two criteria have some similarities, they mainly reflect the conflicting approaches regarding the definition and clinical features of cervicogenic headache discussed above (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Definition and clinical features'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The CHISG criteria has an obligatory requirement for symptoms or signs of neck involvement that may be fulfilled if head pain is precipitated by neck movement, sustained awkward head positioning, or by external pressure over the upper cervical or occipital region on the symptomatic side [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/22\">",
"       22",
"      </a>",
"      ]. This criterion may also be fulfilled by the combination of both restricted neck range of motion and ipsilateral neck, shoulder, or arm pain that is vague and nonradicular or radicular in nature. The CHISG criteria also require confirmatory evidence by anesthetic blocks, but this requirement is only obligatory for \"scientific works.\"",
"      <br/>",
"      <br/>",
"      The CHISG criteria describe the headache as nonthrobbing and nonlancinating, but these are not obligatory features. In addition, the CHISG criteria permit the occasional presence of certain migrainous features, including nausea, phonophobia and photophobia, dizziness, and ipsilateral blurred vision.",
"     </li>",
"     <li>",
"      The IHS criteria require that head pain be referred from an identifiable anatomic source in the neck, as demonstrated by clinical signs that implicate a neck source or by abolition of headache following diagnostic blockade of a cervical structure or its nerve [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/28\">",
"       28",
"      </a>",
"      ]. There must be clinical, laboratory,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      imaging evidence of a disorder or lesion within the cervical spine or soft tissues of the neck known to be, or generally accepted as, a valid cause of headache. In addition, the pain must resolve within three months after successful treatment of the causative disorder or lesion.",
"      <br/>",
"      <br/>",
"      The IHS criteria do not delineate clinical headache features beyond stating that pain may be perceived in one or more regions of the head",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      face.",
"      <br/>",
"      <br/>",
"      The IHS notes that tumors, fractures, infections, and rheumatoid arthritis of the upper cervical spine have not been validated formally as causes of headache. Nevertheless, these conditions are accepted as valid causes when demonstrated to be so in individual cases [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/28\">",
"       28",
"      </a>",
"      ]. In contrast, cervical spondylosis and osteochondritis are",
"      <strong>",
"       not",
"      </strong>",
"      accepted as valid causes of headache by the IHS. Furthermore, the IHS criteria state that the headache should be coded as tension-type headache when myofascial tender spots are believed to be the primary cause of headache.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The utility of the CHISG criteria for cervicogenic headache appear to be limited by the nonspecific nature of the clinical features. A critical review of cervicogenic headache diagnostic criteria concluded that although neck structures play a role in the pathophysiology of some headaches, clinical patterns indicating a neck-headache relationship have still not been adequately defined [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The IHS criteria acknowledge this shortcoming, noting that neck pain, focal neck tenderness, history of neck trauma, mechanical exacerbation of pain, unilaterality, coexisting shoulder pain, reduced range of motion in the neck, nuchal onset, nausea, vomiting, and photophobia are not unique to cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/28\">",
"     28",
"    </a>",
"    ]. These signs and symptoms may be features of cervicogenic headache, but they do not define the relationship between the disorder and the source of the headache.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnostic anesthetic blockade",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic anesthetic blocks for cervicogenic headache are not generally performed as office procedures and are not readily available to many practitioners [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/24\">",
"     24",
"    </a>",
"    ]. Rather, these anesthetic blocks require specialized skills and facilities, a limitation that adds to the difficulty of confirming the diagnosis.",
"   </p>",
"   <p>",
"    Diagnostic anesthetic blockade for the evaluation of cervicogenic headache are directed to several anatomic structures [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6,9,29\">",
"     6,9,29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The lateral atlanto-axial joint, by intraarticular blocks",
"     </li>",
"     <li>",
"      The C2-3 zygapophyseal joint, by blocking the third occipital nerve where it crosses the joint",
"     </li>",
"     <li>",
"      The C3-4 zygapophyseal, by blocking the deep medial branches of the C3 and C4 dorsal rami",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When the diagnosis is in doubt, anesthetic blocks should be performed in a blinded fashion using saline or other appropriate controls in order to identify true-positive cases and exclude placebo responders [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fluoroscopic or interventional MRI guided blockade may be necessary to assure accurate and specific localization of the pain source [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/32-34\">",
"     32-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no anatomic rationale for greater occipital nerve blockade in the diagnosis or treatment of cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6\">",
"     6",
"    </a>",
"    ]. Such blockade is performed close to where the nerve crosses the superior nuchal line, beyond which the nerve supplies the scalp of the occipital region. Thus, greater occipital nerve blockade does",
"    <strong>",
"     not",
"    </strong>",
"    confirm a cervical source of pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Internal carotid or vertebral artery dissection, which present with neck pain and headache, is an important consideration in the differential diagnosis of acute cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. Other conditions in the differential include posterior fossa tumor, Arnold-Chiari malformation, cervical spondylosis or arthropathy, herniated intervertebral disc, spinal nerve compression or tumor, arteriovenous malformation, and intramedullary or extramedullary spinal tumor. In addition, migraine and tension-type headache are common conditions that should be considered in cases of suspected cervicogenic headache, particularly when chronic [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Migraine and tension-type headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neck pain and muscle tension are common symptoms of a migraine attack [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/1,38-40\">",
"     1,38-40",
"    </a>",
"    ]. Muscle tenderness in the posterior head and upper neck is common in tension-type headache as well. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=see_link\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32441?source=see_link\">",
"     \"Tension-type headache in adults: Pathophysiology, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one study of 50 patients with migraine, neck pain or stiffness associated with the migraine attack was reported by 32 patients (64 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/1\">",
"     1",
"    </a>",
"    ]. Referred pain into the ipsilateral shoulder was present in seven (14 percent). In another report of 144 patients, neck pain associated with migraine attacks was noted by 108 patients (75 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/39\">",
"     39",
"    </a>",
"    ]. Of these 108 patients, the pain was described as tightness by 69 percent, stiffness by 17 percent, and throbbing by 5 percent. The neck pain was unilateral in 57 percent, among whom it was ipsilateral to the side of headache in 98 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     C2 spinal nerve lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two distinctive clinical syndromes caused by lesions or injury affecting the C2 spinal nerve that may be confused with cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      C2 neuralgia is characterized by a paroxysmal sharp or shock-like pain centered in the occipital region [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/41-43\">",
"       41-43",
"      </a>",
"      ]. Ipsilateral eye lacrimation and conjunctival injection are common associated signs. These features contrast with the dull aching pain associated with cervicogenic headache [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6\">",
"       6",
"      </a>",
"      ]. Arterial or venous compression of the C2 spinal nerve or its dorsal root ganglion has been implicated as a cause for C2 neuralgia in some cases [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/41,44-46\">",
"       41,44-46",
"      </a>",
"      ]. Meningioma has been rarely implicated [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Neck&mdash;tongue syndrome is precipitated when rapid head turning causes subluxation of the posterior atlanto-axial joint [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/48,49\">",
"       48,49",
"      </a>",
"      ]. The symptoms include occipital pain from joint capsule irritation and numbness of the tongue from C2 spinal root compression.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Occipital neuralgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occipital neuralgia is a pain disorder characterized by paroxysmal jabbing pain in the distribution of the greater or lesser occipital nerves or of the third occipital nerve, sometimes accompanied by diminished sensation or dysesthesia in the affected area [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/28\">",
"     28",
"    </a>",
"    ]. In the classic description of occipital neuralgia, additional features include constant deep or burning pain with superimposed paroxysms of shooting pain. The pain is temporarily reduced or abolished by anesthetic blockade of the nerve.",
"   </p>",
"   <p>",
"    Occipital neuralgia must be distinguished from occipital referral of pain from the atlanto-axial or upper zygapophyseal joints or from tender trigger points in neck muscles or their insertions [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/28\">",
"     28",
"    </a>",
"    ]. In our experience, this distinction may be difficult despite careful evaluation of clinical features and thorough examination. In such cases, the use of image-directed anesthetic blockade can usually permit an accurate diagnosis.",
"   </p>",
"   <p>",
"    Occipital neuralgia is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31509?source=see_link\">",
"     \"Occipital neuralgia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no proven effective treatment for cervicogenic headache. However, a number of different treatment modalities are available. Physical therapy is the preferred initial treatment because it is noninvasive. The available evidence suggests that pharmacologic therapy and botulinum toxin injections are",
"    <strong>",
"     not",
"    </strong>",
"    beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6,50\">",
"     6,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Physical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical therapy may provide long-term improvement for cervicogenic headache. Based upon two randomized controlled trials that investigated cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/51,52\">",
"     51,52",
"    </a>",
"    ], a 2012 systematic review concluded that there is low to moderate quality evidence supporting the use of specific exercises for the treatment of subacute or chronic cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/53\">",
"     53",
"    </a>",
"    ]. In the larger of the two included trials, which evaluated 200 patients with cervicogenic headache, treatment was unblinded and assessment was blinded [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/51\">",
"     51",
"    </a>",
"    ]. Compared with controls who received no treatment, those assigned to six weeks of active treatment with either manipulative therapy, low-load endurance exercise therapy, or a combination of both therapies had a significant reduction in headache frequency at 12 months. The effect size was reported as moderate and clinically relevant. Combined treatment was not significantly better than either manipulative therapy or exercise alone.",
"   </p>",
"   <p>",
"    Of concern, the cervical joint manipulation regimen used in this study consisted of both low-velocity and high-velocity techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/51\">",
"     51",
"    </a>",
"    ]. The concern arises because high-velocity chiropractic manipulation has been linked to a risk of arterial dissection and stroke in the vertebrobasilar territory. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41222?source=see_link&amp;anchor=H13#H13\">",
"     \"Spinal manipulation in the treatment of musculoskeletal pain\", section on 'Serious adverse events'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given these data, we suggest physical therapy with exercise as the initial treatment option for patients with cervicogenic headache. We recommend",
"    <strong>",
"     not",
"    </strong>",
"    using high-velocity manipulation therapy because it is associated with a risk of stroke, and because the available limited evidence suggests that manipulation has no advantage over exercise therapy.",
"   </p>",
"   <p>",
"    In our clinical experience, the intensity of headache may initially worsen during or after physical therapy, especially if it is vigorously applied. Physical treatment is better tolerated when initiated with gentle muscle stretching and manual cervical traction. Therapy can be slowly advanced as tolerated to include strengthening and aerobic conditioning. Using anesthetic blockade for temporary pain relief may enhance patient tolerance of physical therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Anesthetic blockade",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anesthetic injections of the lateral atlanto-axial joint, the C2-3 zygapophyseal joint,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the C3-4 zygapophyseal joint can temporarily reduce or relieve pain and may allow greater participation in physical treatments.",
"   </p>",
"   <p>",
"    Greater and lesser occipital nerve blockade may provide temporary pain relief in some cases, but the benefit of this treatment is not specific for cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6,54\">",
"     6,54",
"    </a>",
"    ]. In addition, there is no anatomic rationale for greater occipital nerve blockade in the diagnosis or treatment of cervicogenic headache. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Diagnostic anesthetic blockade'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Radiofrequency neurotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous radiofrequency neurotomy can be considered for cervicogenic headache arising from the C2-3 zygapophyseal joint if diagnostic anesthetic nerve blockade is temporarily successful in providing complete pain relief. Although the benefit of this procedure specifically for cervicogenic headache has not been established by adequate randomized controlled trials, there is evidence of benefit in a well-performed uncontrolled study [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/55\">",
"     55",
"    </a>",
"    ], and in a randomized trial that evaluated patients with neck pain [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/56\">",
"     56",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 49 patients with cervicogenic headache, selected on the basis of controlled diagnostic blocks of the third occipital nerve, treatment with radiofrequency neurotomy was associated with complete relief of pain in 43 patients (88 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/55\">",
"       55",
"      </a>",
"      ]. The median duration of relief was 297 days. After recurrence, headache relief could be reestablished by repeating the procedure. Side effects of the procedure were consistent with denervation of the third occipital nerve and included mild ataxia, numbness, and temporary dysesthesia. None of these side effects required intervention.",
"     </li>",
"     <li>",
"      In a randomized controlled trial that evaluated 24 patients with neck pain (chronic cervical zygapophyseal joint pain but",
"      <strong>",
"       not",
"      </strong>",
"      cervicogenic headache), subjects were selected on the basis of complete pain relief with diagnostic nerve blockade using double-blind, placebo-controlled local anesthesia [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/56\">",
"       56",
"      </a>",
"      ]. Patients assigned to radiofrequency neurotomy had a significantly longer pain relief compared with those assigned to sham neurotomy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, a randomized controlled trial of 12 patients diagnosed with cervicogenic headache on the basis of purely clinical criteria found that radiofrequency neurotomy was",
"    <strong>",
"     not",
"    </strong>",
"    beneficial compared with sham treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/57\">",
"     57",
"    </a>",
"    ]. A major limitation of this study is that all included patients had an incomplete response to diagnostic anesthetic blockade and, thus, might not be expected to respond to radiofrequency denervation [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/58\">",
"     58",
"    </a>",
"    ]. In addition, neurotomy was performed from C3 to C6, but these levels have",
"    <strong>",
"     not",
"    </strong>",
"    been credibly identified as sources of headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the available data, we suggest radiofrequency neurotomy for patients with cervicogenic headache arising from the C2-3 zygapophyseal joint who have the diagnosis confirmed by complete pain relief in response to controlled anesthetic block and who are refractory to noninvasive therapy. The benefit of radiofrequency neurotomy for other etiologies of cervicogenic headache is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Glucocorticoid injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no controlled trials evaluating glucocorticoid injections for cervicogenic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/6\">",
"     6",
"    </a>",
"    ]. However, results from small retrospective studies suggest that some patients may obtain relief from intraarticular glucocorticoid injections [",
"    <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, 18 patients with cervicogenic headache had fluoroscopically guided therapeutic intraarticular glucocorticoid injections at the C2-3 zygapophyseal joint. At 19 months after injection, reduced headache frequency was noted for 11 patients (61 percent), and freedom from pain for two (11 percent).",
"     </li>",
"     <li>",
"      Another study identified 32 patients cervicogenic headache related to atlanto-axial joint pain, confirmed by diagnostic block [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/60\">",
"       60",
"      </a>",
"      ]. Immediately following intraarticular glucocorticoid injections, a &ge;50 percent decrease in pain scores was noted by 26 patients (82 percent). However, at six months, the difference between pre- and postprocedure pain scores was not statistically significant.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of surgical interventions have been performed for presumed cases of cervicogenic headache. The available data are limited to small retrospective studies, but suggest that surgery may be beneficial for three specific causes &mdash; 1) C2 spinal nerve compression by",
"    <span class=\"nowrap\">",
"     vascular/ligamentous",
"    </span>",
"    structures, 2) osteoarthritis of the lateral atlanto-axial joint, and 3) upper cervical intervertebral disc pathology &mdash; of cervicogenic headache.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgical decompression and microsurgical neurolysis of the C2 spinal nerve was reported in one series of 31 patients who met clinical criteria for cervicogenic headache, including headache relief from diagnostic block of the C2 spinal nerve. Treatment was associated with complete pain relief in 14 patients (45 percent) and \"adequate improvement\" in 16 (52 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Arthrodesis is an option for the treatment of cervical pain and headache related to osteoarthritis of the lateral atlanto-axial joint. In three studies that reported a total of 24 patients, complete relief of pain or an \"excellent result\" was achieved in almost all patients, with benefit lasting two or more years [",
"      <a class=\"abstract\" href=\"UTD.htm?25/60/26568/abstract/61-63\">",
"       61-63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intensification of pain and anesthesia dolorosa are potential adverse outcomes that must be considered when contemplating the use of surgical interventions.",
"   </p>",
"   <p>",
"    Surgical procedures for cervicogenic headache are",
"    <strong>",
"     not",
"    </strong>",
"    recommended unless there is compelling evidence of a surgically amenable lesion causing cervicogenic headache in patients who are refractory to all reasonable nonsurgical treatments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/31/23026?source=see_link\">",
"       \"Patient information: Neck pain (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/45/17106?source=see_link\">",
"       \"Patient information: Whiplash (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?26/35/27188?source=see_link\">",
"       \"Patient information: Neck pain (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The underlying pathophysiology and source of pain in cervicogenic headache are controversial. The most persuasive explanation is that cervicogenic headache is caused by referred pain from the upper cervical joints (",
"      <a class=\"graphic graphic_figure graphicRef81107 \" href=\"UTD.htm?41/36/42563\">",
"       figure 1",
"      </a>",
"      ). The first three cervical spinal nerves and their rami are the primary peripheral nerve structures that can refer pain to the head (",
"      <a class=\"graphic graphic_figure graphicRef58357 \" href=\"UTD.htm?1/0/1029\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology and anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no consensus regarding the definition of cervicogenic headache, but two conflicting viewpoints are widely recognized. One relies on clinical features, while the other ignores clinical features and relies on the demonstration of a distinct anatomic source in the neck that can cause head pain. The definitive criterion for the latter definition is complete relief of pain after controlled anesthetic blocks of cervical structures or their nerve supply. Conflicting diagnostic criteria have also been proposed. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Definition and clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since accurate diagnosis of cervicogenic headache is a prerequisite to treatment, we suggest that the diagnosis should be confirmed by controlled anesthetic blocks of cervical structures or their nerve supply if available. Other headache etiologies should be pursued if the response to diagnostic blockade is incomplete. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic anesthetic blockade'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dissection of the internal carotid or vertebral artery is an important consideration in cases of suspected acute cervicogenic headache. In addition, the differential diagnosis includes posterior fossa lesions, migraine and tension-type headache, particularly when head pain is chronic. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no proven treatment for cervicogenic headache. For patients with probable cervicogenic headache that is diagnosed by clinical criteria, with or without confirmatory diagnostic anesthetic block, we suggest physical therapy as the initial treatment option (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, high-velocity cervical manipulation techniques are associated with a risk of ischemic vertebrobasilar territory stroke and should",
"      <strong>",
"       not",
"      </strong>",
"      be used as part of the treatment regimen. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Physical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with cervicogenic headache who are refractory to physical therapy and who have a source of pain confirmed by diagnostic blockade, treatment options depend on the site causing the headache:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with cervicogenic headache stemming from the C2-3 zygapophyseal joint, confirmed by complete pain relief with diagnostic blockade, we suggest radiofrequency neurotomy of the third occipital nerve (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For patients who do not want neurotomy, we suggest intraarticular glucocorticoid injections (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Radiofrequency neurotomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Glucocorticoid injection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with cervicogenic headache stemming from the atlanto-axial joint &ndash; confirmed by complete pain relief with diagnostic blockade &ndash; who are refractory to physical therapy, we suggest arthrodesis of the joint (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/1\">",
"      Blau JN, MacGregor EA. Migraine and the neck. Headache 1994; 34:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/2\">",
"      Sjaastad O, Saunte C, Hovdahl H, et al. \"Cervicogenic\" headache. An hypothesis. Cephalalgia 1983; 3:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/3\">",
"      P&ouml;llmann W, Keidel M, Pfaffenrath V. Headache and the cervical spine: a critical review. Cephalalgia 1997; 17:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/4\">",
"      Leone M, D'Amico D, Grazzi L, et al. Cervicogenic headache: a critical review of the current diagnostic criteria. Pain 1998; 78:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/5\">",
"      Frese A, Evers S. Biological markers of cervicogenic headache. Cephalalgia 2008; 28 Suppl 1:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/6\">",
"      Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol 2009; 8:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/7\">",
"      Rana MV. Managing and treating headache of cervicogenic origin. Med Clin North Am 2013; 97:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/8\">",
"      Bogduk N. The anatomical basis for cervicogenic headache. J Manipulative Physiol Ther 1992; 15:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/9\">",
"      Lord SM, Barnsley L, Wallis BJ, Bogduk N. Third occipital nerve headache: a prevalence study. J Neurol Neurosurg Psychiatry 1994; 57:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/10\">",
"      Cooper G, Bailey B, Bogduk N. Cervical zygapophysial joint pain maps. Pain Med 2007; 8:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/11\">",
"      Dwyer A, Aprill C, Bogduk N. Cervical zygapophyseal joint pain patterns. I: A study in normal volunteers. Spine (Phila Pa 1976) 1990; 15:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/12\">",
"      Bogduk N, Marsland A. The cervical zygapophysial joints as a source of neck pain. Spine (Phila Pa 1976) 1988; 13:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/13\">",
"      Bogduk N, Marsland A. On the concept of third occipital headache. J Neurol Neurosurg Psychiatry 1986; 49:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/14\">",
"      Schofferman J, Garges K, Goldthwaite N, et al. Upper cervical anterior diskectomy and fusion improves discogenic cervical headaches. Spine (Phila Pa 1976) 2002; 27:2240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/15\">",
"      Park SW, Park YS, Nam TK, Cho TG. The effect of radiofrequency neurotomy of lower cervical medial branches on cervicogenic headache. J Korean Neurosurg Soc 2011; 50:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/16\">",
"      Sjaastad O. Cervicogenic headache: comparison with migraine without aura; V&aring;g&aring; study. Cephalalgia 2008; 28 Suppl 1:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/17\">",
"      Nilsson N. The prevalence of cervicogenic headache in a random population sample of 20-59 year olds. Spine (Phila Pa 1976) 1995; 20:1884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/18\">",
"      Sjaastad O, Fredriksen TA. Cervicogenic headache: criteria, classification and epidemiology. Clin Exp Rheumatol 2000; 18:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/19\">",
"      Haldeman S, Dagenais S. Cervicogenic headaches: a critical review. Spine J 2001; 1:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/20\">",
"      Bogduk, N. Distinguishing primary headache disorders from cervicogenic headache: clinical and therapeutic implications. Headache Currents 2005; 2:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/21\">",
"      Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. Headache 1990; 30:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/22\">",
"      Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. The Cervicogenic Headache International Study Group. Headache 1998; 38:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/23\">",
"      Jull G, Amiri M, Bullock-Saxton J, et al. Cervical musculoskeletal impairment in frequent intermittent headache. Part 1: Subjects with single headaches. Cephalalgia 2007; 27:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/24\">",
"      Bogduk N. The neck and headaches. Neurol Clin 2004; 22:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/25\">",
"      Fredriksen TA, Fougner R, Tangerud A, Sjaastad O. Cervicogenic headache. Radiological investigations concerning head/neck. Cephalalgia 1989; 9:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/26\">",
"      Knackstedt H, Kr&aring;kenes J, Bansevicius D, Russell MB. Magnetic resonance imaging of craniovertebral structures: clinical significance in cervicogenic headaches. J Headache Pain 2012; 13:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/27\">",
"      Delfini R, Salvati M, Passacantilli E, Pacciani E. Symptomatic cervicogenic headache. Clin Exp Rheumatol 2000; 18:S29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/28\">",
"      Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/29\">",
"      Aprill C, Axinn MJ, Bogduk N. Occipital headaches stemming from the lateral atlanto-axial (C1-2) joint. Cephalalgia 2002; 22:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/30\">",
"      Barnsley L, Lord S, Bogduk N. Comparative local anaesthetic blocks in the diagnosis of cervical zygapophysial joint pain. Pain 1993; 55:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/31\">",
"      Lord SM, Barnsley L, Bogduk N. The utility of comparative local anesthetic blocks versus placebo-controlled blocks for the diagnosis of cervical zygapophysial joint pain. Clin J Pain 1995; 11:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/32\">",
"      Stolker RJ, Vervest AC, Groen GJ. The management of chronic spinal pain by blockades: a review. Pain 1994; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/33\">",
"      Schellhas KP. Facet nerve blockade and radiofrequency neurotomy. Neuroimaging Clin N Am 2000; 10:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/34\">",
"      Bovim G, Berg R, Dale LG. Cervicogenic headache: anesthetic blockades of cervical nerves (C2-C5) and facet joint (C2/C3). Pain 1992; 49:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/35\">",
"      Campos CR, Calderaro M, Scaff M, Conforto AB. Primary headaches and painful spontaneous cervical artery dissection. J Headache Pain 2007; 8:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/36\">",
"      Saeed AB, Shuaib A, Al-Sulaiti G, Emery D. Vertebral artery dissection: warning symptoms, clinical features and prognosis in 26 patients. Can J Neurol Sci 2000; 27:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/37\">",
"      de Sousa JE, Halfon MJ, Bonardo P, et al. Different pain patterns in patients with vertebral artery dissections. Neurology 2005; 64:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/38\">",
"      Tfelt-Hansen P, Lous I, Olesen J. Prevalence and significance of muscle tenderness during common migraine attacks. Headache 1981; 21:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/39\">",
"      Kaniecki RG. Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology 2002; 58:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/40\">",
"      Waelkens J. Warning symptoms in migraine: characteristics and therapeutic implications. Cephalalgia 1985; 5:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/41\">",
"      Jansen J, Bardosi A, Hildebrandt J, L&uuml;cke A. Cervicogenic, hemicranial attacks associated with vascular irritation or compression of the cervical nerve root C2. Clinical manifestations and morphological findings. Pain 1989; 39:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/42\">",
"      Jansen J, Markakis E, Rama B, Hildebrandt J. Hemicranial attacks or permanent hemicrania--a sequel of upper cervical root compression. Cephalalgia 1989; 9:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/43\">",
"      Hildebrandt J, Jansen J. Vascular compression of the C2 and C3 roots--yet another cause of chronic intermittent hemicrania? Cephalalgia 1984; 4:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/44\">",
"      Sharma RR, Parekh HC, Prabhu S, et al. Compression of the C-2 root by a rare anomalous ectatic vertebral artery. Case report. J Neurosurg 1993; 78:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/45\">",
"      Pikus HJ, Phillips JM. Characteristics of patients successfully treated for cervicogenic headache by surgical decompression of the second cervical root. Headache 1995; 35:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/46\">",
"      Pikus HJ, Phillips JM. Outcome of surgical decompression of the second cervical root for cervicogenic headache. Neurosurgery 1996; 39:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/47\">",
"      Kuritzky A. Cluster headache-like pain caused by an upper cervical meningioma. Cephalalgia 1984; 4:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/48\">",
"      Lance JW, Anthony M. Neck-tongue syndrome on sudden turning of the head. J Neurol Neurosurg Psychiatry 1980; 43:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/49\">",
"      Bogduk N. An anatomical basis for the neck-tongue syndrome. J Neurol Neurosurg Psychiatry 1981; 44:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/50\">",
"      Linde M, Hagen K, Salvesen &Oslash;, et al. Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study. Cephalalgia 2011; 31:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/51\">",
"      Jull G, Trott P, Potter H, et al. A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Spine (Phila Pa 1976) 2002; 27:1835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/52\">",
"      Hall T, Chan HT, Christensen L, et al. Efficacy of a C1-C2 self-sustained natural apophyseal glide (SNAG) in the management of cervicogenic headache. J Orthop Sports Phys Ther 2007; 37:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/53\">",
"      Kay TM, Gross A, Goldsmith CH, et al. Exercises for mechanical neck disorders. Cochrane Database Syst Rev 2012; 8:CD004250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/54\">",
"      Anthony M. Cervicogenic headache: prevalence and response to local steroid therapy. Clin Exp Rheumatol 2000; 18:S59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/55\">",
"      Govind J, King W, Bailey B, Bogduk N. Radiofrequency neurotomy for the treatment of third occipital headache. J Neurol Neurosurg Psychiatry 2003; 74:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/56\">",
"      Lord SM, Barnsley L, Wallis BJ, et al. Percutaneous radio-frequency neurotomy for chronic cervical zygapophyseal-joint pain. N Engl J Med 1996; 335:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/57\">",
"      Stovner LJ, Kolstad F, Helde G. Radiofrequency denervation of facet joints C2-C6 in cervicogenic headache: a randomized, double-blind, sham-controlled study. Cephalalgia 2004; 24:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/58\">",
"      Bogduk N. Cervicogenic headache. Cephalalgia 2004; 24:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/59\">",
"      Slipman CW, Lipetz JS, Plastaras CT, et al. Therapeutic zygapophyseal joint injections for headaches emanating from the C2-3 joint. Am J Phys Med Rehabil 2001; 80:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/60\">",
"      Narouze SN, Casanova J, Mekhail N. The longitudinal effectiveness of lateral atlantoaxial intra-articular steroid injection in the treatment of cervicogenic headache. Pain Med 2007; 8:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/61\">",
"      Joseph B, Kumar B. Gallie's fusion for atlantoaxial arthrosis with occipital neuralgia. Spine (Phila Pa 1976) 1994; 19:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/62\">",
"      Ghanayem AJ, Leventhal M, Bohlman HH. Osteoarthrosis of the atlanto-axial joints. Long-term follow-up after treatment with arthrodesis. J Bone Joint Surg Am 1996; 78:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/60/26568/abstract/63\">",
"      Schaeren S, Jeanneret B. Atlantoaxial osteoarthritis: case series and review of the literature. Eur Spine J 2005; 14:501.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3354 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-47BF19C4B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26568=[""].join("\n");
var outline_f25_60_26568=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY AND ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DEFINITION AND CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnostic anesthetic blockade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Migraine and tension-type headache",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      C2 spinal nerve lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Occipital neuralgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Physical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Anesthetic blockade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Radiofrequency neurotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Glucocorticoid injection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/3354\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/3354|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/36/42563\" title=\"figure 1\">",
"      Trigeminocervical nucleus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/0/1029\" title=\"figure 2\">",
"      Upper cervical spinal nerves",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31509?source=related_link\">",
"      Occipital neuralgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=related_link\">",
"      Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/35/27188?source=related_link\">",
"      Patient information: Neck pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/31/23026?source=related_link\">",
"      Patient information: Neck pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/45/17106?source=related_link\">",
"      Patient information: Whiplash (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41222?source=related_link\">",
"      Spinal manipulation in the treatment of musculoskeletal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32441?source=related_link\">",
"      Tension-type headache in adults: Pathophysiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_60_26569="Complete mole path histo";
var content_f25_60_26569=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Complete hydatidform mole",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 478px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Complete hydatidiform mole. A) Complete mole in which the entire uterine cavity is filled with swollen villi. B) The villi are each 1 to 3 mm in diameter and appear grapelike. C) Individual molar villi, many of which have cavitated central cisterns, exhibit considerable trophoblastic hyperplasia and atypia. The blood vessels of the villi have atrophied and disappeared.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rubin E MD and Farber JL MD. Pathology, 3rd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 1999. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26569=[""].join("\n");
var outline_f25_60_26569=null;
var title_f25_60_26570="Nodular BCC 10x";
var content_f25_60_26570=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F68853%7EONC%2F79258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F68853%7EONC%2F79258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nodular basal cell carcinoma (10x)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 311px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gary Goldenberg, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nodular basal cell carcinoma (20x)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFDAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0DWvHvg/4hNLoJa/iuLKYTCZoSiRyoSuM9+pGPenWVnI2tXAEOBIzKHQnMYxg5PXB7Vy0d9fW2ozXM0PzRlWjZEAG0HDEj16da9Y8L7V0WS+voirkcled/wBK9ucFh4e5t631Z7nIqELdP8y/YeEdMM9rfywg3CxlTjhW3AA5HfitFl0/R7cIixwQxchUwCfrXJeI/EOsS6Za3Oip5doJ/JuQB+8QYyMe30rFZbi+G+e581JJtzsjZxjjH1rCGHqVNaktOxzKlUqO85adi14laLxDOGVbkKjFflTduHYir1r4Pv3bTGhu/wDRVDLcliVZ1PQAD8RzUPiG307w0+mfbXnuJ5V2xb32IMY9O/NQf8JJrOh+JFtLrzJrOdd8MYiLA987x93+XFdSc5U0qG2tr9fQ2XM4fuvxHv4AmGsw3mq+TfLA3+hmNdn2deuDxkn3/lVeW0miupo7WCBp70MEZpSq7v4tgJ44rW1HxmdVRLTRIr0I8Zdr6KISRxsM/Jk9WyKxNI1i11RA7WPmavbMYzMdy+UOpYxk5U/p706bruN6q2/rX5ihKq1eaLUmdK1LTE0mwSW6+WOa3L7IycffyRyf8KoSa+yvLZxQ2cTtJm6uZlyirnGB61paxq6WxtYLjT5bq4D5ivhwu78O31qDTfBTXOpm/unWd5EZZonYMpI5Xb6c1UZQUear/wAOaKy96Z21xq9paWMVpaxhpjHxEi42jHU+lcYx1SewkWK7itLhy0kiiPcSgPAUnofel0hdUeC8guY1kvvNH2iffyqY+6PQDArW0290iDXrie8u7dns7JS0hOVUZySOxrnjBUb8ur37mKUaadld7k2izSQ6aWltbeJJQY1t+ruT13e9RR39osE2m2kMcAFu0bSwHasRPHHp9RWbd65aeVBLo8LtLOTMplI83bkfMR2z1+mKfeahLqyvBYQG3vrjZGIpiAqruyZT78Gj2TbvJWuHLfVrcwwtzpiW0NzZxzJZxFVuocKsjH+FSeTj17k1PofhKSbUby/upHCX6srpJKCyN1A46Adq0fGV0uI0kK/YRGUiu1ALsw4JwOAM8UzwfosuqaLuF5dwtNKSJEJG1V4+8epPNbuq1S572ua+0ajzbDtdsh4c0y1kjCXU6Ng+a4Dkeig9aztJ8Uz68h8nTprb+zmIimhn27wR0KnqKl1Rni8QSQagJruWIKIZtmAqDqo9feoLAW+m66W1e2YwSIQUBJDKBxge2RSik4Xkry3X/DCteN5K7LCOb0t9oila2iPnSlwA24dhmtbQ9VsNS0nbJZi3t5ZDDGlwNwZh3P49K3oNOsJtKlcAXFtIMhGblPbPXtXGrFJLZPYWUtxYvEWeGGdMeYynkAng8GsFONVNbWIU4yWnQo6beaxqeu3WnXdw2HVwscf3FjXjOO30qXWrm11LUNLhLwjT1hYpngxsvDbvcjgVFp5vRpX2rTY5VuTcPFdTTfeRcEHHtkZrmrnVJLLT7JJU+3wM/lnyl+bO7B5711xp80vd6afmbqHvaDNJ8Kajq9reS6VPHiS6kxcOv70xg/Lk9gBxitvWbfU/B2oQ3SvbzWskGwpJgZkGORXbWVsvh7SA1lbSoiR+YIV5ZiRnFcx4te11KLTZtXgNs7qH8uQ/vS39xR/U1CxMqtSzV4/iN1HOSvsMezs7+B7y6kmihuExcQN8q+5/Pmq194itU8mx0iVktUAQbUOSB/DmtHVZJLu3017K1nhWXcGtnx0H8Rb39K3/AAxpsUqMsujw21qgEkbH7zv3JBrNzUI809fK5MqkYrVHGxW01vHfMC8UMOZVilX5GLDAwR+RrktDGpR6hDewxXsk0bncqJwy/wB0Zr2+8urezjlgtkge6YfM7j5V9BWFZyTWNlIb6/3uxO1VUAqPUUU8W7P3dyqdVyT90peJtGj1C2stTu70WMKgJNG6gnB/hHvmvPtc0pBrrXWmISkSBN0qYRec4UD7xzzgV3k2q6bDKLa5liN0g80POd5wT1FZ+vXUlwwtndoridWSCULhEbHBbHb271VCrOnp0/Q3pU6l9TFuWhtNOhme2a6mMg8yTeiyZ6Y5Pp2q/qH9m3GnixfT9RE7SAK0caEQ+hkA7Z9Kx4yuma4Ybkb3hjBHy53NnBcAd6Lm8a3kuL14zCo3FEQk7h7jqTVSk7pnd9UvsP8AF3h6yu1juNUmW0jjKxvJbRcn5cAlvx/CqHhy3sYbGN7a4ElzpUDfZJ5QY1d2J4cnuTx7V0+o2B1bTCsbSWmpRQpdvCzcRlTnLL056Vy8t/qXieyfRNXsoYZ7mP7XE8bBdgHGVA6nI/WtaU5Tp8rei38v89L9ThmmnY9B8DatftJfaTrN6moG3dZJY3X5os8lM/xAHoa9TsIY7cuIhhZDvr558I+Obq806G8h0G9vb5IfLnlQqEd42IKN36YOfWvcPCusQ67ZxXix+VPsAkjJ5Q+leTjaM4SbasjxsVBr3krI6OigU193Gwjr3rgOIdRQKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDgH8P2813LezWscOmmLzDI05yr/xBl7Dgcg1yfiLxRbN9psriKVbK3IELQ8ZPYgH+ddHAbv+w72PWbqGCzjjM/2i5k2pt77z0x7mvM9Z0xLzxNp0eoXcEtrICIA6Z3Y5wrp9cjPWvdwdNTm1N3t/X3nv043m4zexveCpvEM9xdShWk0cOyQp7EZ5+v8ASuutGsNFujpflMLi3Jv1LLhZRgkjPrWHqOmajpulDS9L1W4YX/3HCYMQ6BPoc8kVrzwX1smlWviS4geAWCxxyw/eklTG4EnnlefwPvWtVqbumrPot9Ov5k1GpPTZieJ2bW9K0ydy40othpXAZ4mY8OvfIPH0qEXWv3qJDOLW10i3dIRPMMvcR4OGBB69BjHOa2tLsrNNJuBdypNYzA+WsjbVjJH/ANfrXNJaibTtQt0sS8tvCcRxymQB1OVyO/HNZwcbOKWif5/qZxaty22NPSvDsWgx+Tczy/Z7h3jhQ/cIYFtxI78Y5pE0S1mlu7Oz1GRL5Ask0gba0Q6qC316jmj/AISGS8vrXS5YmWOazVmDoyCB9vdux4NSfZbnw/oV150lmTMh3MP3hkyerMeTgcCk5VL3k/ef4ibn13YtxpwstIvotauGS0jUbJ9mSHYc7AOvNXdO1CwtdFsdOsJdhdignf5QxTqST6nApk9mus2C2V4k9tDbSIfMbkyvtyT6beetUUs4tWsNPtNTtxDe2t6zwRqfvpu4P06flWbtJe++v6aMVubR9/6ZrW2mWT6K8czeUJ8NcgPtGM/3j2OP1rjdXubvTtPuIfDOj2yalLdxxsLwbgI88vjjIHoPrzXY6jf2M2rnQJreGZfLy5ZcjeB2HtWemoWGp3hlkD4kj+ylpUIViOyn+fenSlJe9JXW/wDkEG/kzKupJL7X7KS30+KWdkKTXSx8CTpz7DH5VagN5Fd31xMljLcQoNvBC+hXPTnNTyh5DcadoluILmIBi7TZVgflIX07VPHpmnXel2tu1xJhEfZHLx5rLguxx2HvVSmklfb9NxykluYl+J7G3uPtXlzrBEsUkUURY26tjJA7896v6Tr11p9qsVxavFCkqAAvsKqenFVrO/t5dIl13TZJbiG8bO+YbSjA7duR244z1qPVrMSQ2tyJYrl2K/amd8gIBkAg8A9wRVNKXuzX/Djsn7sjorLw/K2rT6veSzXjqcxRq+wKD14HBrmvEN/qesXL6fpSjTrQHMxdN006A42g/wAIJweOwrtfDWr3WoaFdzCKMKhcQMOuMcBl65H61T8OaZZT6wJ5DKb+O2USAN+7DZ649ea5o1HCUnUXw7GKnZtzWxz+m6rqFncmcyCPSrZTBclyCAAMBlHru61dTUY2tLkef9sBnVJDOfmiUg/NH/tGoIDqenR6hE2mWsemmR1cuM/KTywHc45/CslLJtQ8VQ2+pxt9qt7cPvjwqsg5Vsf3iK25YSbf5f1+pq4KTKt9fK2uRyabLcw2PloZI8FjM2OF9uuDXUaRpUOm3oaZFCHBMarxwOmfqTRp3h5NNvIpfOBgiXKqRn5j1zV3V763sdOlvpyWCttL4+WL3Pr9KirV5rQpl3Wy2LOs6zFp9lcahc5CR/dCjJJ7D864bXNTF7a6XfT6XPPqO0tnGEiBPy7/AEx1xTp5b4Latrep2sYYiWziZivm5OQXXrj0Fdr4U0K20fTZpb1/td7dEySM6YHPovYUkoYePM9X/X9MluNNX/I465sLkXD6jqFw6adHLE6JD8/mvjlRjp061bvviEY7aWe8t0sLdsR20LvmR2wTgDucCtl76O8h1Ty0eOOJdkT8DDHIyF9ua8w+IVtEJLCyNv5+ovB9phnbkqwdVO30J3c+gq4JVpKNRa/kb4enGtUSmiC78SavdM9+9otraCMyRGd/L82Tqieue5Nbfhq6lmsbaS5Ec0xTLqh+VTjoPpXNLp/2i5uLmO5kv455Nht5JQI4lxj5QegHPA5NX9FtYNKu49J0qOedvLadGLfu/vcpuroqKDjZbnsumoqyVjS1i3gW4BuivmSKVjHB5OSBXS+ErC3vdARruVlkMfV/vFsc5rm0vJprhjd3MUMMUjLJCFGEbbkgt7YpLPUrrTtLeaG3e/LyYV1kEaYPO49c8elc04txUU9TKrGpUp8qdmiHW9J1S61OWKwjHmom+GRgSM4wAR3HtUVnp+pJqVlDccalGgEyRplA3bHoAcmq1rqeoTa7byX5NxcPLIkJgJWKIdMMepOMDp3NWJYtQ8L29/eF4FlurnJijJbr3yeQcCt1CWkdLiqV5U/ddr2E+IGg3uk6qHh1S9ujewkXkaABZJM/u489etZ17pFz4Tu7SUrLqeoFFSC1iiLNCrcsgbp16k9Bnirdnf6zq9zNPd2EEFvYK3lM5YSFj0xng1Tm8T+IfDV/IxR7q2hieYvKA5BPygZ9cnpW8I1FFU9G1v5nBeb31Zu+DfEGqz65/Y0GhQWrgOXa3ACxsfmww/vE9c1oRrP4O8Q3fiS3ngktJokjntWm8qJZC4Dtk9xzisoW97d+JpbvwpexaXqjW0L3yzR71lY5wynHUjOcVs+KhZJpN7Y6nZmSW3X7VIx27H7/AMXA5/KuOcY+00Wklqv6/CxzzjGT5baNa9z2DSdVstWtRcafcxXEO4pvjYMCR1GRV+vAPBWt6ZaeHItL0W8N6i3nm4tl2m33tkKPX/8AXXo1n4yvbnWdKsodGuFtp/MFzcTsFMJT1Az17V51bCypyaW2u+h5lbDSp7bHcfNuPI20tAORkUVynMFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHDQLY363FpcH7TaSwgPFKN0ZUDoQR3FcbaTqdJuvt9nGrQXTLCoGG8ottXaB3x+lddpOx4YnTC5Xa4PbFczfafp8OujTrq/ijuTGbqNCcOUzgAfjn3ya9vDNJtP8Aqx9DKKjNr+tC7c2uoyPrWnaTIZ7mweKWEkgOoI+ZOePp9K6C+htPFuhwadPOtjqkBW4wn3oJRnoOPUjHoTXKS6nq0+nQT6VdLbakl0huJiBtMShso3XPb8al1LVLY3HkahG8Wosiz+ZGNjOnYe//ANatJ0pya7rtvey19OpzyhJ27r+vuM3V9M1Wx08x3FxHMY3/AHoiIdNo6tj3wOMV0Hgfw1fXPh+3ujezRJPOJjFKuHaMcbSeozjPtSpbtDcrqRmnntJY9zRgBRF/vex/Ws3R/iLrQurmO8so58OVhiC7WOASOnrxVVHWqU2qVr9f8ip+0lC1O1+puXukxm/nsIlkknaMiEDnLAZ+duwzXPXtre315BFDaIt/HCRLNIS1vCqkBgQpzk//AF66e51PUPs1heXcaWt1cgSG2fBZMe49K5Ea3O3i3T4LWxljNzLIzPCxVSpGCW7E+xqKPtH52X5bjownLrsbE0Euri6tZr1JYEZY1RCVwQOBxzj3qXTVfRvEiSX4e6vrmLyVdSNtuoHCj6460/UDZ6CQkXM4kWRwBlnbrgfSuV8rWtZtL3U96rc3F7J9mtV4aOLBCFz7+lOC9onraOxXLdW6GpfTi31O/luJLi4luEjeYRD/AFPIAye3ByfpVuPSprW1lQSQXNhNIZbRkcFixxkEd89aZbPqGlaG80qrEyNEJJGXJlG3awOeozx9K24NN+zpG9hPbmWGYNOgUYgXHZR/KlOfKrL+rW+4ynLl0OLs7PU9E1mfaUMcqxtFCifvlY5DO24hdu7B4rski1WxuI3cW0wtIxE6yHb5isRubd698VzniXTktfDl9daxfrcyxOqQXfmHfGrkbcKPXpj61FJfXF3piRaFLJDYxxCTyzukMx6sCSM/gPSnJOqlLTtt/XQcvfSt8zrbrV7CLRLmzu7a18veyRJCAsZ/u4GOvfNcxqMynQbO3e3L2hD78gJvJOAjt7hv0rTsrgNLLYX0EzSXEaGNLZT5kSbeWbIzg+vJqsIJfLjeG4hfTpGMc1tdkE+YQcDdnrnHpjNZ04qD/EiMUnoamlX8Pk2mmwwNaNdRMrGH5lQ4wrbu/GPyq3ei/wBO05V0RrdtRtyFvJJBgS4XJ61nRTi/t7DTtIZdPkhmY888J1Xn1qrdQavqWofYrqSS2gu4HEssfGwBhlz7n7orNwTld6ev9fgS48z/AMy7putyahevpvmLPc+VvckFS4I+XHpjPJ71qQNaWlxD5rrdavJGIS6rkgAdyKyBa2r3jaVpZMaQrm7nhyJJQBwgbsPpVbU4TZaY0MaLZGXCoiE7gp9T6n9KTjGTtHS/9f0i+RXttc3NXuo4wUbfNK5ChYsEjPf2ql4wMKaBHa2VzhEdSYVQM+B3+v1rgYBdaheXFloMjW7CIo9wc5d17An1x0q/YWOrW2nJZX80FvcRoXn899gmU88EHPH862+rKm0+bVdDR00ra7Dra2ht/ElnfPbi4aZsxyT/AHvl7A9zwBjA611U+oeItRtbSaWS00iVro/uJTndGo/n3rktCE9zqEVrbOILeAMUcjgE9Srmu5ttD+3QQS6tcfapYUaMSngnceTipxDjFrm6fP8A4AqqSacjl5blLS5hkvbp5RfSsyNHD+7CKcYJHfmqfiW2GpIwK7JrPP2eQL99G4KfyP4Ve1qxtrXxDDM1zLG1gmIbQqRGingknuTmsXVImkglnluLmSFpNzCKXaFAz0x/DWkEpWkv6/pGtGfI1KLOdu7VLWCzEMYmVW3mLa4kZgOAuPy5IrZ8MaLrkt/Dea3GNNjyGS2tgRsUZCxt6jkkn1qwjK97bSWVwtwkmFZ2i8t4zjJAHfjv1q/qWq6dK8yTajc29pGu5/LPJbtk+nt7Vc+ZrlS3OupjaklZIueMLKwFslqsEMksyMDG3HmE+pHSuRurC6gtGiS9lhg8v/j2hA3R47da1NGvILaY3DR3V20wBtS5JOz+8c1fltJpJIZtO0uO4uJGw7YyAe2RnA9ahL2fusxpV50vdv8AeY+m2cmk2qXTusf2iNh5sh2iIc5xnozd2POKfpWgOunxane3SvYnLzSlyc88Y/A0tx4u1PR7iW2UqtxG5R4LqAiMjttYjk/SummRvFMiWl4xEaKs4jTAUkDqV6kZOac5VIK70T6+RnOdRtyl16mBr2k3lxqmmXuihpkePYbkEMsar9w8/XrWDB4f1XT4ru8ng83UdphWLzOJlcktMRzkjsOK6J9J1jwxas63qyWRb165PRR2HSuXa8u9b12JbO8VZeC9w1wIlIHVCD1HStKTk42i04rr/mOL00asNax1iy0SzuhrBiuGVVjt5m2OuMAcd+ByOla/hf7VBrF9qPjbVUhs5LcW/k3AUhvmzux0I9/fFReLfCkp0y5lN2r6gJjcQhpd52nBwp7ADoKxtek06/i0y2Ed7d3iDypboKPMBC5wQeGXr0q1atG3e92lsNpThvv5HaLP4Zk1nUb7S5SlzbwhZ9LdfLBfBMbqBwWbtg85rntF8ZSW3hmWbVNUF9M6bXswAk0RBJKkA53+v0rntMuFmtb280yW4stQhMcipO5lhuGhXA8rd1LY5HXpW7Z2Ph/xj4Rm1rVLK1iuZGlknvIo/IEDDk89zyevU1EqMYL95dq6XmjD2ahbn1/Q9b+HfiK+v9Os4L6MyzFcvKSNw74IHTAwK7yvlj4V69Dod/LFYR3BjUGVfs7mV7pefn25wO3HBr6V0LVItU0+GdCQzoGKsNrDIzyDyK8rHYd0ajstDzsXR9nO6WhpUVTN+v8Aan2LypC3l79+PlHtn1q5XE1Y5WrBRRRSEFFFFABRRRQAUUUUAFFFFABRRRQB5TpupwW1+kTS7szm32n7u/BIU/XBxVvxFp0F6YNVFra3F9ZOQGmTmNWGCVPtweKoRWenXFtPZi3MYv388zKcsJRgq3sRtGK0tGvWnmvdNcMJYfmAY5DAjrXt25Wpx6f0/wDI+nrR5m5LdfkYVir6Yuqi5YTee++2G3/VowAH1PIrQ1S2uV0BpJbT7ZqJiHlRoQZcdCV79B071T8Q30ujXUSQbTeXMiiAvjYCBwDnrirvhttN0o2l1eXF217HDJLIoX5VJYnLDr3PTjBrom24qp/TsvwOSTaXMTeAHQadqbateu08aYe0mXY6KFzgqev9KwbPxv4e0LxexeEM8sORceYMq3OFcdVPuexrUutXuNW0LUdZXTUGqODp8T2xLCWNiCrg9R6c1yeo+ArLU/DV0rFf+EhcbvN3DeW4BRz/ABL29aKcKcpSda6vpZdP+AOEVJt1NL6WOtsLuTxZr8dzqNrPY3ltAfs8iPuhlRjyR6Ee9WL9JfDt7YWujW3mpezs00jtkxHb99fTOBntUel+F20Lw5ptg980lxHzKScZQdEJHvRYavJcX0wij+0SW6nex4ROCQPasZNN2p6xV9P1+80hGOso/CiQ6aNSv7yN3kMqhVWYx7gMnlgehziuf8OvJpd8ZVu41tLi+FuyMhZg6lgxz2HQVqaPqg01GjV1R7xDmEE7LdT2GOvUn8KzPDNnYXeh6lcaWN8lxdvPFLKxZFI+UjHbufrWsU4xkpbaE3bvfbQ7r4gXFzanTjawQS2oYtKrdsYKke3WsLwhrSLIrXECJcXjPI0gG0yNnoAe+Ky5rTWbHWNNgg1O0u0kikdEfky4wWUe4B6UQyx3ek3xcJBeWMnmwxMmMt7E9zWUKMY0uS9/Ner/AFMY01GHLv5kviiyu9TuXtrK1+e6fCzyoW+RATuI6Bh2qnNZQ3FtNNo95LC9vhowqMFJTiQYGM9cED0q7D4ou9RheRrWK3uFUwvOsmfLLDKOV6lSePUGm2N9b2GiCyuNQnsr3cksw2CQM4wwKemec/Q1ovaQSjbb5/10KvJJIsSXENvbai8kqyXIlQIY5xwhAwoPYZ7deaXxBa2LLa6JLp7rLG7NaSuxcRuY93zjvnBwT3xVTT4LOz1h202XS0urx2MY+zsEZncMc5yAdvH4dq0Zhql3r1va2hEItsyX2ozcgJnhR2LEcewqH7rTT8+3T+vW4ktTR0fRJ9R0WB5yLfUJIPvCPb5bhsF/xA6e9b2p38dpqdtYwWwuLyReZGHyoPf+dZ2q6pPPLDb6Ldx2lojeZdXTjJ2j+Fc+vrWVouvWN/q16sE93cSZ2BimyN8dSvc4ricZ1bya0107Gfs5SfNNfL/P/I17SGLRLfULkzCe5fMr7RkgdyB35rz7V7oX0Yub2+S4USCN02lGwT0x2PbitzU9aaK9uGsbfDxwFQxOc/UdcVw1lpd/qN5c3MTRm2kz58QOChPIOD157124ala85ux0Qg7uUjdu5zpjprFvIohnOwwTDad/T5fwzzWa9hN/aoutSiaeGQ7Q8u5hsOflX37ZqzeXltpukrZ3SXUly7qEaYeZGvYYJ4/L8a9O0W1SbRIpL9I5pUAYblwQCMg47Gqq1vYR5rb6fIJVPZK7OJvbmysJILfSoALbaPmY5wc/nUet+KL6awC6QTC/nMjZ42r6/nVrUrDT31aCa3umWfLSuCvAwOD+Gf1rFaG4NvNPG6zWkmRDbthZWbOCQPzpQjB2bV35grStd/eQ3Op6pcsDPc+bItsDKj/PGVHXj1ratWMum2N1pBs/ssiEXPmA5AHt6CqGnahYWlsILqz8q5SH5A2S7N7+3ep9EiN3p5vkglcQb0MIXYrk54I/rVVFZbWS+4bS6In1S4t1077RZNbKmAqgoVRT/FtI6inR3GnRWjulvay2pWONkGEZpOpY55Of0H1qlBpvl6VK86GEyHdFG0oVVwegz1rKvtPs54gzeVbTFt29mJDA+vp9RUxhCXu3Gqeh0GvvpradBeT2AmuUkHkxiTYoOM5b/ZFY+kajcfZNbkuo7mGeU+Z5kYx8xHG0+tWJbKC4JhVgu7G51fcBjsAelVfEmnzvo13ZWN5PDcFD9nkHTfgEjj2GPx4oiopcjLjBOyfUojxB4f1CGCI6kkxtolVBcIxkVw33ix9z+NX9Q0m701LbWLa8sjPKoVp5BhgrHgAj0rk/Bdu9/ZNP4hFxNJGx8uCFOkoHBcH359q6HV7aKJILS5vIVs2U+YsrlUkbH3R3rVpKXLH59f8AI3r0o0pKCZpr4ye50qXT9dhiuRFGX3iLCuwPb8xXn2qRW9tdWVwbLTZtSuARbxXSMInXdkxvxgHHOetX/D2n3mvtFpM9xNHZx5aGaP5m+Xux9MV1HifSoIbC0R9RjFvcKZCrg7mCrwP51a9nQnyR3fY52oQfKtLmB4ra41HSGu5I4ooYJhara2+Mq/C7Y+M7SfzpjeH/ABFBc2N1biCCcP5JupJAWhTbgbUYckk49q6bQrnSNP0+2FtNDpepO4XzZC212Kkr7ZAz7VzHiO7nmIt7q7nmmAVxJaAsBz3PcnrgU6cpv93FWS7oVOV/dSKd34dt9J0zVLHxJfw29zZTxyxC3JYwbyPmbJyAc9qwtH1RbGXULi3e4uPDEjTJPaRsoSLfgKVA6DPIOPbmvTk0JPEmmahp/wDZtzp9zqaqZr+aABpmUDlQxycAD0rM+Ingay0PwTa22kKNQCr5MoWTypcDL7h16HPBop4mDl7Oo9W/l5vy121CNWMmoz3ZyvhS603wpb6dcxWDnULyUskMrBZAFPzc46Ecgd677xX4kvbHVbXUtIiVReny2dJNrRHjkqeM9R+FeS6VZJd63Dp128lwUKtBPFJ5hSNgP3br7cgsDXU2HibRRPqNj4osIra5S4VQSGk+0gKQiD+6cDhuPeqr0E587XM+vo9uv9dSqsFdStoesDxPqfh+OTUNUgvNQaUwp+6ClNpHLoo+b0yPWvR7K+afHmRNHuGQSOMe9eaXqaLqegxnTreSO5a3QmB5TGYlHRSQfl59K1/DfiiDUvDUI1C5gtr6JQs6xy70Rh239D2rwatPmXMl6nkVaaaTSPQ8iisTTro/ZVjkLbjyC3QCtK1ulmXoysDjDDGa5GmjllFos0UUUiQooooAKKKKACiiigAooooA8wmhe1W3kjiIjWQIQozt+vt2qe5lWw8y/ePcVUBtq8tGTxj6U7RrgO8tpO7GQ7gwP9KseZEtoxmJEakoxb64r2LvZn1M20+Vr/goydX8LQeKEtYriUwW0TF0aMhnZD1+nStbQNY0m38R3lnd3sEV1bQCBvOZBvX7wAPtnpVPw7BA99cyrFJDetmJhuOxtvoO3Fcd4x0Wz1DUDb6lNJGfNVkCQg7Wz1Ldyf5VtBKt+6nJ2t91zlr0uaTpyeh0/gHxK+seHfE1/YWUNrbQXjC2lVRskUEHIHpj+dHhBVa+lJuIZ7iaaRzLgY2ZzjHY5yKxbi+vRJb2Hhm2Mmn2wCyyysRG6DlicH1yMVRt4il1p09iyw6WtwXihs8syOThgSeo6nNbexT5rac3+XX1tchU93tf/I6vxlqsccmqW2nzGXVltW8iEKThtpIAHTJqpoZGiaZawXlvGr3luLi7+fDrJs5PuPapZNV+0+No49Hto5EjiK3d2FAOQBnnvgdazdRaPUDeTLffaBJE8cdptz5owehHQdKyhC0VBrS1/P8ArqUtKag+pTv9E1LxX4O0W88PadLp8l3cciU8iHPysT/dxzj6V0er+DJLOygtbGSeG1d1Nw9rnzJBjrz0Of0qZvEeow+GvCFtZiG1vbqMJcRsMGPy0wygdju4qy95qlnYT/bLuSZpj5asv/LP6+lKVWteysld2W/W34dDPnqW6JXf5jFWDTrrSv7PtnSwUFykoG+MfdOM8g8VytpqJ1PW9Z8zSQLWWV41aQcOgOA+R3OCeO2KsJdx6jrE8GpefE0IUCcSblmTnH4+oFVdL1aztvEt3aeW0EUYym4feU+mPUZ5rSFNpPS7t+ty4rlT72JzHpsunIujQjAf9/uJM0Dr29SPTt3FXbD4aSXepXTX93JLpzkSQbTtkifg5z3Gc/nTLbTZ4PGFo9lHugkH7wocZUqNpH06e4r0DxV4q0rwjpX2jU5+VwiQxjdJIx6BVFY1q9SDjGjq5fNmVWrONo09WyO60/S9E02S81HyBHCoLyFQucdDn1rkrbxPceKo7iG3e3gt0fCqVJD4649R0rIu9TvvFWq2t3eQNBpqSBo4rtCVLZ6CMffPfngV6DoS6bZ2cl3BatEsA8sb4wuBnnA7DNc06bpJOesvyNEo4eDdRc0+nZf8E5X+ztQsXe686zmup2CiGZtiwJjG8gdfpVK/iaCUm0urP7U2GeYEgN/sgYOBmk8V69FPeXtlaWSpI2SwxgTLj72R1GK0kvLBFtDeWsdpAV8uJiNzKwGQCevPOCe9dKU0lKS3HzSSu0ZlnplvdXdu9zLvu5eQY3BCnPr1xj2qV4W8Oz3c2qMjxvnENth5vmPB7Yqza/bdPivdTt5pJ41JHkeSoI565x+gqPUb6/1aa11S2hWNIk/0iQkRnK9ue/pReTdvsk3k35Frwjb2XibTmgluJnto3LG1uosYB6Een4Vfe2tvC9nLHaBIlb/V+fIxDkfw89OKbF4llm8hbaF5LgkeYFQFlHbdXMyx6lrF5c6TrUnnwq/MgAJjK8j/AArLklOT5naPYhRk27vTsacmrabO2oPJpszyoQrxrkMwxzj8q2LK40K5SC8ghT7RbQghG5dAAf4e56jNZE4tIf8ASdUnWHzJAsU33SR/CD9Km0JLa08T3fywSWbWuEkY9G9M96U4pxdr/wBdAlFWb1MKC/06C5F1cPetPMS8gugrH6DHCj2rf8PeJrR4J7uezktoWcxx55LKvVgvpnvWd4pjS7tLCayhj+yysySs3RcHlc9gaSSa7XwxbPBp0sb2jmAjyjLmMnOeO1aSjGpFNrV6b7FNKcV5kOp3Y1qZmaazudOuoysBMY82FunAP41zesW81jLb2sXmTMCI/LVMgqeB0znHWut8F6Ejzm91GOCeBkDZ6FpCTjA7ADA/OmXVhqWk21zBb2K2ds8pkjkYmWTjqfQewq4VYwlyR6f1/WhcaihLlRHfaV9qbybe2idFi2Mx4IboCT/hWdY2moWWn3Nvq1xFFPFzDLlQwXofw7dK2Irea4TTba2uXhgkLT3E8oy646/Uk9+1cpp9u/i3VtRufDt0bsxysv2mX7kaqcFceoPPvRTd01J6L+vxCMr6Nl3w+kcEDSs6OzvzcK42ye5NGq2vnXZuNSaO70mNwg0+BAJAcn5wT1ByKh1G2l0698vUIIZLOGHYLid/KErE8MQv3Rnt1OKy9BingvbmS8u4SkUyrBG+SjyMvJDEZxjGCfStlG95p/1+hTbk+ZsluYmj1Sx0/SjFaadKRKHGd67eTkY/Ci01zTteuhY6ja219dQuTBNPLjY+R8pGDgH1PFS2m+0hjK4maWbYsrDeAed+cd84qaPxA/hO8v4U0SK7gkbdHsjC7PcnGWz6dqpq+iV301t6ja00V2KNO0nR9k+ulGsJQwtUGWTJPzEnv6D+lZfjUW9vLpt9oDWo+zxKTauDkhjwwwev1xWj4zu92m2GrxW7Xts6DZaqQsULHsw6k5yc0vhLTdF07wxfzarKtxq13CsbRt+6Kw5yiHPJJP8AT0qYycYqrK7e1v6/FkXaSluPQ32peKdD1LU7pJLISLb/ALqYq1s2OPl98Y96i+L+j6rpn7ua7in0y9mAhlCFZ4WPByRwRjvWhBo9xf8Ah2xa11KK0la+E86Rr8wiJ469xjjtV3xR4bkn0i2tdR1i5uZbu8LWsjrgL3VPaso1Iwqxd1ppaxCmozjZ6bHn0nhmw063Tzb65htdCmDNJb2yg3bOAeX3Z2qCR0ArkbSxhsdMsl1GOa60O/YzSvjBhbJXcON3AAGM45rqdVs9SstAnOr29u1vMiyXNtBKWmAU5PXjAIH5+1aUl1c+MZbTydDS0S3tn8xXfyzKCmAEH0rvjUkldu66vT+r3OmDtr36k2jtqniDSLubRrT7RZqfsk8xGxmRR95f73Hb3p3g3X7aTTrLw7Y2sMU+GmeNg0YMI+YHd1BJI96i+EOqaj4Vt7uC+mtv7ILERpNcKGDgdVA5x2PWue8ZQLe+I4dT05nhuIo8PbI5jOQ5JQHuTnOPSsPZ89SVJ/D0fn5kOLlKUGttj3231YQ21vDeeQbh49zQxSbh9FJ61paDcte3ETvFLDIV3tFIRuj9ASOteceD9asvFukNay2ccYtP3UqsRuU4yfpXaaedTt/tU0sdvHagL9mKE79mMfNXjVaXs24vRnnVKXLePU70UVyj3d8Etp4WaVSQJETBIB789h1NW7PxBFONrkDJIV+xrldN7o5HTfQ3XkVDgnmoXuRkBBnnBJ4xWT9rkWRhKT03KW/lWXqeolYoyCyq5ojC5UKTk7HZKwYZBB+lLXPaPesoWMncW5we1b0cgcZBBqWrMznHkdh9FFFIkKKKKAPF/D91dprcqzp98ESjGQsing/iO1dPfqrrcxOQ8NymWTHK9jUEmwXwutg23ShumPmxVuW2D+VcCUBgNjLjg17M58zvax9VVknJSfYzdMuX+2R2/mq0VvIIrgsfnUkfu2yPXpitfxBosOpQxyyRidoGLxgHaGY8ZOOuBWPrLraNFDZT2sV7djaBLw8hU5Cjt0zVizur22ljE8h8iT5DkfdPvSlfScdP61MZU3V9+LtY4Czu7zSTNpU9xDh5fKMqHC7Sw4Hocda6LSdPtm1mwKmRYoldFgC/utxyc4IyM+tad74etft06mZYpbgBtigZBz978a6fRdJi0XTo1RjJFG26MvguxY9Ce/Wt62Ki43W7/wAjGrUjFXXUoq9lY6Xf3jiKCIr5J2rgFnPzfjiudvdMtLXU4kgtg0S2/mJMh3NEv8OB6EkV0PiPT7qXw5OLd44Ea58z5wPuccgnp3rhNC1+6ttWutJklgafz8W9zJ91kxzn2qMNFzjKUHr2+78iIJyvJO4yD+0Bq+gaoiyFbdprN2ZDiZch1Yn1yB1qe/1S7Goanb2FtA0N0yvMs8xUpuQ52fQjP0Ndhq9q2narJc2tyY7fUWj3xkloRKFxuXH3c9D9Ko2WnQX6xQwSRPdxHY5wA3BOM/qK0VeMkpNaf8G/4MFOLV2jmdCurlVubG+sYJYV25wA3BGQw9T9K6Dwva6Xq+mx64stsNPlBKTSZjK4yGVgenIPFbg8GWQeO8vppoVtgW+V8ZTrhh7VXOmNrCiGKzjGnpITCqoQuDzk54yayqYmE78jt3GpxqNtOy6voZlxr13a3EP9jf8AHrIBDaxRRb5HxzuJI6Vbk0nxDc6vZ3M9pYW1oJBJeXV1JvkZR/CiDgZ6cmt7T7aw8KWMs13cie5/ikI+4OyjHQVha94lmuLuO3b91DK2I9o3huM5Hbt3rGEpTl+7j82J1LytQWnfqzo5tS0+O/eOGEGQRsQ4PAwP4fSuPbU7t7h45me5sZy0DMEwUK9A49cH8RUcNgxhe5SWQy7459m7nYOuPqD0qbVLO51CVNRtrpYHklRLcKPmkdBycDjpmrp0oQdv6/r/ACIhCMXa/wB5hW8VtBqt4VC3cVmpZIzhjwOV3HnnHFTTXemtqyXOoyXH9nTqJBEYyWg47fTmul8Qw6DFcWsQsrf7TcDewKld7emem6s55Wm0i7exiEU6lYpA6ho1U4O9c/lW0anOlKz7FqfMr2ZDp5iaWebQ4r1ZDHwZ5S0FwvZsdN2PpUt5puoRWirZws93MvCKwMQJ/i59Ku6He6bb3DyS28ktrcRYaSTAjVO5C9OT6Ukmr6PbFtM0K2EZjiM4BY45B+UDOQf5Vm5S5tF/XnqTztO1jG/s3VLG4i1HRZBcztIY7llGQwVMcDuM/wAqt/brq3ki8ucTXZjBLBejZwQx7kZz+FZGh6xHLbo80M1jOXwPLPy7iM4Pvwfzq3BbXGgapJc2919us5XjkPlRBmQE4KAA8joc9hWs4u9p7/n8ymnrfc0fFk9jcWsGmJHJfv5mEiiTLE8ZJboOe/4VkWlqqrf2d/JPBBbBZyzRlmVgeFAHt1FQ22oXt9PLameKzuDcMsKwDbkHkDv83eugSLUJ9KD39wtvFbIxuhIuHmPTc2Oc1NnSio3G/cjylSNIprNrHSl8y0wJZY5ODg/xr6cipjqt3bKlnoWptOApkEsh/hHBA9az9OZricn7SJEtYo7mHMZR2jyVbKjqPatDw3eQw3Agv7eCzupJysS4wJO5298Fex71M42vdXsS0tdLlPVBD/acetTaisV1dWP2SV0J2LgkjGOByRzjNVNQ126fR0ju7iVZYiUWcNlW9Gauxt9OsYre+jt1Mcdw+3y3TcuPp7VzieFLWaO4hsZ1uRHnzB2DEZGPWpp1ab+LoEXDr0Ob0xr/AF+6aKeO4naGLYkjlRG2emCBkkjI7iu8s7xvC9ndSXdpY21lM4cPbDLGXaN28AcnI61zOgave6FYQyXdh5kM7eXFcQsu0DONzEfdH+FFxqp1PdZ7GFvGR56wk7vmP3lb+7WlaDqStb3Spx53a3umXJBPrHiF9TtlknaIhxtl+RTnOCD147Yq3p7a5/bV5dx2NsGEeyOXaxikVlzuK44YHjjsKq22i3mHFpPfpZI5YKjbQ2e7d26dKu6Rfa/dAwWkjpFDcxnzLV1HmR5wVOR6dcf0rWe3u2stNRy17Gb4P8K6nP4mudStriS10tdxht/4Gmwd0nsCT0GT6njFamteEmR3vrrXCtxbo88pZgSZDgDgchQOMVv+KLXU4vFFrNYarbWlkYwhikbDNznKDof/AK9c5rVnbHVLm9sAEQxCETrksrA5kOOQQRwM+9ZQqzqSU+a112/Bke0cmnczxNbm2hl0yaFZpYGGJYnZA39/8OTgd6rDTEvLuz1bVb0zvDOiqzEIsoBwoJ9a6xPENmNMWOKzaZFRLaKYqFWV2HOMdAM/nXBW0MsiNY2E89+jTtDJF5JCRk9wfat6blK/T/L1NYa3ex011qF5o66lrkhhvbyZwqxIxKWSZO3djqpPb3zXSNqE2uW+kahNGh86Istg3DJcDoyt7Vzvhd7Pwx4vk0uTUHtIIR/pSuu+GZiBgsx6HGOnFdB4uvz9uitfDiWt9qloDOhzhIQ4xuJHHAya5KkbzSS+e2lvw+855pOSSXz8jlfEekhEn869huyxMJsrqTZJGrdSjdyOTg1U0K2lXwvc3TO+oNaXfmQSyuVfYODn/ZC8Y6k1qtpmq3LJcz3EV6bWJk+1XahQ7Z+8SMg+nrWfrWo30emzWGn2Qw8ixedAMxbTyxb36810RblFQTubRbelzhYtOtNY8Tkwxw6Yv2pL2J2ViJQGxt5OBnGcYrRvpr+SAWz29tAr6k4aMSiWR2GfK7fKPb6VZ1/w7YyraaTZzp9oXbIZXdjuPQcg8bcZ9Oaj8KRhdT1KbSImvbOxYrGWABuCB97nqcjINdkpqS5107/5+Z03T1Oi+Et5e6RFfpJpGnbblXeS/tmDSvOOkbDpxkjjjNaHh/UNU1/UJJLy5vbOfTxGZ7aZflfIOAvb61yvgy6s9N8RDU47m6tNI8wq1ozBkjnYdT7e1dT4p1SQazp9lb3UnmPHvmkEZ8sgZI6dD71w1qf72SS1avft37nLKklUdlubWr3Wq2ard6VFHdpvMcwWQAqvfv27+npW54UtxqNzHqNzOhtzCqwWgXARhyW55JrjLW9vrbQrLSYDbPJMXklvRGqKpJJ2hB1IHc9cZrTXxhFo8atLmSC1iIEAiP2iVgcDbnjBrjqUpuPLFa/oYVKU5RaS1PQ78Ws3+vZQB8mScc1wuu3FxYanEsjLNbQszrbpzLcfKdqKemS2KraVCfEOt6TdeJ3e11qHdcx2EMx8tI2Py716M2K6OHzZNfvLi5ghFtEu2CYn5t56ADsMd6wUPYuz10/qxzQXs7p66Do9XlvNPhVdOa1v5ohuiZgTHnkoWHU/SptFvr1pmKMFiXgRnPGOCaTwg17LbXC6nbKk8UpCSD7rg/xL/KtDTLRoLqbMeUY/fLcn8Kzk1G8bEOUYpxtsbdhei5XIPfHPrV+sNIoLFfNRCOcnBzWnZXUdzHuibI6H2rBrqjBrqtizRRRSJPFfDU2q3+pzR3Kqli1ssttHu3GF1+UqfqBmtSeG+m1vSmgnZLJkYzRgZyw/z1qh4MbTbGaI288huLomZEZMkp3BI9MGt/zhb3t1C7bVH7xCRjg+le/Wly1dF07fI+rk7tpdB+oQi9t5Y4orY6gq7rZ513CNv73qCKXQ9Wt9XVlXKSWzLDJ5i7SJF4JwexNRQXMbILhJI3aNvKkYHlT2P41ka7JcWHiBL1preLTjaMZExh5pByOfYc/hWMY814P5f15mDpq9jpdStm843rWhudUi+VDggEHvVs30r2YWSPyp4G/eL1Az3FRWWptc2NtfJtZSQMqwOQe5qjqtn9i1K7aWQRxXjF4ZWORnHf15rDryy6GMIcz5Z7rb5bok+I2qJBpUFr9neaGRRkqPlA6cmuFt9A029t1lS6jtLtASsd4R8xHVRg5HA7Zrodbg+0LBdX128UFshDKrEgkDPC89a5F7Kx1g6PqMscsVkjuUjRiplccZJ/Pp1zXfhYqFO0XbzFSh7Jcqex1cQhbJh1VZBLA0ZiSbgA8fhyODR4KsFsWmtr2UokshjWWVzvkyOMZ7jmuds/sL6zcWllp8g1C2hZQ3lHbKhOcYHUg9Dmuxu2vIkt5r+1F7K7BIoYgu22XgZJJBYnv9KVVOK5O/9Ipr7mWtY13S4Hj0k3Qgt1Ch25csOwJ7DiubvvF93b6jdRXF60WnRnfEIBgyRcdD69Kwb7TxfeMr/S722nhmjIlzEw2op5Vs/wB0jPB71NqsES3EtjuaK3SQR7JF3buM5B9PpVU8PTja+rav/wAEqMIJJf16lq313Wbz9zLHbmAthLjd84Q8jcBwe3NbdsqOlskl2HvnckfdCoMHAGOG5H1rF0XW9P0p/s2p26XG9QolSHG1c4y394frgVf0i20nT4HnWWzuNszSDypSCQB/CD0/+vRUjbaNu1luRUS6KxJpc0l1C9r+6DxufN/hk2oTuHX3/KrVkqXWq3EU9w1pbadGlzGkh254PzqemMZBIqTQNCm1nXb/AFDUnnEdx81sJ4gpXggrxww2nFW9G8ISDUpPtt2k9tGphSNh0Xvj2Pp/KsJ1IRbTetv6/wAjJzir3epHPdfbrlJLqFlgGGtrjYH2v0y2R0FVZreeDQp9M0aKzu7tpEa9WRysYRm5ZRzk8YC8DJz2rf8AHmo2ei+GWt2l8pLhPJjZf4eODn8Kx9JjTTvDKHY97JdJ8xZsNhe1Zwk3BSS0vp8iIy5o8yRQv7TyLNbGzWSKCBRIqJHuUoD93696s3elQ6nrWn39iqmyZFNyuVVmfqMrgEfnStrsc2nfZtHhjT7NB5yvcSEhNoAwcdSB+tY5SSKCbUI/OdftKSxi1xIpZs89eBWqUuuj/wAzRXN/SNAh0uzuFtE8qGW4e4Yyjdj0wT2HrVHSYIdPk3HUjFHktujlAJI5P4Y6/WrEmh35nuraG+IScuRGCTuBHr/CPr3rNvtJ02x0SxnvjJ9tgkVY5IlDbld8BeRjGDyQM4qU1LeV7gpJvV7l3XbP7JGur2pnaMzC5RYypDk9FHdRz1qO4hXSrTUJ9Kmlv7y5hFzLG5LOqlv4eOQM03VdQudQtJbyGRlgtLeS2CBNql3IAZfXCg/ia1bfVtPjls7a4Di4jtsPIkfyMjDkA9eCKT5lFXV/66i5pRSZw8MF5L5F1P5s0yws4l8zG9GyAAo7g10UNl9qt0lS1RpYJGillkfa8apj5h2B3Fh9MU6+0WTRNNebw7Ifs0p3M9wQGjXPVS3fPFczrmpz2sr6N4YkaVXMck63OCN3V2VjyScjpkcVur1n7n9evY0v7R3ib0Op3S/2qdGmuJo3kKzqy7jCxxgg91NVGg1XR7z7JpU0wi84xMqADAZQAy+u3PWqmma7pmja5aPqN3JLfCVw0fOCuMYCgcgcnnvXrOoXtlcaTPexzRW8RhIS9aIHyWI4OD6ZBrGtOVFpct0/x/zMak3Tfw6M8ZtzJNe2mn6sTb2kIMTDJBfBxyB1Jbv716hZ+FtM0jT2EpAMgJIJ55Odo7155ImreH7qz1WW6bWo0tvNkn2iNGPQHZ1LHg4qO48Tazqeq219Yt5qTPsiV0PloSAGLHt3NaVqc61uSVo/r/Xc1qQnUS5XZG7/AGrp+o6vfaTbvNbeQDGCqsCf7xye3arumvFo76fp1sySh5ir28aZYZXKs56151Pq11qeu2d1byh9+JQYR8jAn7x9seteseHtQiuNavyLJTqEaAG5VesfYZ9qzxFJ0o+VtvPYitHkj8jmPE88/wDaE9lq8Fv5qIDZQxucbs4OD7iqd7atrcd1ZSTRWl8oWJokQ4QH+H3Bx1FP8Y3Fw9wdQYy/Y5JTb+aqhnhxgkgn6datLp0l00+o/wCjFHhQ2t+kpaUYGOR03Y6mrj7kIy2/z0/p9Rr3Uh9poVwtidKlVref5UivYTlQe4UetZmrxaja28s0Fm+nYcwSOi7pZDjCkL2yTktWro+uaZFFa6hfSTyz2UmclSGII25K/hVvxsF1y902S0vjGl2F8qFTtZmBzk/T0qFOaqWmtCbyjO0loc3pmnrfaxLi/iuHis/Kljdjl5k5wVI54zzk9K6XSZrWOw1EW+nRQTXsCqgK7BIVH3CfbmuZurC4i1N7qG2n/wBAIYQ48szzMDnaBnPGc10d39ll8JaOZhcRTXMw8rIy4b1P0ore9bW6dv8AMJ62/rzOZ8Stc22ioPDki7o7hXEcj+ZEWm4O4DOF69KzdSiaaRbVI2j1K3kDSwQnYJ1VSfkHQgd/rXaX1zoWlS3CxeVH++SGfERALqAQK4Gf7TdafdXyyRIBPJK8hBDAdlVj2ArfDtyV7W835mtP3lcr2EQvNckMlpbJNDYTKtgsm5o8twxY8Fi2Kh8Qz6hoD3FxpupQC+80LLZxKrrCpUBQHH93B4A70/wvfWNxq5uhH5MENuWuzLyOuFXPUk9faqbT2l1qmpw6bbWbiS4UhiAVkGMsAexrr5Xz6rRL+v8AP9ToUddRtoI9M0t9L1F7e68Q6ypYsDlVQuFUkjgPyfy5rtovD50PUPPu57rU4orNYnDSBd7ZGwKMdTyM1wiadqU1nKPClvZpJCrXBillPnwKO6hhjBOT14wK1NJbVpNR0ANcXZnmhNvcQRRhkRVUDc7Ho5yen61lXi5XtLvf+uisZSvrZlPwZpht/iZJc6/ZlILp5GDPKXWGQ/cUY74713fhQXyyajP4ltGtoftLCygdf3mxeN3/AAI8j2qW7eyi1vbdPARHAGwzjcMNySvf61pai8uqalE0WZI0IHmRyAbkPbjP0I71yV6rqu7Vk1+XYyre8/IqRzY1ZNQfy1klH2fzM7X8vngEdBk1oWE9zYaYw02O3uI4xiKBZMqSOoLHqazNYgcJGLUEb3wz9FCr/EF6n0wKsardPZSywaWUuGS3WQQGAoTKwz16c/pWDipWsZSipNK251GkeI7W4sbcRRn7S58ryVUgKw6jmsXxbpOt3t/Z/Z5kQiTzCYpCm0DsfUVk6VqRnnjhukaPVSFZoYgWUHH8J7Ctm61SaW6EkMhjggbyZAygbhjnk9s1j7N0p3ivvMfZckvdN+yBlsjZnUo5LhU2yYYEj6Vv6EpS1VDtYr8pdRw1cToGi/atXS/fdHHEhUBVAWXPf1r0KzWOKFUjAUDsK5atk7JnNXtF8qZYpCwHemyuFjZvQVwCahqKSvJPcEo0zlVA5A7AVMIcxEKbnsc1plxNa3aW2niGCJlWQzMgcyA9vUVq2moQ6tcTw/Kl/ZDZMnGPw/Oqd7ZySQ20Vtd+SUID5GS654FZ1rbasniiB7W2Pmea8eoLjbuVlyjgkc9O3WvecY1E297f19/+R9LKyldF+5VbDXJYhmOO8gCkdBvA4x6HH8q047O31fT0sb47zBhWYDqGGMH1FP1JIp7fyJiN6lWhfuG/h/wqlo0809vDcxk75BsliB6OD1+vFYNuUebqv6/Icvfj5k3gRtOt4JNItJzJ9ld4JEb+A5OU/DtTtegvzrtqWvJDbWsB2WJQFZGLZ8zd14HGKradawnxdczxq1vLIhaWNFA3zZ++TXTarH/aFnDcRZW6gY/KRgnA+Ye/rUVpWmprqvzMOZRqqUv+Gf8AkUNHjOoIsWoXUE9+dzeUqhQF7DjjgVF4ztbA6XbwTWe1LVxhPMWJAfTJ4/IVhX7f2drVldrLMjKGZ4kIVWB6HPY9eK3vEc1vd6OLuS3E6qRLHblu45z7nPOKUbqcZJlYig4SjUXwv8/6/wCHHWr29ufL3K11LBtiaPiNWxnbnq31NclLFqyR3jIWkLAL5MzDBK5O5c8jr1qvHqotra8vLkyJFaxtNvmXmMfzPXAqj4N8YpeeJZrg3MEturbRAVJk2tj5x6c8c13U8POKlKKvYyUZO73OylEGoW9tBfAJezosDXUYyWAPCsR6GqviL7Jp0P8AY72lzJJHGpS6K5RSOg3etX59FudJtbmPQIpppBIkkJlXOC3UZ+nrVTxR4ltPsk1vcaf9olgYJdIhGFbbn8jWELykuTVf1qZRd37uxh6Tfzaj4jOkTae3/Hv5fmlcg55549zz7V22p+DbaxtLe4tlkuLi0VgFztMpYY2k+n+Fcw2u3Cwj7BbJFHEq75W5ZVOPlO3p9K7W08V6Yv2HT7yRVuJ49wi3bieMk+vB60sS6qadNW7pCre0TTgvVGNe/aofEOkRXUjiNHARIQTg4xsb07c1T8zVLu7msNcla2unuSYVQYYxEY4A6jOcHNdlqxgiEn2WaJZp4SLd3I2o4HHXoTmsrTfFtuLl7bULdpLuzXbI5Ubw4HO0dcdeawhUlKN4xvYyjNtXSuc1qVmtj4d+xazZssSyEqbjLKEBOMdwQG4rc1lo5/BdvqGhNCsgKxwmQ7EIHGOfpU2k6zb+KL24Gp2HkQpIIkSVsF1I9PrWP8UtPZ7e002ForHSIk27y2I4+Rgnvnj+tWm5VI056O932LjJuUYy0e/kV9PNn/bFrcTaey7pfLikQ7o23DnPqM1Wh1aO2mu7aSO4FjGWmfykEJQI3AB9D6VNevDY2dpb28N1Fbw2o2QRjMbSKATg5zggnmo4NM1bWJ4ovJS1ghjEoUurBFP3UwTlh65rf3filt6lXT32NzQ/EtvcSkLa3kUE8fmm5mARBnkIO7Zx2qTUDLd2E8Ekis0rJLayspMcTDGO36VzOixXt8upXusrLMltutIPLwF2jGSAp7c1LrviKXUHsNK0OZJNRhiEkViilgf9pmHGAOnvWbofvPc+fl1E6d5aE0kDX16yaXfvd3sTrm02BY95yGYZ/h4pFlnjhu1W/WS3tVwFAA3sSRnPTAI7Vp6Ro+rxLa/2jBaQyNGy3M0KbZHLfwqeuPeqN1oejz2Wo6QN1g0QdIJvMJJmPVsdSR+A60c8b8t7r7/6/wCCHMr2bHeGraPVS9s0UlxaFD5g8/cAw5BPYHnrXTWvhrSreS3u9Qt4Lu8WLywQmTGh/hXvj3NYWua/Y+FdL0/SdOnSysEQNf6kU3mNBxwBndJI3GTwMnrxXM+H/GmrXOpefY3IMUzFraO5QKjqRhQxHIHSpdKtVTnDSJPJUqpyjovzIfHHhnTLLWh/ZsMEV1zi3Mo81izZzySfwFaHh26u9O1GW21SQSWcwXzjPJ8kS7fuqOmf1rspfD17rNxp2rXNxp9reKhju/IhDblPUI5+YcfzrTtrPRrC5bS7iJHEqh0NyoZXzxgEjGamWLvTVOXvP+uopYlcvK9X1OF17xJZ36xafp1qoMSkRTSf6vA6+2enWqGjRTJDrVjZtHuMKXNurn5Xb+Ig9AB2FdL4q0LwxpBuLpy8YlkHmwRksu4DgAfw54rH8NyyadIuLN7iCeVldFfeLdMA/MO7fWtISg6d6afz77lwmnT9zYxJLyz0u4iiijM9+0ABEQJyclmGDwBmt+xvp9PhXUsSrZzIG+xCMCXJ6lmOOFA6VW8RaLZJey6jc3jmC2BeSRMJKuP4QB1HQVo6HdafqUhbVGkKXgR4oLoYGwDHA755Oac5RlBSSv3/AMipyUo3Of164aS4hsdPtx/Y+pTLC9wshYRttYyMQOF4GB2yRW7LpFtoWkXNtZX8slt9nwse8MYQB98ep9qvwpY2todN0y18qAuUEUTcKOuPX6+lcxrdjLpHiC3bS5JPKlyqyPH5iRRkc856555qYy9p7qdl+fr5iXvWjsQweGL7V7KzurR2j87y7j512Mh/2l9e+K0NSbUXn3QCzmitrkxRvECRC4HJOO56H0NXdB03+z9BmWbVLmd7uUyzXBfliR8oUfQAcVW0q50F9Pvksv7SSKEEtCVYbHVsMcg9WbJOfU03Ubb6peQTm79yF5P7KukEGlNBECJHu7uT5WbBwQQexP3T2rWsLWBNFS0SY3N7HK1xbhW3NCe491GfyrO0JHutSubGUm60x0Nw+9cs8x6DPTgY6elPtkbTL9p/DoEjIMyFTlOcBjn1wOlTNX93r/W5Elf1Mf7JPfoP7TvLWVWRg0kRJZtuAGKHodwxnrxWdd6Et/ockmo3U1nIHxDGw/d8kYyvc4H61vzWdpd6fdtMj2aSOTJJHy77jkgfWse1mFtqjT2sE9xZQ7JwkrHcOcZK9epzXRCcvsu1jaLa1Ry2q6W2o6xfadp7S20EaYndzhflAwMD19KLvR49Au9H1KBl3Sz4ltywPPr+Xb1Nen6FZCfUdTubuxETxHIlxgXJK53YP4CvOGhs9c8RL5EF23myCaQyEgQYPOD2zW9LEObcX8KWv3G8anNp2G+NNITRrm8uGK3U+px7UglY5iR+HOB7HH40a/qN4qw2WhXZj08QgTi2cmQhVwYx3yT3rV+Ih1JNZjSPSjd2rxR/ZwqZLuDzuPXA64q/YWOneHtPu9QS2Z7yBBJOkY+Ys3UAdh9KUaiUISlq/wDhvut+YLZN6nHPYwNpJP2eez1HUJEgtpHuNzohAwZPQcHtmtHSp9d8La5DaW99Dfaaq+Y8KKFYKepGepzk9a1NAtJ7rWJLgWEccFwvmOhl3sAR6dRUjaffXFyZ9Wi0uHRTmAhnAkjPZlb1onUTvCWq+/7v+HJlLRpkl98QdGXWfJngvrQW5BN20W5Gz1GewrrdV8Nf239m1PSdTluSrrcSKsnMgA+6uegPSvNbe8g0CS/0ZtOn12OUhyUYMY1xyMdSfr1qDSPJs5t2i6/fpcm1aeOznbarY7HB4wB0FYzw63pXX43/AFRlKlreDtb57nS2li2ixvcanoh0+1aZJPs2nuXuUkY4yzg4KgYyBXoWmaPuhjuiTfRykM6yrtPXuPauG8Pa5Lq2kpYSawtxqN3CXRXhBCtng++MV0Pw88Q6pY6t/wAI94kktpcputbqEFd5H3lYdj6Vx4mNSz7r128rnLXjUUXJfM7TV9a0/SIGNzIEAQsETliAOcCsLRPEUF7pY1O0up5rK5Hm2xlQq236dcVpeKNGtLy6sr6SJWubQth842qRzn2rk42u7u2W7gu7e5gmGIfsz5Rhu/hPoBXJTpwlDzOejThJL8ToP7VuodPiMrSSG8k2Kw/5Z+/0rnvF2nXxsboRpM155TYcEBJ8g/LgdPwrdukh8qwgAJG4uMc81prdQLBJFesZbuCLzDtTkDtj3qoz5GpRRXN7NqSRz0kZ2+ZCds20qrYrmjr9/wCEzJNJM91DtLYkyxSRugOew4x25NdJBMv2NJScqPmHv7Vl3dlZa3YzsHEiy8I0bgruU8gn1r1KbSupq66nvSim7S2JReS6npkM10FimYDcq/whuQcfWty1ia2tI3bYHJ6HjJ9a5HTl1KTxHe6fcSLNF5e+2EcOwKoXIBP8TZHX1rb1SG31TR9Pa5lkjeCZJFkQnKnOOR3BrOpFKSj0ev3jnrCJQ8V38Fp4mtUtdNe91e5tHNsx+6oVhuH1712NvPKmjyzXKFZQMyJ3Bx1rNVpZZ2txL9nnhdWRwgbeueV57HFaenyw6g13AP7u2WNj91ulYzleCVtv6/rzOOrordjJ1KEXOiJx++3qoPqM9/wrE1K9Nj4pstPSdRbx2hJjuDgMWP3gf6fSu2lhiitwCnyIvTPf61xPi1YYbqG4uJ7eRZELIhwGJ6YHfBxV4aSc7PbUrn5426ajfEcOmDQrn+3zcLprW4eTdwTtOUUKeclscAGuafStO0yW21Lw79ntpYo/tE6BvnuDkcDPA5wNvvmqOqar/bFnDLrF1BpUUPzWln5wa4kA+UlQcH5hkZ6dcVu6ReaBDr8e9YptJhQ22ml8ltzACTKdcDAAJ/CvRjCdKPV76dP8m/66BFOmtTrra71q4tls7udo0uY/MEhO5lbIbBI446VnaH4WafXbuym+1JewuJV1BQGjmXOcEfp+daOqwwWdkbCbe12Q7KEUlQhBAP8A9asDwl4guNPiaWyia4I2wxI7/NuPUMemPoOK5IqThKVLT+tzCN3B8uh1C+C7m11y4uLL7L/Zd6pF4r7g+4cgjPbP41xtx4Oi07xBJqj38j36Foo4nGEjQphV9WBHBJxW3ZeLtS1bXYRq07adFF5sU2mrFwzYKlvMz82OCMVY1W5g1C/TTpzcx3zARedGMgZGVYgjngdqVN16btN9Nbdv1+XkEZVoO0uxHFqdgnh+eW706Wa4t2SSaSJgdqswRwn+4DyK0L/TrnTbazbTYYpbmVd0+qGFWbGchW9sd/atDTfDWj3lhJbw3Z8+K5E8rRttZXA+ZSPQ45BrmYJdauZpLaw1AG3sWeH5HwspIOA3HFZqUZt8ult73+X4mSak3y9O5dtprYpHcagxu7hZ3NvJDykZwNvHHU9BTYtUTUtDj/tfyluWjDNC4DDeJGBPPQcCqunx/wBnR6bHLewadfTSGW7dVaSGQKMnYT6ZHXrioNGt7LU9Vu7xo7m5tjDLGZHhZN+4Z3DPbHPtmtHGOr7f16ammjv5FwzxX9ol3c3JdSBHFIvzMCGzhSDkggge1a+n2xs4JdXu3hhilUR28DwfNADwEOOozg/jXG6Np1u+p6dZ2f2bTo41KorfvHCDkHBOBnkk1RPjS+stZTR4tQtNZYPLNPLAjyu5C/LFEg5467unWqlQc7xp+vy/FDdNt2j/AEjc+Hum/wBt65rFvqN+9wLU+Wy23yJ82cjI/KvQksvD3gnT573Za6dbkgyzYAZz2BPU/SvP7G61fQPDkVythcaMLyYvJmJWkC4OC4J+T2HX1qMWOseNZXu7/wCz3thbR4tBIg2K5P39vRmHPOKyr03Vm5SlaH+X4bmVWEqkruVof18ifxNqV94rmgngtmh0Yspt5klKyZHJkcLzjA+7WXrsyS6ZbXpv7g30rnzHcBAVUcAkDvwPxrVurbxbaC1XFnaQJKMP5Y3GIdSew3dOaybPWNW1W5v7KaGwvIsBIYbcAY59cc+9bU1ZLktZeZvBKKXLsvMyPC/ha78R62Z9XH2dJZGmuZSQ0LBfuqoJwcZwB7Zr0iKTRIo7jTtHiWHUNpKXV3ECiH+96fgK5i6sbRwpkiuvNtpNrQtEVRXxxuPcDtUWvTWDy2VheWswtfLVmKQgF2boCOp6fqKVW9eSu9O39bhVbqtdF2/rc9H0LRzLG813rk2pxXEQidBtWEnuVA6H8a4jxToEemo9tcTXLWcMhaFZnDb0IySCem0n9KEivtPG3S4WsdNMgaMySMrMfVV6DPvWl4csbnxHq13fXd21zCzhJoJ13RBB1QLjAPTmuaKdJuo5af120OdKVNubehk+Gpb63je1tZbTVUDhoZ5ZgwPqCB/EKueGYtQ0++1d0tRefN9sxCPKXfn7p3cnI/lXW3XguG6t/JlvZUiSTfFHFGkax+igAdK5ufw74i0zUbx7e+s5YruIL9rlUeaMHhRnikq9OpzJNK/cXto1LpNajpI72XU3utTsrSI3RAhbzN6MvdSOxHNYt2LNdRhSRBeyJNmOeTI8hQp6D04wB6muh1K/vNIsobYXFjfaqq7I45BxG5xz7cVzmmyRanNP9u3xauwbbIsZjjTZ15I5GT15q6adnLp5f1sXBu1y9purWS6x9iuQZLpEM+eVCbuit/td6ziFa+n03ZMmmPNgMJGZpW98dE/nV6PTlvxYXN5PuvYt13KwTc3lZxye544qowkvfENzpkFnsyiz+crsuyIsNobsSep9Pwq48qbt21/zKTW5v+FLNMXf260+xWvllojKNzMM4yAegAHT3rJgv7S7S9uWsrZLG4ZY+XMbCAAhndM93H45qeHSH1L7T/aUzPpNiGz+925AwSnrgEZq3eRvqOpWX2C2042eoRB0MrlGESjgYx3ycfSsnbmb/pf8ExbXNqOi/s8aZZ3O5jJauVtiR5ccrMMDIHUcjH0pPD2nWcVgs+RE0btvUsVVs8HA/ugVEdK8+31ESBkjSTEADblBQYUgdjnt61xB1DVEtbq0SO4jk8n9yCCXkwfvH0HWqhT9omoyNIQ5loy7czrY+KLxxayXEIuDctcSKRCqY4A+gzgCrB8nVbmzuIkdEvH8wq64LgHj6DjNY1+uu3WIZ1l/0oL5gkb5VXrjH8I/WujtIra933EEjpYwxsqtE2RIVHzAn+EeldE0opPr/X9fI2asrmz41v4YtNjs7co4kAMiA4bYO4x15rznWGvbHXpZC8FotwipZSE7i/yjBK9uTWhFrFpd+I3yrBXgH2cR/Mygdcn8DTr+W21mWxmezS0kjJG2Y5neIDG5R2ye9FGm6PutaW1Kpx9nZAmvX1vpN5FO7oILQKmoFclpMd/qc1maF4oez0VLe5sReSXJLTNO5XEeODnPc5rW0jT7e8s72Nop47aJlGLpuJD2p2saE1xfWyzSWkOiLh7oycYAHQH6VSlSTcJL+rGnutWZy0uuWulXMt3qGjSW9xdw+RDLaTb3kRhx07gc5qbRbe0svC4GxZBNcb7eC7Uys/PJbsD9K6U+H7lUutS0TUrTUYWJNrGQEjjxwAD2wMCuRmv7qOSKJLhZ5oGxcQxDcI89dpP862jKNRWj89/12HFqa90aNPuEj1K60uKCPVbc+ZH9kk+8Cc/vATzjpUmm64sOleRqF3FC/lvK6Wunq3ku38TN1YdyBV3w5d6TqniK7snsJ7GwhtyjKQIlZweWLdSDnrXPeKpy1tJZ+H9P/wBEjbIu4gRvXPzKfatEueXJNdnfT8/0Fy8900ddpmopY6xdajpOjSNp0WniU3+0L9pcdQg7Hv8AhzWnoerX3iC9uY7zOmWv2db+wvIYBudP7rk5GcjtUMdrqZ8PyaPosdw1ktmZLW6UKuJG/wCWeD/nFcj4p1rVRpFml7fXOl6ha2pg8kLu8/HAPB9c1yRpKtKytfbu7dNDD2ftNDvfCXjeN9F/s/x9f2yahqNw0NrEitukToAwHIyfX1rp9DjVbJLeG3htLeEGNIUXjyhxxjpXmvww0C10cw6vrcIvNSu4A7lzl4w2RkA8jPeu3uUu/D0Nr9ijBtpmdfOaTiBcE72LcYBrkxFOCqONPr93yMJwim1Hqdj4d06zggiS2ZnSJiUVjnb+JrL1uy8Uz3F7PZNp8LL/AMeuAckf7Z7nFaegxX/9lW7vLA7s6kPEMgp3PuTXRuAeCMg9a851HCbe5wSqOE29zzjTYymnCKVt53dcdfemyWJ0qKytrG0hW3mZn2D5Rvzknjv0o0x/NsLeVfYkfhVibU4lgMrLvSJyo4J2E8Zr1ryvofS1VKMrGDYOo1QeJbm5ntYrJGkuI3GVKrnIGOorengEkN/ZWkiCSUSRWzMMr8w3xk+3IrLkW7vb6RtQkiS0DKI4HUAXJwQybf4t2a3NRhMutRzQBUWWFJFC/wAJT5SPY0V3qmRFqTcXpp/X6jbm5XStKS8v0DtFB+88o5OccgH0znmsHw2l34fs5b6G+k1K1unEsTSL86xnkIT34J5rVsD/AGSbewaFWtmdoYwwLbAeRnOSec89K0xD+4kTjy22gbRjBU8cehqObkTXR/l+hF0n7yumXbyaGUrZRnEk0JlUHPI9M+uTXK+I7CaOxtrmRE8y3OMogZlJ75x0HPHvXSajteFL5T5kVugAjRQGBJGSG9MHGKfcFbqzCmJRayqQVfpgj0rKnLkakv6/pHPFtKx45aeF7DR/DuoeIdTFlf3tuskljI6hzG6gldxHQA9vetPwXoRvLe41bUbdZI5ilxaeVgDd5eTz6HOMeopPG1g+j6bqs0sjR6deQpaGCILxucA7PRiM81V0zVrfTPEk1tYa2yaXflIdNjGW8qNVKlsHhRnPOOa9m86tOUou7f6W006/8E11acl1O+0vSdU1SE6zNdq2w7YngG9yFIwQBwRjg+9RXGlW2i+I7220dYbiKWDzJba5Yqm8t1WQcq2TyD1FRaJdXErPp9pLcqkIkt4XhYIkxwCCGH3TuGef71a+oNZ6Ytr50sOnl0ee4tZJcs0jfMdx6nBwR7V50nKM+Xo+i7f1/SORuXNb8DFtrTVE1rdfSwv5asnlxnzEbg4K55wM4/OtjwFI897NHqLKl5HGUBlXLkhsbt3cdPpXGaVZXX/CQX93pkrF1cSFLg7UEg5LBugByflPXArS1PWSNPuptdEJhXes8qDDRh9oBUdOoB4PvWlSm5+4uqXr9xpOPMuVGzpGnTWnjXWo44FludgcXHnYaRjyAy59M81n3vh+/tbifWNPmujLGd9xpm4IJAeCxz1I45FTopgul1G3dy8MMJnaQkSSoG+Vhj6kZpllcO/iCC+N7dG2juDDKJ23t5bnAGe65OQfSoTmnzJ9Levl8ybyT+RnaZNNryQaWNSsp5mLbowBmEsf4R34HWlW5hil1O0trq7U2byxK0h3ySAHDOc8bTyBgV2IvfDOk6sEulsluIpGktpY4+Y1OeMj8fauY1e6tIby6bSjYtY3aLHJcvhsyycAEnoMkCnCo5ysotIIz5ntoafhLwDZlrLXFuC80gMkqOm8kEH5ASeBVj4m6dpdp4dZ7KytdP1i8dIIpowsMmNwLbnXkqFByB9KvfD8Xkdvaw3+oxNd7WeSBYwuU6Lj269K43xLJbz+Pb+6g1KW5vIYiqWsmRGgUchc9zWMeepibylfl1/Hb0JSnUr+9LRf1Y19N8F6pe3st/ea2y2F0APs5yxC45IY55POPQGktF03w1rOmSaF4icaW8pt57aZjN5jdgpxxV3T9a1mf+zBfFY7e6gwYYcEq/I5OMkYxVbwb4NvU1fUda8SmNZt2bdIs8KDnOD07Ad6bm0pe2lpbZW16dunccm7N1Xp2X/DGjq/ii1v7u50/VNLjGmKcLPcsDmReQSnUD3rF+H0cEHiD7Y9vC7zq/mTRzARwKBkHb05IwDxiui1PV/DDQI+pwwxyXLi3UBB5hJ9fT6mud1W00aDS5oLCxuzbMER4omCl0Zidxf0yOn0qaSXI4KLV9PL8/8AgGcEuVwSaudJ4iuLWy16ASbltNRQB7iNiAjAnkt0xjHFVzNpl69hPrthDHeWtxi1ae4jUyDs+1SfQYBzVu00d5oZNOvEiOlqitBATvkjOOCfU1zEfh6fQ9a+26i1m8rTiSMyruIiUZOzjO72FZ01Brlvqvx/pbkQUWrX1X9f8OdD4oiu9ah+xhYU804xIxBYZ6jHPWsV28TxeINPgsMad4ftd32ozqoeZkJDHB5KkAEEduakk1l9PvpdYe7e/sRKcSBAoRD0Ue3PaqXjG7fxFZ2t1ZJMsjSBDsl2Mg7r9TkAitKUJRtFpcv5N+ppCL0jZWOo0zxBJLZ28ktx9sguJXAby/LYJ7jsPeoJde0LTLSaGygJEQM6xyMdofPYk9z6ViX+qr/Yws5bW4S4mdoIniAdxgZLNj7oGO/XNQabp0DwwaWsKXVyAXhZzxuUEgP65Pap9hHVy0/rcXsobsiu9XW80qfWNXsoLa8mKxubNgxK7sDnruwOlVPDs11suyktyjtIVUzOCkMWcb1z0J/LrV/QdJPkXELK1tc3I8xlAB8mTHLIO3QisjU9QfUdIOn6ZYql01wN5mLBo1TI+cD72Se3FdMVF3hHa/3I2SXwxL919t0hobu1N5qMUKMss5I3Sx9eB0PzFQPpWxDfG8nsr0LHaWEMZmmn8wfvCUPyccfKetaXhx7LRNEksZIXuJ1jdvJjcSecO5HoD6dhWL4cttNudOvINMtntnEjSGzuRkR5GBxk/LkZx1rnclJNtbdfJ/16GTle+mxqXKTRzRrFYz6nHJmdGWQIYzsPJHfPArEmSNNHtLmUsbdIzHJAygyLNnON56KMfhU8FlPa2uoRPIss0bR+VLMzclUHmOMdtxIA4ziptcn0nX7V9MefctuQ03IVXbH3BjqfWiOjVtu/9evkKPxeRgw3GoT2dncape2wtkuGuDDbEsoQfdGf4znkn2qxHrlncXjOlmxuVjAWV5gi49vf2AqHS5bhJE8u28iwhTBnRgUwOwX6cVd1ZNH1C0gv3jNx9mfzVEPHIraXKpWa+7+v1OhQu9UVJdLudaSKS7gjG99s4SQtiPsQfWpNRTT4YjpGlW8cYcZYBtoC98/lUnhXxG+q3t1af2fLBDB92bjZjsD6GmyRagb28mkewW3aI+Y6gF+O+e3ap99S5Z6W2VytnZmV9u0y7jsUjkjhPm/Z02JtJUjjHGcelWvAvg5Ir2W6u45pNrMkMk0oYsmeuB0rL0p7WBE/tGCGF1YvbNndg7cZJ9fauhk8TpaaZaQWVu5eRjI7khQmO5z69hWlVVEnCl1JnzL3YFrxpdx2UsdjbwG4ZY/M2KpxuzwN3SuB1mxuNbvI7WXTrkfbH/fYchFx0J7Y9a3tV1WXVxBLeKY7CAsXhzuJbsXA7e1TWvjm8ttDm+xaZFcXAZlSR4yoVPXHf6U6UalKK5Fd+pUOeCXKrs4/WNLa01xoUvPN06Hy28mOQAZ7kqOnP50uq3V7bRteaRb2UPnZXzLnC7Ce5Pepf9FvNVvLuZrdbi4hQxLDEVDOMZyTVDVHu7vTnP2ItCJhHHDJHtLnqXx3FdsdbKX4mylfc6DwnoEurSQtrbJPNesEuo45MDyRzuGO56Y4rRvLSWx1OFLa0NtokE+EiONu0fryeeawdCjFnq/27S7NtL1MwbZ2JLB1A/hU9+n4VrWeo6tdJHaxrJfoXCyTTxhdrdckelclSMnJtvTt2/Qxlfmbvoa/xJ13+ztPRLZ7e3+0HyWhbhnDf3T/AA/WuJvfCFnNHZ6qbmfU7HToCWsYSWlYjncPXGRmnfESa6jvvs+qWMdw8ckcMUynCzA84B7kGut8NO/hn+1p5ZTc2E8YnjuZFARGbgxZ7iiN6FGLpvV/j/X3kq9OC5d3+Jb8G3NtrcNjrVtpm+aOy8o3UuN6ktzHjtgc5rsreyi1bRprG4gS7tZTh4p+QQeT+FeW+DvE8PgjVvECeI4zZW18VvLQynCPlfmVa9C+Gus2WqS31zbXsc6XTb4ArcBRwQo9Aa4MXSnBucVorWf9djjxEJRUpLpax09xcWWg6civiG3jXChR6dgK4V/ixpd4L2LR7O/uZ7eNzu8nCBgM8nNc58adQvJddttIgtHkuJmV7aSZmjijPTIYdTnnBrmNBurfwZpmoLqjT6rdRKfPhjG2KTeeSp/ix0zWuHwMHSU5ayeyKo4SLgpS1bO/8KEnTGU8jnH4VoafYqIrmCRyfOfK84GPT1rN0IfZdVv7FjhopnQc+/8A9atPVGFrYxXJZUFudxZuh+taJtvTrY97GfxG111+/Uh1e3jJs9koi1G2ZZIJtu8Kemf8fpS2UWtaTLYx+IYYWuZN0s0lu2UUkgEKOwOM1Bb6ug137R9lD2yJ8qrzhgSSPxqvrsNzqOtafr1o80lpFEHmt2bBPmEKGCg8gDNXyvSEtv16LyOSOk1zbG9cX8D6jeaVDJJ/akUJliZlwCpBwM9xnH0qlpV7c33hlxch7S98pvMbGdjL1I9eBWmk4+2Wim5giublDDH5oA3SKOMe/GcCqGmO0XnFpJROLkJLbNGcRN3K+qGsFbldl2/r0Ft7rMzwnrVzAvl3k8d1aT3GxHU8hG5UMO3PH413V/bgnawHlsNo9q81it10vxtbaa9pI9vcY2SpwsIOSARjkZ6HtxXpVzdr9hy4ZmJ2kqMhWHtRiklJSj1M63xRlHqc34u0Oz13Q5LS7jnkuIRmMRtn5um4DoTjp6Zrh/D/AIWg8IWd9d6jpBvLsxHy2diRbxdsdvcmvVZp4o0tp3VkXAzin6zpj3ka3OmyLIkqfNE43B1H8OD2p0cVKnH2bfuszlVcVyvZnnOiXlpHCgl08mPVZzcpAGKJHLEo+YEdyCCfXaa6HVk0LW7nSIdet4INVvVkYTLjIcZVQSD16cVyvi3T7ldDt47WH7BLG58uOMt8rdDjngY54rWsbKeDwzp2r3MMl7cQ3ABYAMVBGBKMdeQM11zUJJVE7O7W+vl+n3BOO0k7G34d1GA+CbTT9TMRkNybV1Qg+Zgnkg9M4rntR02e6e5t4JY76yWQIljdqGaI4Ifax9ux6Vu/2BY2WgHULi9h0tVl8yKd5PlcsOVIPXnOMc1i2/hnxeHE3nI8Jk803CttkkTrjkZHXpjNZU5Q5pSUra9e/l/VzOLim2n1/EhS1nfw9BaWl011bs6xxxrhpgu7gAexyfoK3dLludYtdQnNqGtHtFjjmjQFgFPzD68Z71Rk0yWbTt9nbGwtNOYOt442SAYO7gHkEk/nXYaZLFF4WtLSO5j+03Y2KypglnzhsdSMY5qa9T3dNXf+thVJ2XzOI+xaRfXd7d/vQ0Mpgt4nIDyZTcy4HVecc+tY1r4esdctLeK1lSCJpVSWOQkMCDkoR2Pau1+H+heRdxf27JDNqlpuZFQ52qR1PqcgkGqsV7ax/Eg29np8aQJG17cu0nLOAQm3sCeWNWq7jKUabeivfpp/X3miqWbjHWyubGreGLDRdBvdUmnmWW1tzJlflVVUZ2gDnHGMZrhvDN9petW8Wtatp/nq8hWG5A2bXHC+YOpJOMda6bxZr0vibZoUFleR2s0my6AIUzoMZRWweD39qr3fh648M6/Ba6QIrfRriLfGPLBdXVgfKH4EnPtWdFuMLVX7z216fIypuSjao/ef5Fxb/Wdfv2sUhhtbjbse4h5Ee3k59CcgCuk0vUt+pyadcSyWz24AxIVAl4521yq65LqXiWaPw/LJCyx/NEbf9yXTOWdyBjBOOOuDWPpUGpWOszXGuW5iUufMFwN0ckrnBKMTk/e6CodFTTTstNF1uKUOZWenl1On8TaLBD4gi1EmCZbhTEEIXCk9ZW7nGe1ZWk6D8tzpYYy/ZpHE091L5ZlkwGBjQ8MpDAbs8VmpHK2sXMEenXFzp1nceQqx3A89d/RxnkDrXYJpsyanp9ne2UOp6fbqRDJex75UkOMEE+i5z9Kcm6UVHm6f8N1E3KEUrmVfajp8F/HPYW187afbZ8+zcFZv4SpAzypPNbQW4ubkWsl3b6lZxtm4SRlMtsNowDg8MQc+vNWrPwNo9h+8g82FwDuaN9gxnJ4HAzXPmTQbG41y60x4pYjGskpscGSWQvhiwAwT05znrWPNCppTu7eRmpRn8HTyL93pMGmaVepaeXewQhvIguD8kWME89+tZwtYbrR5Ir7Y9xcyNLEsa5G9VBPQZOO1a1tDb6xrx/tCzhSxksStuXmKSsXAEismeeAOcVAbW8stNt7WxWGO+sJGitWZg7TW4wNwz3x1/wB2iMmtG9d/6/Uam9m9f6/pnITXUk/2m68MNAJp4VeWKSMhzkkHJ9+SAO1SaJqS2cFxDdS3k80ZaGOSOJVeNiOVRsfgDmtnSb37Jql1HrH2e6a6Uy20VrAANo4+8On0qsUu9S14xm3FtBKGMYkcDEi424B5znHNdXMtYtab3/rc6HK6s1oMt9QtrO30+/ksHaKOI20iB8tAvcN6kZyT9aq3moXH9o3q6SoZWWNJfNYbUi5Pm56jPAxzWvc6Rdy6jZz3c6WUUMeZtpGTLznPY54rOtbOzj19pdR8ubTnXKPHF99zuTY3thjx9DUxcHeW/wCPUXu7ljTo9IW8haTMytm0FxHLhevzDB9zjiqmqs+j213DY211YO0TyeZE6l/LQYRST93J6Nz3rf1O9sJNOazitrZbBebiWRgvksfu7R/ES2O3NczDpst7K1zNqyOUXZhgYzKo55z/AAg9u9Km7+9Lbz1Jjq7skeW3RYri3FxP9sKT3szOViQhAuBxzyCcDqabp2gW144FqkkUaS+YtwR8vHPNSWFprE+swym9aO02bDaSAOjd9wwcg9fqKPHetXmiu1lkRWUkKKGjXLGRm6DueM/hVNyvyU3qzWnFykoRZqa5qLTWcyWVss1uFKkKNqt7ewqhpGm/2lokDRWcljIp3iBjgjtz7UuhXmqapPJeBX/s2QiNItgjAjGPmx+f1qzqWvy6fqssEkaRW+B5OD8z+5rLklH93Dfcq7iuSKFvLePRNOKxhjLdNtaTbkDPsO1c1rlrdB4LSFfLs54DPNdKDgg/dXJ6HgkjHQ9q2fDepz6umqzyXA2OQIhnHlkdvauW1O41LV7uS0kDSW2nKTJPuwNxzkH19q3owlGbTe244xd9TVs7Ca/j+1lLdoUiUWTMMY9yPXHarpjsb/Tbd9W0/ZKzmKOZFAIwPvbTxkduKb4d07/R1fUy53SKU2KRvIX5dw7Yqzq1rO8sk8tyWnhfcI5BxGncj1NTKa5rX/r+tyN5WuRaNJ4at9DuU0/Sr65Zt3mS3mUlnb1z6enT6VkeI1lk0S3k0G3kijTJmVZcsnt7iqcfi7TYNQlgM8yxCGSWaVUJdAOOD0B9O5q/pGpW8UIMck4Dc4uF+fHQE+56/jVqEqcuazv53OhUZQTm0/vMwXOk3iW8dpb4nTaZZZyV2k8cdqgvdTgt79BGl1AkaSQoZFyQehIA657Vpzn7SxWzghjuCSyqVOCPUgda0rTU5pmltU0qG42ICkhkCMHxztB5xWrly9L/ADIaS1OeXUItd0ie2soJ4tQtokdLgfebB5zjnpRa6pc6Bo/2rabmB5vLM7H75zgqV7Yrb8E6lbaNdi61CaVreZmj8piCYu5YkdRWjeWun6lbmXwpbvHHHfmeeHcW85mxlwpzx7cVE5qMuRx90ynUSly20KWoXv8AaotZbbSYLzR28tIZ5Dh1diQ5CYJ+UdCetc5EmqgxeEb/AFFINPupXxK2JGnhwQFA6rzjmn+Lba70zWbK7SC4S1SJ5J7eGYIjyjkbc8A4BJobRdM1O1fXoLuObUI4FvrIbiGZucoenHGKcIxjG/R7aXs+g1ZJee3qcrqGleIbq/WDxlb3ECQ28NpZ3luwDRy8+W7Hnr0Ndt4Oks5tX0uPVIYLX+ymFuEgym25bqTjG5XPPpxXPeFr1rURza1dvJe3TCea3lyzJEFZvunnjjmn2urDULvTLywie61Gd2tY79IGVQC2FO0jkr/e7c1rWjKacXslutEE46WOg+KWlan4qOjWJQw+IYw0k7BisYgLEHA7tjbx71P8OpPCuneI/s9vHJHdyW+EW+5fIJyqg9FGCcnk1z/jLXL3/hP7WHSdYuI9VjiFlcfuv3fmJ8pfJ/3q7DWfCd1HrseqWcltdSRjdeT3R+5GBgIgHr8xJrnkuWlGlN2TWn/B8uxja1NQk7XRXn1ND4vvWhTIa6EmT02MSPz6V2ohE6mORcqeMdq86vNJa08UPZ3DK8qSZEhHUK/X9K9JtziVATgFuBWDa5I2PdzCMY8rg7ppfkYNo0ttPdxfZESBW2QM3V2J5A9eCag8N3r6bc6u0syvp9qzMZwS211+9Hg84A/Co/FV1Kkj3rLKxsZ8CGN+ZQ7AYx9cHNP+26ZJu1G5aeOa7ZbGKzMPypI3LdOu4Hqe9bqLlG9r3/PQ896rVbmr4vtbJkSee0+0x20qX9umCT25XHORnNaGtRrNFY31pfSIInMkhWMMJUxyjccexp+uL5EtmEQp5Shgjf3cfd/Q1kQWL6l59m0lxp9rHcJcQyJOM5z02+lctOzSu9v+G2J3pxnfb/hhXutR07xHBqH2iCTRTEqiB4/3iMTyQ3oQenqK09VjvIdVuI7R5Fi4lRV4DDuKha2luvE1zbTlTaWxyqIBtfcOh9CDg/jRBfXt3fX0M0SAq3lwqVw2B70PWzVtF+HT5mf2rrt/wxoQlLiY2d6MiQFkI7H1qpoMt14dhEFzO01um55DJyV5OCv4dqsRyStD5MpUXMabwTxuFZviDVrqy1XT1Fn51tOmGBPBb3FZxTl7i2f6FKLm3C2j6fqdVfaxpVvDayXbRyC8cRxYgLGQn2x05qtbz6QGkWCxW1kAPCx7FJB6Hbx+dZGn2mlv4oulhl/4mEkMdwtu33URRtDL25OakGm6jb6rNq2oalaS6ckR22scWMyf3mbPIFT7OEdLtaf0jhjThF2bZsXk9gm3ztPWYwkOsjw/Ireqsw6/Suc8T+N4IIhbSSW8BMXnSrKSN0ZO0YPpk8ntXMeJmm8SXcCF9glhcjr8pAJypU8YweuKytVfRNU01L3UQb24gsDbQgsYzcbjgle25Soxn+8etddHBwVpTuzenh4prmV2a9jc6NqVpqDifULS0twEYnJEhUjO0HqMng+1d41rDc6JNdHyoZzGI4ZQ23I/hwfQjFcd8O9G1RLKx0/xDZQJBFFuErTh2cklvLKjvgruJ7ip/GutvbR3dhElpbQWyqmPvncTwMevIp1o+0q+zpvZ976EzjzT5Yszo9Wl8Ka1o9vM9qbqRGjkgkkBnRXU+Wox94Fxkk9BV3S9Ilu9CvLa+P2i/u9smYfmVdowwDHucY+gFZs9xLNrWnSNolvPNp6yFrphlVxGwXzG7J8xPHIxWnBatY6dHfSW9vGgldYpLObeqRtgq3vzk8cEYrSey6N/5uxpLT1Y3TdSt9IfT7m7jviz3C28Fq0yqRIBtGF6sMDPHPtXT+IJ7bWNWt10+9U39irmOHOAXYYO76AVBd+FNO1Kxhv4XM8u9bln2hnd0GPlz91sEjjFUdZsotOvobixkhtF+yO0sLvumYngtz1x8v5VyuUKkrr4tTG8Jzut9TN3w6ZFPKY5NRuzaNDcIGb7NEgJJxjkknGSOnatvSrq6vIbWCayLspCSEEtFCxUFTHuGSvTmub0rU2t/MM4+0faB5BkUbgsvqVHABGBXTeAbTVYLm4uNWmDC6aSTy0bds5GMegwK0rrli3LcqorRbZz1pZao/iRmj04WzNP+9lt5Iyo2nmRV6nnIz25Feia5b3N29mLOWSCdXwJWztAxycdzjjmvP7LR7mSS/uLayuLWf7Q0ZlyS4RmzuUDtktW5HLK/im0RLoMbeEo/lytvm2j+70PXnpUV1ztNNaL+urIqq7TT2NfytQS3u4L6+S6aZGHkuAnH1HbGc1zXhEXG77Lpy2m071Z4ovKjt+MqBxliT+nNT65JqCa5cor3R0+WFXjmABZMnlFHYdqoLNbwTjT4dRuJykgd3hkEUlmCOdp6HpzSpw9x+fkOKfK/M3otMsb7Urey142762luyl4gQ2w+jEfjn1rm30qOHUL+1t5L28mtt4O9sCOIrjYjfn+dbEV/PqDWWpl0eaQy7ZI48BI1PEZJ79Tn3p8lzp+p+IYBZG7iupIUk4H7vAJJ3ep4xmiLnBu/b5L/gCi5R1MK3jeKCGW0Xy50i32kUzCONR6E/3uvHNF9cQaLqei3mp7jcTARhBGScseT6rz+daGqWEs93qkc8EF5Gro9vaNLtdhtKjaP4cGk8NafeQiS6l1K2a88sRloxuWSQYDcHjjGOPSteeNuZv+n/Xb/gaX6k5a4u9Jms75rS51PLyxw2r4EbA/dYj1/XFR6Dewhl0/VBYxO+ZRZWilmiYZLPI/bPoTUOj6ffWOqywSSWaXdwWkd7cbeOTkD8ecelRS+TbaJqE0l6pWCUb44VCJjnG44yxzyT+FS4p3iuvb+v67ktX0JYtRk0qyaS7tEurYyG4kutgIhGdqsT3YnhQKp63bf2Bdx/ZLSK9e4AA85sBc8nc3Yc9KyG1K4vprSO5v/wDQ/NWS1tzGVyR0dxjJAPQcAYycnpcuFEMSmVPt92kheVpG2qWJyWK9TgdB6CtlT5Xd9f68tjRRs9TpNP3QLLNcIqzPGdkcB4OB2J9cYrlZV1e8hWB4xLrEkh5i5+zqQPlBPcDgmutmv1t47T7bcRyz3J+QIMbh1wo7AVlXUVlba1fXyw3EU0fWWViUOP7vtmsKTabbXp/XYIPl23ZA7yafO0dlqTyyki3HndtvDAdj9ak103Q06We4sBemBOCo3HI7DHSq8lwl1a28t4ZE1BpG+zxyw7ZHU55VR7464qezt7/SrK5uL+ZrdmQlUD+YxIHBfHGfYVb0s3v+Yct2u5z9gptYbOJLFIXvSZ7ksdzNJ/CmAflA6k+1RaKLec3USi5ZCB9oQHA3hjgEenv3p2gvd3mj34vYlurtpHEcvmbd8O4bT7d8gZr0rw14ctrCw+3XjIGkiHmFuMD0yf61dauqSd9y61RU1q9TkdDv5tYFxYSlw8LSmOJwY/P2DBAH90even2yaq1nLJeWu+dl8tEUj5cdAT0AqbxBqAOpveWirDJZN5UfmZy6sOSMdqwbfzrS5EsN88mn3JDEITmOReufUVMY8yvaxKjd3SsLqmgXLxR27WzxbkDy+TnbuHQBh0I/WsDw54c1m0aSXU7W61G5uZsy3Mrbcn+EKM8KB6V1C+deTwzQ6rJFZkiQKx289xirP/CR6hpd3Lpd6Vd2jeS2niPLL7+1aKdRLljZ/ebOtUa5d7G5pNza2Wg31yrQz3kGUeSIBtjAdM9jXl1tqNlbi/1zVZHluFTbGjqVJkOcLjNaPhSO/t4JYtFtHhs5ZvMmLAsruerNmtPxZoun2+hedrM8MNzJIohcjIWQnghR2xTpxhSm4N35n03JjaEnfqZmnWlvfNbT2tysUD24jltbjLbHbkYOOlXtAa/Ns11qKS6fa6XeF3mWPBnTptwMcZrH0nWnt/E6w/ZHuIpGSABGG0DPMhHbp1PSvabS1e70+6toVhTIBQk7wrds+vY1GKqulpJbmOIn7PRnnnjhE8U6RfaNdwPp9yrLcWM+w7XHbPp1wRV+Dwa+h+ENCGh28V1dQsFupJsZETcuB7A8gUzVG1bQYJ9S1u+ab7NIxkWXaBOnGNgHTHNSeIPFF9deF5To0DTK8Ikk28MEPYe+Ky/eOMY037t/lfYhKclFQ2T+RzHie0hv/GkF1ptv8tpGVnMuQjgqeB/e96i0nTZ/D/hvSNe1+SfT7bTZ2kWC3OcIeFhIz0PHqaoprd5p1uYBCyfbJRHZlVLCMjghs5OK0tJg1PWNUvND8XF3Nu4nhuVkADKD8q+gx+ddcoyjFKT91ffbZ2+83nF8qT2/GxltNY3HjlvEEwkjtFYrNGRlkD4IZh/D9Bk1teMNP1u7mvG0GVYtOuo0a5AkzMVXkKinpnik8N6B5Ohz+RDBqRjvJLoS7OGYZC7yeuOvHpTPCuv3esXdxFp+mRXVnAsjXt+QYW83bwiofU+tKcnzOcPs6a/gKUrO66aGr49ka18eW+4bpJlk2gDoAzdfwrpXDypaSL8pVlY4PTpXL6wy3njS0l+ZlheaNdx/gDECutsenPU9u1ci0pxPWxKcaVJPdR/VkdwLZNYbc5Z7mIAIQMAg5JNUGu7UQq32W28uObak03yLCwON2T1JB4ArTuLa2u54Z5po0KbtuR7evasTXLEXj2EMMMdxbWsv2mU+hK5AX1zwKunytpM89W2Z0Hj3TJvEfgswWtz5V8bfeJVJBG0jJ45x1/OqKtDYWkFtKbc6tdFbfyzKEaTA527uuBzxzitXRtbh1G90h7O3c2d5HNGfkx5IXGAfYnOD3xWV4nEK61o8M+ltqBaddpxxA6A4kz1GRgVlT5ov2UttX/X3GVJyt7L5/iTtdRabbG4vZUaK3+WWVDkAehx3pur31m8tjMLoCUK0sLJlvNUckDtyKx4NJvo9djs7A2cehTA5j83zMncCxf1PVfxq5rNzZeH9AHmQMbRbgWytEP8AVE5xkHoM8Gr5Y8y5dW/6+/yNXZpPqdFDPbX+j22oWxV4nxjfwwJ7fX2qO9hWePzZMsIzkx469s1zGj3r3/hz/R5o3+zXQ8xIwRtPX5gcc811lxZ74IfKlMSLJlgO7Hk5+prGpD2c2n3IcfZ2d+pGtrJfpdSQW6R3MY8qCTnd5ZGW57Drgc1rXkUNh4Xn/cmSJYRmJVGW9eDWLo2tQ31nNarkOGK89cg96pfEW9RtAg0VtRhtLi5xv3vs3oDyAfWoVOU5qHmYVac+dQeiv+Hc4LT5LWCy1G5n8P3MFw5cQ/aGC7+cKq5OSSe2OK7O18H2Nv4Z0/WPEFsY76wha4+z78xxynuPUjoPc1zWiLAfFVjb6vE0cdkVa0WSTd5zL8zH3IXGPXGK9H8d61pMfhySK6lSeO7jysUTgu8fdlGckDjkV3YqpNTjCF9e3bbTXtuOtOSlGMepwHh20vYdO1HVNIjhDv8AvpZLjcclc7tvYgDgjtisXRo7iS11a712eKaBpzKksyZdUTOGAx1JJOTXX/De1S5068/4RqZhYxzSwzfaoiqs+Odo9Dnk9zS+DdJfW9M1C/ltPKtLlR9lt5YihG04JAJ+4duRnrmrlWUHO/l6+hbqKLlzeXqaEU8NzFYWFrDHeWl7bGK4G7aWLDG5/rzxUus+F9MtNKisrCG8WKyjISCNyFcY3Yz654984q3DBpMMEN/LOLaaEGQvGOFUZyOKxPFfiiW+0KWHSI2W9MQWR3OHVGP309SOtckeeU0qd0r6/wCZiuaU1yjNA1C+Njf6VeySadKoGwyLtw7HIUY9hz9ay7zT7rUdWju4ZJL5Ra/ZX5BR1wMFT654rckAl1G+sNT82awgS3miuZMFw2CS4I6g5PB6VS8TaQ7+Cp44fs1jEH32cyzZRg2Aqt3BJ7+tbRmlO60vb01/H5FRlaV9r/qQ6dHdafctY3TRtpUaAyRSYUkjPA7kjAosNb1Sa7udEtLZy0bgPcNhVMTLkCPoccnk56VQ8MW88XhhoL2G6iurVNjR+WXkMhbtnlgfWrGpw3ltrmlW001xcD7qbhggOxIyexArRqLk4uz/AOB1KcVdr+vU39O1G6t2ln0W0W6SZEibdNh0dF5j6YXrkHnmqWk+JW0+cmaSCKeKTN3byJukIb/bGRuAHOOKs3GozaPY2RtmstOnllkmlgkV382NCFzwCR1HNZHim/1KTXkntNLurW2ZlMt+u1oZohkh2/uYHrzWMaanKzSs/Pt/XQiHK7xcd+vp/XQu+LNEsr++muEubuyuZ2aREmnYRysFJygGMnB6Z5qKVNNudAs4LKxmW7jgFpNdBSzWhK7uh6k9z9ea3dSbT9Z0+9RvNb7MVWG8gwd5Kg5jb0/hOKz7wRX97BHY3HmR3kkhNsAIggwA27ucDpShOXKk76f5f5d/+AJNtK/Qhl1ZrKwFkL6K9Cy4BRCrRx4AwAB1GTV3QEnltJNQXUjDB522OKSLYyrnGMdcE4/nVJrjQbG/h1KwZ51xL/pEeWjLfdKgex7isi41ue3827sri5t4EhLCJLZmM+MljyOAOMVapuatFW9V/wAAfK2rI375Yl1GCea+cX8RMNvNHKFTB9V/iI5FcxaT/Z7HVFsmuZ5IkZjMkITq3RQTgEnJ+nNXI/Cep6gLFdPmWxgSMPicZeQNzkdduM9+uKWZba6SfQPt82qTQMI7hngEbbs4DqehUe1XDlSsnfv5a/11Ljy7J3C5u7HRILFYmvvtlysZWSaMyOR1K5HTJ6mrll4enufEq3cdzJHpEUXmNbocNLIeScfU966XU/Dc0WlRTWTebfQxqoMuSFUdcD1xmuPt9SWxuLq4vRNBPHGRvPzAj0YevGAKzhU9pFum9diYSU0+Rm9c2NpHpU2pTN9omLBYklYAISxAyR1PNYlyjr4lluLyO3toBkKrHKyoq5LZ/hyf5U4ppviDSY7mJbgJuV0QnyyDn7wX0NM8W29nFotzDIwnuHiEDqckxhiFBBHPenTVpcrvd6emw4qzsynq63E8+mvagRyXMeYmVSxjXq+B29j7itAfa72L7LeXMgNufNmI6sByAT+FMjGraZ4qu7C1PnwLEoVQo/d8YDD2wMH3rphYwhJZr3EXmxeXKobZljx1oqVFFJfd3KlLRGfosF3rk/8AaJkEal2VAseCUxwM/jmoPHkmmW2nW1tcmSR4nB2qx3sewHrXYXdzaaFoywxskXlR7UPXbxwPeuDa2vNU0vfJcz+cXMhnUBdqD1OMgVhSlzz9o9IrYzpScpc2y6FCxvNRN1BaafpbWKlQ8jyDL7euFqvq01zqnl2survLNG7SmIP8qHsuBwSPxruPDmqaf/YF1qDW127R5i3SqDLKAPvADtXFalfwa1HE8cU1naAktK6BOAe4789q6acnKb921vzNYSvJ6WsXoNJniu3vr1mnjS32pGDknjnj1PrXLxrfXOtwrJYmz06WPiFSWJIP6fWujvdRubR1hgiSWZfkPl53be3XrXZ6Hp1pNpEcgMYLNtaRGAkT1z7j0pSrOkuaSvcr2/sveZ5vqE1ol6bO/uiocqYbZBh1x1Gcd/SrNzcaPb+LYZ7bRZCQhia4eYsmHA3KBnr2/OqeiWMNv4t1D+1ilx5EsjQxN+8kmwchhjpXX6n4d0qaSJ4hLp88mJN8q4BPZRzwfrWlScINRd9vl+H/AAQnUSl8jPWLUtO1i1tdNUQ2DhhLYJhmJP8AET1AxiquswW2mwrcanPGLmZzthkTOe3eiCdtF8U20/7y2vp9yLHOzO7oBgv6Be9cZrcn9n+IdUl1aGeaee+zYyK7OgXjJGeBnr7c0oxbd/L5v+u5phqPt6nLe2n3nV3VhDbhX1NV8mYAiO1g+Yem4jtXX+DdZsnnaytzJZ+Ug3LIcE57iuH8L39/YyXMWrOiHUJPMt3ibcEixwGHUN1roNWt7aCyV7S7jdMYklmQGRkbqEYemayqx5/cl8n0McRS1cJGf8Ur611hJIoftiS2CsoupYysQYkAE/3uvHaqfw98O3dlruqQ3GpNcTyWio+0HYjkHHsOK7AWCXWl6LaSai19aquyQHrNEOMHHpxVTWfE2keEryO1t7dheySKDDEhZm3cAn6Uo1JOn7Cmv6uZwnL2fsoI5bxTeX8s0HhnQ7Ge01t0FxLdyoPKWMcEZ/vHtim6Yuma7rFt4iW2kgltof8ASXlfbG20bWfH4de9ej3d5aXF59sktomnjULlwN0fGSfyNeY/GLXbC8SOy0m3aCaKNZby93bVhiJ+6QOuTirw8pVWqajbu/Xf/gDpc0mo2Oh1TxC/iXSpYvD8FzFptq26RrQKZrwjnbGhIwCe561yXjDxB9g8QSvoKTQJJH5U4QB8TABjuHTI6EisHQdMMmtw3ekWlxf6mZd7XUPyQCMKQFwOp3HP4V3GheFYLjzLee+s5Z50aa6jhz5m7ODHuHAX1xz1ro5KWHeuqXT/AD/4NinCFF67ditb3Pn6qt0NwDzMiY5OOvofWu8kZ/sBkU7cLkY64rivC0cXn2rScmEM+M4wW4rs47kG++yP8oKfKfWuLeKPczNr2nIuhBbWMi6ZhpA78FRzkj3JrK8RSXunS6e1orGBy0N5LCOVXb8r47AEDketb12s5vZli3YMOEXoCfQH865vWLZGmsb2O6eLUYlZEwu+IovLDHc4HH0rWm7yvJ/1Y8uL1uzq/AhkuI0dVaC1EDRwrKDuLBhl81Lq8jNNZzoyHk4dT1Knsfpiue0/xXHqXh/+37K2kjjtInjSGcYLIzAM4GeDxnrwKg0x7fRbSPQFeW7t4/LmtLnIzhwCAffk1nOhLmcnuun5/p/SM6cX7Vya/r+mjd0vT7TSbLUDYWxiSSUyyfOCqFjk4HVRmpn8m9UyShZ4pgomjZQyOR91x2JqmLixsfD11IJSv2h9khnJJZ2bpz2JOMdqx7Ty9F0i3tEgNlFB5hhhiJYEfe4zyTk9Peo5XO8uv9f8A1jD3uV97fgjT07UZYdYltriBEglwUZP4uO/0NbUcMi3Uwjcl4SpbjIK7RXIyawNSl06e0hPkXESzJcLnaxJwVb0x6H1rs9NdLU+dJuY3Z8s7jwDjgfmKVeLik7WIqLlT01/r/glCysoLW7luILZJGmfnDc88Gsfxnb2t9rNva3cEE6qpIQjDJnjOc9q0NPMMMhjiBkkSZ1lil525PUfQ1F41iuVkSaJUjQ4U7F3Mx/u1VL3aqInJuSdzHtvCkMvjZZ9XvFtmiEcdg0k26RowuWxn7pJyOM4ArX8SeCYV1a51aGyt/Os7ciwuXkbFuWOWyvQjOT0PWuKtLTVY9WfWvEez+yLEqUi2EzOcgcEd8+vFd7ceOjP4ijsjYXH9k3duU8yRCpV8EnI9MEfnW9ZVlKLhK9lr29PW25jVU1Jcjuktfl+pPoGpwp4ZjUajapcrIwuTGu1ZXPJ2/1xWHdeMtQupZ7HTdtze3q+bYxpkbo14cnI44BwO1cg6Gd5L6JHgltFSG3jGAifOGD4POACef8ACvS9B8TWenw2SasFFzLtiWaKHcGc5JwQM46fjSqUVTvNR5m+n4/19wTgoXaV2c3qFhrdvFJpCC2jikZWjSRhkx5y7L6nnBFS6haW19ZTW2mwx/axEY7e5kzna3APtjJ/Stz4hTedqGnS2VtcTXNvFLcQSwrld2AuxvUHd+lcvc2tzqNtZ+HlkKNcK0Zndj8+VwwYjkH7xxSpTc4qT0/rf8PzHTk5JSehraxbavo2i6assix3jyCBbiJiykYOEc8YUgHnoKq6Fb6prlvOuq2TRRCR0+yx8bYhgqcYxuJ9u1XfGV7ZWdrb6NE8a2On26pHHJnbLKOEQn0wPzPNYg1PVlne/sZlgj8xWm8s5BJ5xz+I/lTpqUoX0TfUUeaUbvctanp+sS7rDUNRlWzgkjuEZGw6oOdjnrgGsXRfEc974j1qy1CWaW4tnjaKSNd0bQbxv2kdwDnOemafLq082ozasrBbKWUx3EEj/ecYK4Pbggiuh0e4kmtZf7EhtLWffHPFKIwokjz86kn8a1acIe8l+Vnpf/g+Rb92OqLus3Fqk9vZaVcOkUH7vyy3yyu2Cu9jyQcjjvXT3gS+0qfTCiW9y0Ox1HRWxwfda5bR/DNnqZuluh9shaZwkqtjo25Mj1Uce+Kd4i025UvBatdi8uNqNK7cRqGydrY9MYzXFJQlJQT1Rg4xbUU9UYtl/aen3eiaVI0Rfz3mIT5YoVB27fTqxOPX1rWv7a90W7bVLh0MqxqIlch0aTHzKpIyMYOPrVqy0xls4rWN0if54pBKmfPOMhxnoR7U2d4JBZadqiTzzQshe4cgtHOzgDGeCmCa1c+aWnz8/wCv61KlO7INSvYtQvNPli01FhFs3+ksyrGWYgBGX2PPNQ6xY3Gj+Gp21S6TU3iuFWFQ5jIyQFU/Qk8+lFy8NtpV7bXEP2m2e4cTrE4fy0yBuG3puzjB71h6C8+satLp+q3s19BcSvParbxFFt7Y9Indv4uOSMn+lwjpdaRX9fL8BxWmmyOxE8tr4ksLW6vHnv7lC6LG2YjGB82T26jH0qpI9hoNo1pp0Ut3cxsztcynI+Ykn5gMYz+Aqib3RLDUIdGkivDfsmxpkAxEv8WD/dA6n9c1qadNp+t2zWv+kTabCjuhz5fmYPZepHoelZShypNp2/PfX/gEtWSfQs23jXdZRIkP2udoi+6DO388frXB6rLNc+In+zNJaz4EsavkpIvRh17H2rU11TpdtItlJKsT4McRHzRr2A/+tV+w0+TUoIbuZ90rxqAT8r7geV/StaahRXtIrRmlNRp+9Fbkmk3uja1djTb3zV1WNVWQCMqMDkEEcCtSLSYbVr+41i7jktSR5e8YKqCDg+pyBVKS3tl1W4uLBUTVvKEMs7Alcr2PqanuNLv9VtIIHu1ADbmkK4OexH0rCbV9HZf1sJx63shFuH1DWPt2kgoxTynJHzuM5H0FP1WztZkY3VxBcT27CUW7ybRv7Z9ata2TpWki10q7htb5+PtEse7e3fPvXDxQziK7n1CdLu9eXcWMOwoAB8qbeozzk880Uoc/vJ2XTuVG0vh0/P8A4Y2prr7RqYn1R7crBGJBap83BOMj059ar6xeR6atrqFlbSSXU8oRLbOQpbglvbArPuFvCYr5CwAbEiKB+8wOMkdQOlXixEtpqd4y2thCSJ3bncf4V4rflSa/L9C1TildsS4vFttct7prGOPgq11LKcRgDkIgPXn8qrgRa9rgSSCVrJykq3DDYHZGBCk5xz6e1aPiuDQW05Tqeq/Z575cRoSQCMeg56GsiaCNIreaK4YsCI4HjHyq2ME4+macLOKaunt1/AmOquanjD+yLdILuae4S+icr5SsCWA+uMdetZ2mWrz2BPlxtFG/nQRnIwT/AHu5496mt7J0jupJ7O2umkugiFnaQxnGCxJ4H0FLblZpp5Lm4kt7qxnK2sUwOWJOCzgcEY6Htmhe7HlT2FGVlY0MXWkeS0yvMzHPmxIu1FOP3bHr7j6VNr9rJ4kGo3NxC8Gn2WVSTcVFwuOo9we9ZF/rllbeKtQuQ8r3ca7JVWPajA8fMP4ivY4qnq+t3R8KC5XUbrVbWKfHkxwCNX4+4+O3epjSneMlo319SVTm5JrcLfWbnWNMhtEtIxrtop3OV3SQxlCQoPqcZqrEZbK3tdI1KBbpfLE6K43EyHk9sg5rrPhzcT6kJr/V9LgsIIRvjIj2c7eSf73Hc1t391pkJOrQR20hEJaLcBz757CplW5Jumo/8P6h7Xlk4pbfmed6Rp+jppmoDUY1sNTVPtElrC2SI2OCWI7/AMq2dQ06wutItYNKhvPszQkx20YGwBBkcn16dateG7ceIku59UsILSWN2T7TGoIki4bGe4qbxTLbXUuiabY3rWyh/Pd0TfFJEvUHHQ8/SnKo3UtrdfNLQJVHzb6lXQ7+ztZUtLLTZ7TYuN74IUtzxjgDJrCvobRtdCXhmfV7FT9qmgcBWB+ZV3HgYHNb/wAPWumu7+0xFJpUMhUv3JPKsB29MVT1iAtc67CdNd4fOEi3AQqF4G4uRy2cACiLUako/r/X3EqVpO39f12MSy8JavINTW7vLyPUY2+0RK0uY3YghXLD7wxjj1plnPHo+k6imv2Zu71bXdNPsDPcpnbsz3OT09K17+bVpru0nm12KHTNxaNVt8SS/wCwP9nHc1z91pGuahqNhcTN+7jMs3lK6iOFSeCemTiuiLc/4klb5r5GsW38TOt8KaZptlayLYQ3WnrDEoEeSVQNznnvgnJrmNKttW+16nDoVukMUjlheF+SM4xn8asX9zNZWJaHUIX8+AvMk7M8krn5UUDooPHFdTomnWWj6HZWOqyo81ygysMm0MRzgEfrWTk6act2/wBCL8qvu2c14St3lSeYxb03KBuON3bA/nXXWiLJcRblAltsKeQetc54NukS1ZUKli+G4zgAjj26k12FlHEZ5posESEDI+tYXsj2cyqN15XH30BmvYSGKpGpk4HPC1yt1NFDiHTb+XT49Mk8y6ZFx5yZ3YX8SQRXRRvP9un80tsYlVOeCMdqxpIo5PEl2L5VmtHQrFBDkCMsnzM/95jyMHgVdJ236K/9feefFdGZumz2reJ5tRjkE9lerhzdSKqQoevynhs4wMVdun07ULFL3QUlV9MJQqUKKdo3rt9R14rm7H7LqOlahZrcyQA3arbtdcrgE8KR0yD0+or0q3uXszpUNtYTeTIWkEqqAkaLjl+eCegrWv7jVt1+SX46aFVPdaa32/A56a3urmPVpbGTyL26WOXcf3sceQBlUPcfrirF/cRrBpcupo0pjmMSPGoLEYw+wZ56A+wrT1Y2mlaxJJPcyQpPIsaD+EhxnB9BnIqndaYmq6tp0qw26Kkxmg807likxglfciuaE72ctv8AgbCnNTimlZb/AIFnQbOK3W5soVAiLO3lMRywJLY/nWnEkd0yQShWXcsic9welc3DKp1y6mW2uoGs7rYfMACmRQAWXHVDmula2t7ZFkgVljkzJjqUY9QKzno9epNW91LuvxMjxHMbPXbOK3tZJFvWaOZ48kRMTncT/CD/AErSvoUnicyssjQQkqq8j06Hjd2B96ilghudShvIixuXUDah4dM4wf1rW09UXWp7eZVDvF9zGemD1/GplNKKtujnk7Qs90jgpfEEllHaWK6dcCG6cRXJASTyk7biTgcfWtuWW11+zjXSZmS1sB5hvMZ3sCAU/IEHPtWd40h0rTvEMpvbxreO6gEEgtmwYx/eI6AntVL4bajBpmjXWlIqy2jXs5B373YfeJYjIBODxXY4KdJVYLX+r/cTo488Vqa2mhGtYH1OKwtrie4MF7KE3c5LIgx0JXAPYH3qvp6XC+INYsdNhhZLK3M8NnKMu5Yn5wT/ABHB9MZxVzVvD1va+FdbtLRnu9r/ANoosZw5VjuKKfcKRnnrXK3Q1G7jtb7STNFeS2ge5MRG6P58kN+A6UqajUu09++3dfqhRtO7T/rc6HS9ZuIo1sDbzx3iRm5G6M4QsufLI9RVQ6kdRns9UggbzJl+aaNNyZGVA9VboT0PFWmvNXuNDnmQPMTGJLXapBkUEckdT3qhoV2V0ya4tbJlvr4SJJBC3yBsn5h79elNRVnJJX/r+vkWluyDTbLUrrw3cXWqfZbi4nIxI4G1hngMo64I6cV0XhPQ7iKG3tdTJK3ERZhCgCBhyDzyBzwOcEVxcUVtD5ltDqcsFwrea6Ahscj5WTPqR+ddJ4ok1Gxs7GXQ4ra6zGXuIC+JHzj5RkjA69KqqnJ8idubysVVTeie5pT2OkPrMNiLBJQ4BaRW+UMvGGHrjFZPh/R7aTULy2i+0Na2zsj2t3uVkXJ+VSOGXk1s+GtNmntrW/dpLUzYMkUw2lM/w46H04qprWs+ddXZsPs9zHbRt5luh2PLtYKSW7EdR61jFyu4RZnFu7imYEclzpup6hB4Xu1t5La4iMkVwp+aMcYAPbBxkf1rV1PW7rXJdI1CORrexE6xTQ+UXJkVn3dORgAEVBok2o2PiJV1MLc2z23nW8txtDiIjPlt9M8E9enao9Gs5NO1tbbQLgvp8LC7lidceSHJ5xzkcMOexHpW8rN3drpb/g9fyLdt+q6mrf66qTkpdS2zzOssEki5QIMg7T75GR2rCv5NUePTkuInmtp5h5qSHa4lypjAPoDlvTIGa76HSLLU7eZbl4ZWYlUMK48v2x261xfiS31o3sVhZ+ZYvaYCRygy29xEMZmDDkEZwVODnj3rKhUg5cq0a7/1f+rkUpRbstyEazY31/ZqkrJerI5vXhcpbp5bdJWXqWwRtHXvWlJdagniK3zpSz2UzI9hsQxtChA3M5PGM5OCPSs7T9I0rQb19H0q/ia91FFnjt5I2TeSWPmZH4gD3NXLe4umubCaBL7ZbZj2vkgnozjd9ce1ayUb+6tLdf6+XoU7J6beY+7sU/4TDWXvFUztFEkJJJUxnk5Pr04pjmfTLu3jstLnubm7Gxr9FYrGDj5QPQDjNWtG1zRtQ8RLFd3KieJQohnyjAscZweG6Y/Kuj1rVm03ULSzggVoGQlpAwVYwOMVjKU4yUHHp10WiIk5KSi10KdldCSKe3Mf2uW3byDKY8Zbjgtj5seo+lLPdx6VD9qnxNcMfLj2dE4ySP8AGqUPiewW7eO4nVo3LIqqpbkDkKB1Oc9OTWRDq+mXMsEtpaXUwll8lbhwVVc4OSD0qFQk3dx0LUXtY0NRvri1W1utNithHIxO50ZmB78ZAzn1pNS124tNLW9R3aFnEUkLQkSK+fUdO9ZN9bzW1rFpuiXP2/yJnd41be4HU/Mf4s9hU8mqHRfCt3qdhZyS6pcTrE9vKpGxjn5ivXoOvrW3s1pZX1/q/YfLe3UqXus3xE8OrafBqDwFZLWR5PK+Uno3bIyMV1l5oP2HSre80+RIpyVe4Mp8wkEchT+lctYQNaWUl/e2Zub+V8tG/wAyJEeQWzxkEnisuexu7jWJLpZrq6t3Uwl4ZsKjcZ3DoPT8KqUFN+67Jfc/lexThro7W/E6OO4guNYkjhlgeXyd6Ic4OBzk1lz3VhM0FurQXNxJMi3AOSsYGT0HUckVLca7FpFrbh7ZZfMAiUJyXx1b6f1qTwLouj+D4JL65vJV06/bfGtyfMkeRjnZwMkDJAA/HNFuSPNZ36eYSdld/Iy722t7W1vdQtg+oXUt28lvDPEdyoSBtUf3eDiusbTbW40sLpRgjv5oyMNMpER7sF74NT6lqNvBquoi00yQXaIoiuLg7IpGPGxfTAzn6VnW2pIbRbuFtNMbSJAmzbujxyUB6nJrJynOKdv6/r9SHUlJIrRQiK6uZ0u5lNsgjeGU4CquQZMdPmPNF7DP4gjjk0CO3tdTMKmactnLDkp7ZFVJtKe31XUIZVlXWbw+XCsuWSSEDdtHbA961oAyxCGzt4rO1uIw9xBkRymVcfMmfUACrk0rSi7v+vvCTtZozfHtta3tjaiO7li1KMKLi8gwUicrw0vfaefpWp4Zhu9C8G6RIzwXjPKBKkeNjbj94k98VVilEiz29lo0aRXtuVkkbnecnAYngnNUvGGjXeq6NoMEqrbxW9wrvGrbVyAcDj7xGOBStzRjSk7K/r0BK6UG9DZ8ea3Ff2l7o1lIsFyFRIy5ISVnONuRWZZxxxaNaaTdXhsHs4ALlCnEidCvPXrWadJt9I1W31K7dLrSdMiaExyEmfzHAYN6Eg5xnpVgaZcNqxW21QTiNYw0VwgGI5DnOSeQAMetVGEIxUYvTf5/1+YrRjHljsb2siPSfCAstNuZms0gKMka7pXVs4P055rGtprnUvClq1hENDuUZVRnXEcz5wyH0GBW7aaxrEUvlXGlfaI7gmJJIyoCLg4ORn5TxXOafeWUd/Fb61PdQwNMA1lOP4nbarL7Z71FOLSd9Wnfv+H+ZCTS/HubWqalcaFJemKO0vBb2XnTPbkCRZF5w/qpHSquj+K5hp5k1DT7tHlYshUZjkTqp59jV57OytfGV1p8lrGZbi1LPOB8pjzgIw/rUfxDRNN8P2LRzvbXUTARtGMrtweo9h0qYcknGHLe/X5Dgou0Wt/8jHsdLmutIutb82NbgSl4kVGkdUHVADxmn3d7PqUtlqItpoLSaPyp7IqMg+sjDpnrjtUOlXbsqQzXlxJaTxB0nlPloT3Kg8nOetdVZRaRBpca2n+m2CMWZbXMm5h1zirqScXdq/8Al2HLR3epxKW8mp3cMA+wXM1qzi8WCMq0cWfk2E8Ej1pJtKistU0281KK4gsoAWADktK5OQMfzxXQR+IL7UIL3UrWOCy0eE7EtxCUuJX7Dnua5MQeI9d1KdfMXylQywwyIVaEYyvPrWsHJ35mkl/X6lwu730Lvw4ia3udZKswjmVcqD3IIx9K7TQUljtNs2C+8nj0zWDFpq2eh2VxkpPMiNKy8E/MGA/p+NdLpD5iVlXg8gfXmuLmur/1oetmFRVakqkfT7tCtr0UwvtNWIEKLjzHxjhdprF1KGc20sIvE3oWkIBwd3UDNdTqu0ztuYjYhGRz/DWEdF/tDT7613xQyzx+YS+V2EryN3OBjNa056K5w058sVJnGHSraTV4Ib1PKn1GUS+XG4wARksAOwIz+Nd2l7qmZ7a4hCRwu0MO1fl8pF9fXPf3ri75La3n8Oy6bdCCOBIwFZsvPHuKkEnkLx+RrtPijJPa2tsLC6isTKB5kpIAjXIyT7ZwM10VrylCHe616W/4HqXUkpThH1/AyodbPiqwF5DaEsszRyITyrx8Y/TP41saxplx5lreaawW4ktXWKBlyjORkggnrkA/hWN5txaaSl7b2j37oyr9ltkwZeQpY464+9n0FdMmqyX12LSa1ZfLnykitzERypHrnmuaaa96notf6/EKs3TlyRWiuQNfw/ZrEXgFvcTw4dRlhk/eyenB71heIb3UV07bp0xVrZ1YjGS0YYAg/n+ldrOEiDxzeVLFKzMJAuCM9Rj69qpwvay2so1CBBGqmOcAYYis6dRRkpcpip+7dL+v60M8MlpaWzRkW0c7EzlVy5Z16g54AIyas+Er1LgFo/tM5tiSjM/+sJ4IGfYdM1z99/Y0l7Bd3t9dNFq+yK3gkJMaGMHBUAfKehOetWrm/mW1FlpUKwX1jiZvPico0ZOwlSMZNayp3jbv/X4PQiUboxfEmmTvrVxd753NzKTJE53o4JGwbCDwCO3tXQabFpNnaOLqaOzvIZBJcraxAAkjO5wB6AitS4SebT91tKkN48Z2SRAbwvcKSOD71wOiK+k65JL5JQiJbdySXLpkk7iep55J9a0g/bQ5W9v6/r/gENcyaPQZIj4e0+31TTZhc6bEMzKDkyW+BsIPcp29RWBpekweIdenvLBJLG0dv36ocq5BDdsdevPTJFW/Ad5bTPqmhypFHpU7v9itzJkqhHzxjvjuB2ziqt5LqHhPX7dIXW7tpYEjZUID71+XkehAHJ5zWUVKMpQT962j7r8roximm4p6/oXPE0lhpmsR2d9eTwW62rbPLXHlqSRuJHQKcZ/CmeG4rPSPC1rA1yLgiJpIpmjAaRScbhjnA9ax9X0n+1/DV3aXNxcQoJnnE91KHkhD44BH3gMdO9S2kEt1e6ZLcazp1xiIPbywHYVHoV9Dggj0rTkXs+Vv1+W3T9fvNEvdtcqJo+jSS30cAtotSiaQu8ZKt5LYbf7k4x7Yqb7JKdRso9P1AATAkRTKVOE9D68EcHms74g6VcRXNzqVvcTWl0CspW1OUlXgMCvQjHJNadxJZzm3isIlMsUZuI2MhVREMdx3J5/OtVdxUk73/DQvommMg1G4sdC1ae+W6urHiRZIJPO8slvkKrxx1zj0rZ1e9s2061mvoklmlAUzPb+X5m5flUtjj8etbGjJo0JjnhhCyXSl9wbhhjJOfxNU9PEa3FxqMcP+jtHKkErkEROBnDLnocfp2rmdRNt8u39f1+RlJpvRGZNpEl9quioEaW3e0ktLkJho49uCuechiM4x1wae+nQ6BYwHR9RMs0LpGokIYsmeUY9R8vTNLpviOK4eaZbaK2urXaXMkTRJOxGQVIyMEd+3esPxc1xBqsmugTLK0StNYSKjJIigk4cHhwuSD36VpCM5SUJOy/P+r7/eaJS5uVmrqd3aXd9DNpUjQajZgyrcqSN6jG5WX+IYI6+uaz7nxTcatpuh6fqPn2d2Zo3vBGfnXByDjuhI79au3GnX134Ttr7wSkc8k8kUwDOFDoRhuvQ+vtnrVey8F61P4qfU7m3jt18rytxfcxxyO/HPaqi6MV7722vumv8AhxpwS95rT7yy2s3H9uyDTbexjjt4yZYp4iCUBzviI6dfu5x9K5y9i1TXZ7NNN1RoYC7yTFn+YIV4KAjk5AOPwrQv5JRK7adeSzarbkwzxwx5aSPPQBuM9qd4Yltba2a7nju7IR4t1tp2/exln2ggY6ZP61rFezXNFa/1/SKjHlV0ivYafqev2t1q3lQJeCaE2ZuIunlckHHIyw5rem119Us0vLK1tpoFlEUspfy8nfh49uMlhg/nmq/iK7vYr3UNMszsuoI4ovtKITlpFLMSOg47+9bPhdlh062086bLb2lrGkaKG+UMFAyD275NY1Je7ztLyXlb/hvxJm+Zc1v+GMPRfDV1cx3E7EwS/bGdJZYwgjjI4C+rDPWtC7IsLWSzlluJZIgX8tUG6Xnjn0yM1NrmoXjz3Nt5EkFtA29HYh1kQYBP58fjWVDaXmraSZNQd4t24rtHzKh4B6c4POKSbn782rBrL3pMqaNqw0bUJsRRGTa0scQOGJ7npxjkV2Vo1h4lt7S8aTeiHB2nZ5jDsQeTiuPK3FlBN9p+zvIIwouJgMIgzuY4HXvjrWh4c8OG206zSzvJb7ULS6CSSuGRUZhuJweSOlOtGDXPez7hVSS5tmSa3f3dxqpkhZYdPhGwKRsO4dMn0FRQvcTyatZ3s1vDa3Fo7GytkG7njzUYcHjPetTW5L2Z/KvLSW8gDlZotuzKf3l9/wAe9Vri9SwaGa10sQrFBIF3uEJGeBzx0zmoi/dSSX4Exd0kkUE03T57Gwtbsz2+j2So/mFjvnPQJ6k55qW+1q2kT7Ho5toZYImkt7Voy8kgHpkZ3ZP15qTWLhvNR44Le7ulKvZ+aG+UkcjC8Z6V0Pw+0ObTtNku9TgRNUupXlkJ5ZAzZC574pVJxhDnnr2V/wAf82KpJQjzy17I4fWotatNEN8IJrdjCsmy4XesThRuBGM+o/GtTR45fEVvbyaPq1tbWzN5ggW0wYWxhguehH616XdSxQ27vdFRCAd27kYrmdV1TTrq2AiWNUkXKzv8qqexNZRxMqiso69/+HM4VnVVlH5nN6pdWUUCaZpf+nSWMn2e4uZ5zlZHHIB/ib6cCsu5ka4vI9Jtvs0UkDeUtzcvvnYHttOMdeMVLossGp6XHaz6JFcaqsjyZsyVjQnjzeD16Grmk6Fd6wDZverFJZXCyC8jw7y7TypP6V1e7ST5un9X/pGt1DfoV9Q0690to4IblTOkiG2tpGxuXIDPz368Vl3Fv4im8R6VJeukkFtfPdPbhtxZMYXaPQZrr/Htm2rX8VnO8UFpJb4jumHzCUnjafX296yb+PyNcUW+oiSXSrUCG3iGWn2qSylvUkdOaVKq5RTdrtPp8v67DpzvG/Vo0PEmmLdXcN/BBJFcwvII4uDG8pXG5x6Ac81mzyxb0XVdHEulXVusq3MbHznZBlmOPurlsAe9a+samJYtHuXe7tLeMC5uJ9mQhK8o+OoOcGrOpaJcTpp01hrl0liluyiKCAOJe6nPp7VjGfKkp/r+hleySl+pz+i6dcQ26xaPaTwR3Evl3Fq8u5UgQEAgnkNzyPWqk+hzeJPK+xXxEVoyRtLPH+9G0nA+n9RUUcuo2sVzdX91DBYNOt08azZnQqAQrLxncRyB0Brpo7uW8ntXit5ETUV8/wA+JfLij2gYy3fNbTlOD5k/n/w+/wDW5TundFm68KJq3iiw1a+urlZbSEq0cbBVkOMZb/CsnxRHq9zPLBbR213ZTR7bYsMtG44IP1FdJrmoXNlp8l3ZQiWVUw0K9x3Yn0ridU1GwuLJm0xbq31HYrkDIGOpx3/EdaxoKcmpPVLReQqak9fl6Es1qY9NZ9WsAt7pcfkK0jfJ5Z9B0Jp2heHbeHRzpvh/xBNZvdjz1VQBsGeRjqD+Nbdj/a95p1pdHV4reFj8y3NuDIy46ZP865+90nQ9OvdMuLW/ulnubnKiE73mPXr2WtFNtON9fLVaepUW2rJ/5E19oSXo07T7q/uJ/sdwkispIaVwe/rXoVhZLaQzXEw/enLMzDk1yPhvxXaXWvvabWk5ZxI6BVRQcA/ic1p/ETxDPonhaaaxt2nvJDsjjHP1Y+wHNc1WNWc40n/VzKopzkqaRzd1MZZbazhLSQxRjdI3QnHH8q2dK3RQnj5SnynPfpWQJQ8kajn19SavX96LGKKJAGcEbs9s0ld2ij16uyj3H6vC9xexlSwRnBbB6ehpNbtZTI62+JAMw7APv7u/0ANWYZEurm4thIBKuCRnG0d6VlvZfEC28ZVLVkCBlIJLEZJ4rSMmrLscjlbTscD4g0tdLtPDFnbJG+pL5qxyXbbpGQNlBz14LcfSu81DwpYavrY1LWA8y3Omx6fJCDhAQ+/I98n9KwLq9W68Si31KOdhFbS2qRSsMSHBBIGD83GARium1NxZSaCZ7sW0fmmPylydwKkKSa3qzm+VX11d/W7JqOXu99fxON1FVk1C88NvNLbpM0ojuI+WXY27A+oBrs9Z3yeGnuNDghvpkwYwzY+ZTgjPrjNYPh+EW2ugzIxmR5BlvvcnBH5mrEVptn1K1EdxDYtAGkllIVA3JyrZ7YXPAxUSs7Ltr69/0N8U25Jp9n69zfkMNusCSw7Y7tMPGzbjFJjtVW8tpkvYhKQJGjKTIG/1mBwR74/lXN6TY3mu6fHdSa1LbRXLZSG4iy6qONrKcYOBjPB5zWxo9jdW8H2aSUSvENqmXJI/u59sY/Ksp04wur6/MiC5db69f6/roct4lzo99p/h2OPFxIzXlnf3URlhRgc7cfwnGe+M/hXSWkt7dXtpYXVi13Gi7pLoMUAkXkKB1HNatnJLqmj/ANna5HCmop8rbQdjMrcEd8Eflms6OZtKuJ1aYZgfa5Y5wB0JP07+1W6jkuVrVde/mOL54uL0n+fmjo3mEViJ1gMrlDIsS/fzjoPesu3sbDVDpcswa1lmjd1s2Gx3H8QI9RxUFjqVzNJaObaWbMjxzSQgFY0PIb3GRjj1rWi8xIBtnM6Fy4fGCAfT3FYNOHqck4OOl9f+HOE8Q6ZJbaxYw2PlRXVnLutwhG9hjkE+pwKFgS9195JJ3f8Ac+ZdyP8AI6D+Er64Jwce1bWuaVaQz23iC/upvs9rKJp9q53Mpyv0HSsuyWPWNPebw3fi1a9JnFu64ZlOQdrH37e1d0Z3gn20v5/1qUpafqZZ0W8tfDUd9dagt/pVk0gk2Da8Kqx+c8cgdSMdKy1tbSXUfD13FYNNpMisI7yBti7ScIMfw7iQDnqRxWp4X1LxLpd1qFhNa/bFuJWRoZgPlLA4+buCFwOo7VFY61aXekzXE8MV6+nSxrPYRjaQquCrbB6Y4A4OK6F7RN9fR9/u+/Y195N9f+Ca622oafqd0dSnVrJVEkXnAMojY4KHPHQ5HXpTNc03w7okC6vYXTxtKFjDfaA0JXBIiUHJAP8ATrWZ4zvHvCfsN/b3WnyGMvBIzKEUckjPC43dOvNX9V05dMvrO5sbpHiW08uO1lU7djnO4n7pKk1kk/dcnZvpt95nZ6X6nR2FxNb6PbnX5Asl6+FgtU4twfukY6cY5rAvfI1XTtQ0OPUY9HF9I7rL5Q/fP93BYHGTgHggmotItYn1ue9TUIrudERzAjkLGw5J2/xdj6U26ilefy7aWyltWDZtuNodupbqfx7VMaajLTff0+QctmYWkNqtscReVLPbxrZzpO527wvyzL256bT09+M+p6RplxdaXi/QQXJlEjSpgggDPI+uah0XQrOQpPcWkcLphSpADMwHIz0cHqM1p2Vtfz37z3RitdLQHyoEOWbPUsenvXPicQqm2liK1VS8rf18zS0u2itoES0VYrRA21FXaOTnOPzrlPiD4rFhC9ppl5Cl2gSWc8ZWIttJBPHBx1/rUXji+1K6lXTNJvEs03KrquPMlU9g38P9a4+z8L6kt/PHe6fHcw3a7JQ0n75oyckDHbKjJpYfDwuqtV/L/hyaNGN/aVH8ixqmp3bSW15balBHqLIxtjLEyxSlDlhnrnkEj05rSks5pTNr+tyrDEJLa4wp8xMsApAI7BhnHvWdpVvpsOpOl9cRG4t2Z2sg5ZYZlY7Yw5GA+wkMO4rU1DW530S6sbKK2S6vJVmtLZ8YiiyvJ46FgcV1yTuowXz20v0NmndKK/4YnufsS69f3ZuCJblsRyt8ykKM7SPY9P8AeIq5a6Te6zBZJrd2iMXM6tbnyWQg/IAv8R9yKzorKKHTrpJkVIrt/wB40b4OfUenOTUP2u8lTS5bCG61IAeRDMo2PEc4yw54A9/es3Fte67W6/Lv0/r0J1tZP5nQ+MLLX4RaPoqQ3cABS6jk2J+7x2J/UCsnT9evN1rDKsFoFmCzNLJjygBwMcehrX0G81NGvLK6vra6+yJslYoQ3mk52jOMjHeszUraSeeS4NxaXVzGpurWJ7cKVXBG0noT9fSsqei9nNJ266kwulyysznIUl1PW5o1L63buN0oiBSKGMHdnOOSccY9a6O41aa58O3mvtFqUMkRCG2wRHEVxkoMZIJ6sfwqlpz3tpYWcYWAvI6NmSX5z1LOzjg9sAcV0WnnWLfVle6Q3iX8Y3WwbEdvjOWJPXORWlaSvfTTz3tv5a/p1LrT1T7f0zCvZtT1C9FtpepsJ5Lbz7eOU8FmwwB+gq/4s0i/ttFkv7dBLqXlqZ2J3DaozsQe7Yqjq+vv4UvYJr/Txe6hcS7EW2AIt4ycEZHYelbPiPV7yeEwWUjW8ZtluTeEDaBn7pGDg/41L9onBxS5fzJ99ONrWOf8CXL2W7V9bu2nRxtZvL+WOUnLbT3GTivT7K6hvbZJ7aRZIm6MpzXnOoS3GracljDYRSyQoiokbhNzMMlto9OvFQwG78GaI1vprbYrdfmjdTIykkk8fxEk/lUV6Cru+0n06W/ryIrU1W12l+h2vjK+sLTQrpNRkVFlQoo6ncRx+teRzXOt2sFqBJBeWAUM4kIYSNjLYzzkDt7VvWV615qj3F7Cl9bXcaxyJ5Lb4c8g8k8VuXXhAanpM+l3cAEEUqmKcfL5gB4PHIwOOK0pcmFXLPW/9aGlJQoR5ZMx9K0i5ttZ/tTQLdI4sL58Lkgykg4YEep7dK6bw0GitZL97f8Asq4vrkSXNvNIBhunyj361h654a1OK6s5NLtkudPtU8wRtIVkklHCqOeB05NQajZQ2upWVrqWn78os8wE7MY3I7N0PIolasviv+enR6ilafX+vvNn4iaLfyS6ZqGltvW0nLyQOfkVSpy354rm9PsBD4fW/v5xb6uBJG5xtOGyAwHrW0dat7m+itLq+Fvc2826LyAZElTkNE3rwfzrb0g2GoWUkqRboom2sJoCny/3ee9Qpzo01GS2EpSpxUZdDh/Dn9oRaa639uZRDNtwxwlxGuAMj6Hk4xWzbajPdy6dZWmpS2sj3jTHyoP3ZhVvuD2xxmrN5Fpc9/NFeS/6WyGC2t4ZCMjbnn0OOmcVVutF/sq1gvU1Q2cMckZkGDjH9wH3rSUozeqs3tp/w45NSfmWvF1nCPEGjwQXVun2qViI5ofMV2AyT7HH8653U7GSXVrgeIUkt9JjmVIfMm8wMG4yFH3PbNdLqclzqei3k+q2Ci3Eo8nyXyzL2Ixzk9642KQQrevdBtl5JueC5O/OPukHrwOlPDp8tr6rT/hv6YU+bl89jV06AzabNaxXrpFY77VpSzIJI9uMtnkEVh6BDJKul6LpTXEF3GGifVCOCEOcL6qc1nz3tyJ7iwiv2m0swG4kTb+8C9/c8V1mpeYmk6fp2jx3UtzqNtFD9pb90beNcHLEdGxW8k4aX3/Dzf8AkbTXKkl1J/E/hSF9Uje+ur261G4gMMPljCIQPvAZwKxtBh1TSPDQvruL7PdWaOsUt2DhBnGMdcGu58VagdLsrZ7ieSWOMLEWRdzyMR2/rXOST3dxeQ3jXouTtKx2LLwR6kHjjrXNSqTlTSlt/l08jKnKTgubYxLy3gjtbXX4Jy2ort8+F02+cWICkL2HoKv6dqk0k99NqylRJL5UcDAkIvTAXuTS+KNFvr1FuLcA3UxTIxtAYHC4Htkkn2FZI1ea0nhlgudz20hikkK4LYGCBnr061skqkdNX/WhoveidHoUaq0bMxKJjLHkk9zWpsS4cbVVmZs5Yd/X8qwNMl+waXHbbg78vPKR+la2ly+dbqxyqyDP4V5ndnTUbbcmWLCz+zaheTZDPJ+74HXHfPekglvNN16FVjDSXMhVOeGQEHB56+9Xw6W9nFK5CxYK59SWx/hWej3Et/dW4uIAFhd4lYfdwOWz2rWEm737HNLW7ZYW+uJfGLRNYW75ImScAeYqBcMhz0OfTqKfZ6TpcLS6Gl613c28ouGE8m6SDe+9fw7fSq+iuLW+864t555LsqGulYGPYPujcOrDPXNbEN3ZJq2o3dxEsDRqVM7ADeoxxnv1qpNrSPbp3RjK8Ph7fijGvj/xOJ7yMBfLnVwMfwng/wAqo+JdL1LXNJ1CHTtSjtCk8Ykdl3CSI/eTj1z+la9zaiOIRbtzSbgfwwR/Os8+HrXxPpS2kk13ClrNHcMYH2M0iNuA91wQKKclFqV7Wt0uds5pU0+1l8tP+CZNrZ2umm4uYWzJd4EqBiNrBQqOR7AdR6VZvJ9ZkGlSyGeKISeW8saBzKFPRvbGf51W1fWNKtrGS8eV7S0VvM89gS6fNjaV6gZJH41rabcw20d2vnKIVuIrnzHlAVHP9xieS3pXVLmtzNff934XIUnF3aOlYC80wTwBWvLdcMcZLL6g+uOn5VTmVPInDxQsSB5uT94EdfyIP0pYpX0zWp/JYNb7QzoowUDDqB6ZxVG9eOe/RHlRWucqAr4Pv0GO/euGMXfTYyjDXfTdf5EXhqWHR53toZD9iYtt+b7p6n6jnNb0N/apfP5DgQyxq7Ecpk9x6VzFroSu07ecrxRS7I5G+Yo4GTnHOGzitvQ7UW8L4dJLAqUELHJjPdQe4qqqg7yvcdfkl7z3a1/ruWLW1tnvNTt7uOKa11E5ILblYBQvTtXAXi3XhK/g0u5jsHV5iNPmgBV4og+4LIn8QGRyOR710Vve7bm9l0yGaaws3KTJj54z3ZM/eA9OtTeK9Mk8S6BCtlLEk0ZEkdxsDMyY6qRyPp7VpRl7Odp7O1/0YnT5WpfZf5/19/oYr69ei/1B10xLO/WNd9rM4khlPUSoRj5e3seoqWHwzay2763ZGHTtTvisshkTMIYNgxMQc8k8MOfr0rBtNaGo3kFhdWvl3CWwmJK4MjL8rjBHfr9K1dJENxbQBLgwWU07IyMQ6wSk5BIP8JIFdU6bgtNPTXT8e3n2IlFx20NrxRP/AMI2smqmC2l0uC3K3MCRAzM2QFbkcgZ6+1U9IuhqWj3PkW0UMkkvnxrLHmNgyjKj+6GHPHftWKNauov7ciS9j1C9t3K+VKpl/d5IKqfTj7p6YrKsYdQ8RWJm8OzxKJ13vENwMDKcYQ4HB4+Ujg5waIUEoe/pa2v46r9fkV7K0fe+8in8GRoZ5ri0vGiEhKzWu4tGrdQVB4x0966Ox+HWg6DqVp4jMt6Z7aPEcYcqLg4wCykZHXkcCrGn+H4rS7eTW5Lq2FuIpwYLpleR8/d2g5IJGOevNdFpGlzaprd7rmszPEBGILSzR8fZ4jyWb/bY4/ACprYueym7W+/y3+8Jzlbmb0/PyX6mfsvNR1u2vtUkaDTbaNmCRgBVZuCXc9TjAAUev43vE2sz3OmvbaRMUcpuWaMbtq+pz/Kk17WbexgazlhLIqjZCw+WQDqA397Hc96w7+2P9pWN9Zq8WlxlTcG5BQKDjEin1x/L3NYU6abUpK3bsDbnyuS2Wnb/AIczfDej6xOhXX5VSVM/Z7qDk7euCvUDjrW3o1xLL4lAlu4WSO3/AHMjD552UfMAc9u46ipLyzsbZF1u3uPPjaRgG835Bk5znqR14q9oumroYjngt5tUSeVpo2Mar5B28kHrkjitatXmTb66bW16kyqe633MW3lYeI4bq2lX7NNObe6jYKN52nbK2e64Az6VLNp11Pq1jHrRtWtXtZEFxJxIJAQyhM/eGQcr7DFGpQ2etajdWMujTxtFPBLPMjGNct0U556HkiqmveJ11W41G3lKRWelzAyyN86spAMZGfU7h6giqipSa5V01207fn+Q7OTVl/XQZbJff6+wsjLZmIMXfgRyITvQA9exFdBe6mdBWHFu7WcsiNcMvAw4+8p9vSqtha/8JMUmga9s5Ig7JcRPlWJK5yp4BOOldZb2T/Y/smqXCTzOhjLFAokX/dHAP0rGtVimlJeq6/193oZzmk7S+4paxpm3R2n8PNGhYeZw2fN9AGOQPrXGT2fjfVdPeIQWOnmVtlxFIvWPvtf39RVnXo9R0OCDTNK1O3snjmMtvFLJkyr1KHuQfpU+ja1f66s4jvBJGoCyxSrjyyexGM4J6GrpxnThzxaa7talwUoxvdNd2Vm05dHbTbXXLSM2SEIiRuqCLGPm68j6VsWupWk13pVxp265827aGWSFjsiUdCR6Hilg0+DVIjpuutb3bRNmNSxV4yPQ1zsN7o8Fndwz+doukW2JTJCx25zjBGOufbFFvaaO7fltr5b3B3qItXtvDruv6heXDSLbW0rWcsCKMSAfMrAnuTUy3ccdobO/uJLi2MZSaSEZ3oxyqgdmHSnx31jLZPeacS8Us6L5Uq/PG+ODxzg8YPSqFzMH1LybdraV8ma4lm6QMEyhUcDOccc9atRb0a0X4W/r8h76dibRrBr7ydRsNJlg1CKV0jLyYEfIByP931rr4lGiGW61DNxPdNhnVPbgelc1b+JfttnZNp02zU/LMJWUfJJJxvzjvnoO+aWDWNWnuLEy2hD3oaJY71vLIdedyKAeO+ayq06k372i7dfx6Gc4ylvsOl1KH+1LDURpxi1y5hKMBJsUIrgASKepG7jvWw93a+JLxk0DV1mmsblUvEVyQnXt68VzlhoFhourvD/aM8M0ksc8d/Icq7scGI57nGc8da7T7HZaJJcz2FoHuruXzZkiIEkvGC2P4sCs6zhG3Je/T+n0+enUio4rSO/T+mU7q8uNJvQizy30V5M24uwAtQo5A9uprntUh1LRtet7o3rTWdxzcT3CqyR8YiVRjPUk8VbvrWLV5Z411B2ubN9iRsm0h2UE7l4JUgjrWz4m0CPXLG1t9R88IgBL2jbSjjuKUZRptc3XfT7gi4waT67mdbhrJ72LT7HTry9gHnBUfLGUn5hz045rI1y68RWmriLTL21NtJLJl50wiMxHyqP4tqg/i1dGNPsdH1W0ubSze7vCy280qsfMAYYDuOjHjkmtfVtGstXjjWdeYmba0ZwVJGDUqvGElJq6fdfp/W5PtFGSclozyrUfs93ND/aMcs0WoSeWbuFSTyQP4fTHftXSatfW8el2mnW9zIkPmeWJZoNylUPPB/Q1Z8NWc2jeKbyzaBfsEwJt40cHyUUDJYe5PerOsSpqmsWRsrX7RbRI6/ahhkhfoQV9cV0TqJzStotfI2c7yS6FHTzdeJLu7ks7100F4/Igii+Ql14ZvYVy+u6HcW+oWbafGs94BtnEKb04+6ct0+tb/im1i0vR4ZoLx7HT4ZF3ra5DSMx6duSfWsXUZ77xDoltPpkgsUnIkuI5OJNoPUnv0rSje6lF2jt/w/f/ADNaemq2OytLCx0HQ7S6v1F1qEm0NMQA7k84yP4R/IVV0rxXaXGnanNcypfBLkorQYZdv8I9sYrHdL6Wyu7i4ik1SzQosVtKNqpgYJJHUGtLVNWt7KG00vTbC3tppNlw1rFAAoB68DjNc/sr6P3m3vfYxdNbPVmrczmdbCAwCe+kbzEicfLGoHU+mM03w9b6LeazeahDh7yBjbyF/uow67aqi0k09Jr436RfbJN8kkvBjjHVRXE+I/t02qPZeGkli0qaRWkl2bQT1Zt3oaUKSqJpOy7/AJ/8BBCn7S8U7I9FD2M2oTfbZ93lMXjUHnB4HArzfxLaQnXbsRqLeYRb7eCRvlVM/fbHTNV7vQtWXXIGtL6QqSJZJ1zjjoD9Kkh0w3U2oNDb3c87YV7uY48wDtz/AA10U4QpPmUr6G8YKm73L+jwNHZQRTsGcgNIfX/61alldx3byrAcJEdo/L/69c1pOrCS+a3RN2CQ0hbpgc4FaPhXU47k3EtpGghDmJCOjEcHPvXn2lq2bSvqzqLmxk1HSbe0WZYcPv3MPfmqWlX9teanKstqRJLvgaRvuhQMDI9+OlSaxqltpcVsLqRw9xcR20SbSBhs4bPYVmXF7qFzqrWmmwxeX5jxXV0ifPAWAIbPTBxV0k5J321MbNp9iz4Q8So8sukpPaWjJKyJYz27RSsByWXnBB6jNdNqukJq87QSv5cUq7twGTkCsy70i2utMjkiu7aDVrsfZkvkhUSE4/hz3461uaUkekGZLy5ZpUUSM0zZYpjGc/UdKqpOLfPDR/1rt/wTCckk5R3KGqRm10y1kOF2y7CSfmDdMfjj9Kq6VdyRXEc0SO5LtlVHrgcj8jUOu3cl/psDLt2G7imZcYKh1OP6VmXF5caFd28TQyOuoXIhVkwPKAjZ8++cAVUIOScXud1ON6Vpattmn4gm0tdfvLYaS5vGtBLJdJb7lkw2dinpvzyaxAumeI/CWsRLpFzqlxpsnz2c8flSSzDDKFY+n97NdFFq1xBpytFZx+S4KhHk2sSScvk/XqaTw1FaW17c2EGpRPeMEkMRIykYGFOOvJ7960i+SL01Vur6P8P6sczhKEfQ0bXTVvI7W+uYDb6gbJUntkYORkZKbu+Cay9OsbK1hitrpGnhTMYll+8jemR6jGPpWrY28cF9dXYfzLmTCPIH6Yzj+ZxWDGbvQJLeCSa81i3uWKSNd7WkJzwCQBkDpk1krybSYUeZ3jcmeb7DLfNaoZXFvlmc4Sbb0JPqB7dqpve2l5BYavbxStDFICEjbaEbO0naOvNSLPYo00t9b3GnwT3b2CR3mAJ3K5+UjOQQDj6Y61tWq2qJJbwrAgVR+6VAqyKOOMd60vyK9i5yurvf+v68vQL28vprVLrRrRFvC4LeYwCsM8j2Jx3+lRTW2oxWUz6NGiyIWk+xycGNzyRGR2OfunHt6VHr12qSi00xZoJpLYzR3DqWiyDgqSOQw4PuKk+3x7WIkhi1ZY1M0+5gjgAZbHrWSV0nFf15+X4kxUoRTS+X9dPxX3lPTpbTXxbXs8G3UbYkMj8PE3cY9CRVDSh4cttRvp4rkPJFcH7UPM3FX6bWXsD2rSttX1DVtf0hLfTrO90eaGQyaukux43GcKE6nOBkdPy5ksNKgg1qW/0Wa28qeNmuVRR5k7j7gEnZR83HvWl+W8ZO2nR+ez7ejG6kbvRpdv8Ag2/Qjm8MeHpSjWlpfOwXKy2ilCVZt2N/AIzng9MmtK0v47KaWG2sYLKGFNzu7rnpkkheKx7m9a1klvFtL9ry4iELwNK7fdPBx0z1JPpW14dmt3gEtykaLMNiM6/eyPmBz71lUUlH3nchxfI5STa9f6/IoaC0l54re4u7SMiaEPBdBstJGuDt+gZquXt3e2lhHNdpYWmoXNwWdHbcmMkRhmzydoXOOM5xVq3tnt/Edtvm3gRSKEK4wMg5GPqK8/8AFPhQ+MPFF1LPeTxxqgQJbMclh904PAx/n1q6ShUqe+7RS7XJahKabdlb9WZ/iGHWLm40yfT77z1WUwugTG1yf4h3zgiuo1ezvLufQraGKddKtklnmQy/MWJKoreq43HFLYy6z4d0j7Dqaw6hKjriUDY7Af3m7kDGDUEGpXV14ou3tJ4101EV5pGwSgYfd+oORj2rrcpS+G1o3s+/9X0NG2/le39fMpTXhstOSxgiglSOfzJLYnLAdBgZ6Y5/Guw1K/sNSsYIY5poreTYFMfyeW2ehBwfwrKh0No/EdvdL9nnhubZoHmiwJIX6owPoR2rBv5rvQpLy0tZfMu7jJj86MMZ5FXHuFIOOR0qHGFVrl3Wv+f3EOKm9N0WfDti+sXOrX2n31zNLFcvbyxXDE7WTIOD1zyDjnitYW91ba9ZKtlappxd47hnQBiT8yHPc7h0rW8F3h1KyjkvY4otSWNWukjGD5g4PYZHv3qTxK88V1GRqEsBYgqiDK8YyGrKdWUqrptf1/Wxm6j53Fk2p6pHpU1vb2katJLuO3aVBwM8nHFc/d63dy61FK5uEt51VILURZdZOjZPQgYzmsS+W/tdfu1nm1CSwviskTrhlideob079OvFbthrc8dxHM7wPFKfv9VikGAQD1CsM+uDVKgqcU4q7t/X9eXmUqajqld2NvUrQSWbvqsNrJdKGiEpiBwjDkZzwOtUbZJobea0srqzhljt1eMRxfOQOhLdxxWJq1/LdeKBBBqO+3u1woXG0YHHP4kY71cD2WnSxayuq2bxviNYShUEDhgAOc9e1SqTjFJ7vVK34bepKptJL9CpBHdPNcX9uLa9v55FjRypjYN368DaM1Prenf2jqwsNUk06bS5bZtysWPmyDBGcYwQRnPpTtZuNFij0xoXmWO5naUNE4dBnGc4PTPb61XFvY2Q1ESaksEJQiGWYEIJP7y4546GtVd2lqn00+X4Gib3X5FPT49JtIo7B9puNRAeFIg0lvtwQBvHQfjmqr2MGlaTqFw86WuVET2ygPIjBsBw/Vl6n6cVnWA1/V/sUGi2VjNYWR2sUm8sSvnOQeo7f4V3Wn+HNGj1NNU1TyEvYwyiJrncFLY3BhnDHjjitas1RfvO77LX09P69CpyVPd38jPbR4rXSbjTrloXkk3Ss8dvgujDjY/Y55zUllf3UdzpOlz2jPrNtAzi5ZPMRE6BSc9xjJq3rU2mXGqCWxJn1CIgRwplgSPQZxnFWbPTtXuZ45Ly6mEM6Mk8duFRBkYGQeQcdxXM5+7efrrpr/kYt+7eRnzT+XqMk0/lzXrFIWtpbcmIlBnMZ9snntSWVjNLqrXlk5mteRGskmLi2O4lsD+JTngZrU12a8ggTRvDsrR6gI9wlnjby1AH8T4/lmsnTL3T/DN+wf8AtG/nnHmzTqFMUK9cqAQdufrRFuULxWvby/C3kJNuN47kks9hqKPq+iXQi1SSFrOAz4WQOpIJYN1I6c1NpGp6lpKQJ4hfbLLCsYVTuUSAfMxJxxmm+IWQeIdI1mKaI2qxl5oJYxu8o/8ALZcjIK55xW1fS6Xf+SLxfto8lp45o03ptz2I71EmuVJq6f3ryuJu0Umrp/f6HCW0F3e+KkvbbUZIpZJXKFCWR0I6P6Dgj8q62z0O40ueKKOZ4bGGXz1Mcxwc/fD5Bz7Vh6hYXhvL6DSlvrOJR8xiwDIT02H8elVLN9U022/4naX8mltiyuFnmUiFTjMm7OWyT+Fb1E6iXLJbbf11Np+/s16GxaaHYaT4v1PUoNSjgk1eIkRO4JY8ZZB6cjPuav6VodjavbCzN3aw6cxLFW+S4Lclj6896xbiWyS/0/S5NLkFqZGiguQeV+jf3Scd/Sorqe60zw5eaf50iLHIwj4ILJ025+pzmocJzsubV2+7b8iXCUmlfXT/AC/I1orWTWNfurbU7Ivp8cwntZS3Ugdx3HWsLxnpci2uof2TczXl1CFSewDhV2nkZ7478VH4Qlunlsp1vgjKzI1o4Zty4zujft7g+lMutd1KLxLrdqlrZJcsN1hLNuBdsYKOV4PGSM960hCUanuvZfr/AFexoozjLToWbSUX3gixH2ySORYVnMtuSB1wRtPUA8Vcs9LguZ5dWW7ka5e38lCwxlxx1zXPeG7uPUBpsthazfLcjfCP4Y2JDAj0zmu88TadGNMkhhY21vbjzFEI53Y6c1FV+znybXFP3Z8vcfo+l/b9FitdVLyun3lfHA7CrVromxgLgILSPO2MDqO1cppXiP7Hd2c13epBYx2pMsTNks4PUn6V3ml6gt7pyXpASGQblzwcds1x141IO72Zy1faU9tmOktLea0YRxIqsvy4XFeHwQxyajdeHre9eW7ubrz72XzCNiZ+57AV72cFSOxHavmTxf4cv7Dxlq+oW139n0x7hprho2JcjoqADk81pgGnzRbt29f6/E3wD5+aN/Q6iGC2USvbgKzfKSBliB3pNJWaPXVgswY7KCMttUDDue/1zWDournUnSIIVC4DSngE9wD3xRJ4iuYfEl7ptrYyrHBHHKbjaT5jHJwB/nvXPTjK7j5HTqvdZ3niQSW9ldXd5OlvAkKHzJWAUDIyP/1VkwW8Blt9QtYb6SRpFeVInKxv8uPnXuPr0pl3PZ3989vLZSnzIdsvmDIRuuQDTdNe7026s9MvdbkmjvlEtsZLZQFXOCrsvLDgVtRbjG19f0+RMU+U7fz7e60e2uvKij+wSILcxHzEVs8sQpGRx+Yqr43u9Lt5dPfVGmuI9RmSOKKP70hHJOM8IByfaq2jabd2txbWemQW8GkQK220RdodnJJwMcjvn61qwadLqNpFp2osjXSPktGOI9pztHoOg98UoyjGSlfT8bf1qYpKMr3KviTUIbe4i0e1gVv3SOXOc5U8AfgcVo+RDc3ka3kKTSwHdC392QoAMe/JH41S8RBXu4DaPH5gWQK7DOCowM+2aLG5VdS0iKaUeYT5knGNxxgfmc8U1qtDrUbUE15v+vuMjxxoiav4X8RaZLey2j2zRyGaJfMfAKuCBkZHGMZ9altV0/U7vS9Tu9wuDGJ4JVTY8hUYyyr94Z5C81LBrWn+I2lH+m6ReT3EvlPPAfm8kYKkEYOc/dPpV3wz4V0vSri4u7WIGe5fzZJWdicnGQOyrxgAdAK6edwhyzun0+as9fO3ntYyjPlXvdv6t8xukSyxi71GQSC3jBeYLk5AycKvWmHWBeeIbi0g0m9j2WCXMV+8RETIxBwc42uCehGeDWhrs8VhcoySR21qo3y7cnzBznPOR2rI0vVJte0o3fhZP7It2lZZpdRXDs4JA2gjLA8HJbGPxxMU5R52tNr9ibxlLmjon+H9ehYW+V2VJ4beGG5wcTLvjnkHIOw/dcEZBrK1C11i50uSKG+js9RVwY5zACXj/wBpT1yM8jHajXhd6f8AY4ZF1DWdR8zCR2tsPJ3HqxYnEa+5NbF9pI1GExapp91bXSEFJbW4Jb8umPpVJqFpL9Ht5PodMXTVne/9edhmj21wLAxXcon2McSHIIHow/rVqya3cH7HF/psAIUS9XXuufUdvWud8QaLeahpd1Bp+oXIDxhW8hiJYWHIO3uOOoqPw9DPaXtjLI092gjVb2cRjbK+MFigzjnFNKM4t82vb+u4qtFyXNF/15m/pl4kdncyw24lBdgY1zGYmB6OPTP8Q4qO/wBbNtb2sjaJ5t++0yBZBGwH97zRwSPepLp7afxRaSR3Dr5IK/LlQ/oM/wAxUWmeH9Js9QeOPUbqe5V2kSOSfzUVTzsI68HOM9qhKK1mvPr/AJoxlKD11T/r+v6uTeGY9R1C51HUL5bJ7aU4ga1mYyMpzlZFIwGUYGVJB6jHStibSLe4iiuVjkubi2WRYS7fMgkGDg9Ow/KsxtHsptTWKz1W6sngHmGytGVIyzYO4jGa6aO6aGNmADMByvqe9ZVpO94/5HNKUk7x3+4yrWSW1jsHuJFlkTfEz4IOwHClh681xuqLbDWy1pqOpAxPgwm4ykpBPO0Y4yOea6/Vb6xTyFW7jjmvSywxFuWcAsR9cKT+FY1/4a097qPVDFJDP5ZLmFsAMTy3PcjjitcPJQd5XVza6fvvR6lKG2HiLVJLzVfPl1G3gM9vbwvtJib5HwPunJAIBzg47mtrVfDQke2v9KiIlZVhuoA4G9Cwbc2P4h7eprLvbyE+JfDj6c9xHeSTHdDHwgj27WLn0PGB64rLvxf6bpLR2+qyW+p2Tjyyx/dEhjgOO4wfzrblk3HldvL8PuJjCc2rO3l/XQu+FJdUbVbdtaCRgzusenwcC0QA4L9zwBnPrmtPWvEESarobWdmNQvkmaBlg+6qOvL9DxxWL4J1eLWfHgvJEa01wwvbXtoYyY3CBT5qt6HIx9eaueItGt7CSzgju5SyX7T+TD95QE3IMDGQNv605xj7ZKotbfLr+Hn1CaXtLS3t/mN0OfVbXXdW1IeXHaxEedZLE27YAeRwc88j2zWxf6tpuuajLYvFOl1bsAkiryjEA8+xyKz/AA94h1GfV7hpLjzNNniWO1Dr8zS87gAcH5enPrXK+IPC+tWOpwa7puoY1FibYxSkAy25IxvA/un07H2pqlGVT941F20f+f5MOROfv6Poemanp8dxpzRXsxjnRgy3EQCsSMgDB46HmvPr7T7a3tLu2tIrq5uC5lEsM6qZR3KqP4gccdxXTW1tZ6jZTSnVZ5oICPPgOS8Lgcge2aTQ9KtNOt31CGW3WA4V/tr52NkYZSOh9qilL2Kd279ttf6+RMJciZo6N4MsBo8JurcLeyIjO27Owjk7fSodS+HtjMIfsU8luY5zONw35JOcZ4I5P6mrN1q0V5JcWsd1seKHzPNVgq47sTWBf+I9et/BF3cQLI0sJ2x3rIMYBHUdCOxPvWMI4lyup2bfXzIUa17qW7/M0dR8OW9jeqYpQJbhsoPLARZDxkY6dT+dYuvWtxDr09hdQw3dpKokSCRQyuQqlgB1GBk/rTfC/iu+DT3Gq2stxfNGsi28UTAKCeq555PH4V6Fc6Ykl1/aUEam+A3RebkbTtxg/wCfWrnUnhpWqa6fiVKcqTtL+mcQurzSxPa6TY2dvAzAw+SFVmHcY/vcfpUXiO31JZLF7aOwbVZBjdcx7QDu/wBngnHqOtTaRpTweIZL/UboWAluWdbKdgdkp6tGwwNp64PetrxZf39lPby2en6fqUO7cQGKyj/aHUEYFXzqNRRppf157Mu/LJKKOdewsbHWNNvbqOWe5jIkZlXfhuSQOmB74rd1zX9Ot9SguoolkuYo9oLpJhVIznIG386o6XBajWPtNpZzzS3nzn97j7GxHOF9OTmrd3ZXGj2EN5eahZR3ELOZmQ7VnXsuD/EaU3GU0pXvt/W/oTLlckpGd4l1yy1rw9PYiKeOO4Cx3DpOyqsZPZhzg9DjBwataZ4TF5FHNLLbzqMtbyW8hxDgYC89V9q3p7+0vNAtrubT8285CeU4XODxjriuPs9YutN8QafaadpsVpbxxTrNZu7MzOCNhRhlSOvuKmDm4ONJctr9b/1t6dxR5nFqGhf8Q6Q17ZNaTQag+p21sJItrZQg8MqOOvTG08niq2iXE+qR6XG8HkxIC4a3dkG1RwDjg8+o9a6OZtT1rR5LgGSzjkT5Uhf94WB4IPbn1rMPh/VrfU4NS025+zE2wiuoWYMNxk3MwA4zjOTShVXJyzav+QoztGzaudDZGEpLMyiSVoxIIRjLEdwa5nQ3OoambW2jjtdLuVluJbSUmSRpC2CeR8o6HGata7JfQ6iblkNxZmLyY4I5FhDFjncSegAFUdI8RDRNVGl/ZZLmGRfOM8KmRizH7vHYY71MacuRyjq3+H9egcrs5R1f5HVvYwWC2UKsef3QzyWNczrUd1o2nvNqe+5tY25l2B3DM3C4/u9BWr4nmvL7SzJpckUd0ki+QCy7i/cDPQ1z1rrVw1k2lRXEz+JZrZbidlXfBE4O3HpnPalRhK3M9e/+fkOlzpJvU1PD+lx/2gj3UVvbX4BeALNl2jPfZ2rmfH2m6taNJLpF1LBdLJ56x7kxMegQkjOOuBXRWdrp1j4mi1HxAuNbdRDBLuO08cgYOO561zHxOvi+oxXuj+dPewyRxTWqg/Mp9R3/AArahzOsrbW6rT/hjalKbq67W+Rv/D21Q2d1r0tg9hcSpmS3YYKv3+uTzn3rp9VhEvh4/aEeUshZkQ/M7HoP6Ulvpct34dit53e0dl3MqHleOB9BVm2tZLPQrRJ5DJNbRKCw/iIGM/WuGpVUp899b/gclSqpTunrc8g1KL+zbmFrjTZb28aRS0eCYk287eOvauxTxnHa+FY579E+3btpgQbVUs3y/TAqv4h0i7fU3vHe5+ywqHEEYxlvV/Yelc3d2mmaZ4fLTym41GRjc7pASvmE/KMd+OcV2twrKN9X/X4HU1Cpa+rHah8VbqC8XTLOAyyEyDfjJAB449hzXMR6PLc2b3+m6jc3U8jGbzVTlznnOeBznitG5+3alrGm2X9nvEt3vJvYYdmGI6+w4zW7fXmkWmm3WhJqb28Fip+1XqssZHHzYJ4GKUpqnZUlZve2v3/5GqlGnZQVurOS0fAa4AAAjQFcDocitvUHZbHTGBIaSV957nvRRXkQ+Jf10In8a/roT/appJbQSPuzxkgE9PXrV/wrDHf6JqD3aCV7K5f7Ox6xc9j1ooreelJteX5iqaR08vzE+Ctutpe3/lPOfNnbd5kzydCQMbicfhVywv7qLUPFskczK8EshibuuUU/zJooroi+ecnLXRfmiKespX7fqR+HsmygdiS7hmJJzklsn+VPtvn8XqX+YpbArnt9KKKtfxJfM9J/w/kbXhtmk0yVZGLiNyU3HO0lgDj8Ca39RmeK1PlHbuUZwB70UVlJe8cdZJ1ref8AkH9m2l7pAN3CsxkkRnLknccgc/gelZFt4O8Py3mp6VLpcEmnsVuDC+WBkbq2Sc54HeiisoVJx5rN/wBNHC5yXPZ9/wBC7FK+nFLOyIhtoW8tIwBhVBwBzVvU445fDt9cvGn2iO3kZJAoDKQpIII96KK2npyvrdGtdcsYyW55xbapepp9lMlw6yrM6hxgHAJAB9a7a9gj+02E6rsmuFZpHQ7SxHfjofpRRXXjEo2a7v8AU7p6SVvP/wBJKmkO1zq1uLgiTOW+YZ59frXHKPs+qySwFo5PP27lYjg7s/yFFFPD7yXl+pniFapp2X6hITH4bsWQkPdSusz5yzgEYBbrgZNamuXlzFpujXMc8izqjkOGOciPqfWiit3rKPq/1FHVL1Fjsba2njaKFAfOQ8jdyRyee/J5rrb7954ZtZn+aQoELHuORiiiuKs2+RvuZy2j6/ozzfQ7y4k8a6tG0rGO1dIIV7Ih5IH49+tW7td8l+7lnYzInzMSMMDkY96KK9GtpNW7L9DaPxfcdn8NbWB7K5vGiU3S3E0Ilx82wMAB+gqPSYY7i78T3kyB7pWYLIeoAQqMfhRRXlTb56ny/M4qrftZ+q/MzIrmWDw1ZtEwVljuJA20EhgAQc+taOu3EtxpFnNK2ZvMA3gAMPu9x9aKK63Fe67a3f6mjSun5s5u1jWz8c3Qtt0YEcUmFY43Egk/rW94sjRJL3aowuWCkZAIGRx060UVUm3Uh6f5Cu+ePoUWtYHh+zNEhguYU81McNnrUvxkuJbDwc8Nm3kxKEARAAO/GKKKVPXE00+46etWCZu/D2V5rGUyHcVSLaSORuQMRn0yScV1tFFeXi1atL+uhw4n+KzA8Y2Ftd6XM9xEHeKMujZIKkEc8VzMPHi3Q0HCTWzM6joSAcEDt+FFFdOFbdNryf5G1Fvk+8t+CbSCLUppEjHmB3UMSSQPxrc1OKKXWbSylhiltZkZpI5IwwJHfkcUUUqjbrO/Z/kFR/vH6GHpyrJ4lTTnAaxiJKQH7qkA4wKt6fiNbho1RC95cE7VA5XgH2IFFFa1N7eS/UqXxf15lq/jXTtAvryyzFc+Ru3BicH1weKx9PjVPiHZSpuD3OnebN8xw74HJHSiisqbfs5P1/JEptwb9fyR0HiS1guWto541ePJbaemQOP51594juJrLxLFa2kskNv5QOxGIHJGf5miitMA23Z9mbYbWK9Gd94YsrePTbErGNwBfJJJ3dM8+1VNNRIvEeoRxRoirFxtUA8Mcc9aKK5ottzv/WphFtuV/wCtTkfGdpDL4K1GaRC0sd2ZEfccq3TIP41Stz/xeixt/wDli9q7Mv8AeI2YzRRXo023TnftL8kdqbtL5nsFyfljHYuAffmluOIs+4P60UV4a6Hkroee/EG7njmtIo5WSOeTEgXjd9aZeafaXM9kk8COnmjjHoOKKK7ZvlpRa7M9LaKt2Od+LV1PpmuaZLYTSQPsblWPp6VyXjZEudSSKeNHjmsLiSRSow7bAcn1oorWh/Di/JmtPWnF+R//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gary Goldenberg, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26570=[""].join("\n");
var outline_f25_60_26570=null;
var title_f25_60_26571="History and prognosis of RA";
var content_f25_60_26571=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F75843&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F75843&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Natural history and prognosis of rheumatoid arthritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        70 percent of joint erosions detectable by x-ray of hands and feet occur in the first two years of disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        At 20 years, over 60 percent of RA patients belong to functional class III (significantly impaired, self-caring, using aids, requiring joint replacements) or class IV (loss of independence, requiring daily care)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Increased evidence of:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cardiovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lymphomas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Life-expectancy of RA less than age-sex matched control populations, especially in patients with:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Polyarticular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Systemic extraarticular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Persistent disease activity (high ESR, CRP)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Rheumatoid factor and circulatory immune complex positivity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        HLA-DR &amp; chain \"shared epitope\" (especially bialleic)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26571=[""].join("\n");
var outline_f25_60_26571=null;
var title_f25_60_26572="Modified Sartorius HSS";
var content_f25_60_26572=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F67798&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F67798&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Modified Hidradenitis Suppurativa Score (HSS)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Characteristics of HS lesions",
"       </td>",
"       <td class=\"subtitle1\">",
"        Points per lesion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Anatomic region",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Any",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        None",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Types of lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fistula",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nodule",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Abscess",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Scar",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Other",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Total area involved*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &lt;5 cm",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 to 10 cm",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &gt;10 cm",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Are all lesions clearly separated by normal skin?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Yes",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        No",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"2\">",
"        <strong>",
"         Total score:",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The Hidradenitis Suppurative Score (HSS), as modified by Sartorius, was proposed to standardize comparative analyses of treatment for HS.",
"    <div class=\"footnotes\">",
"     * Record the longest distance between two relevant lesions (eg, nodule and fistula) in each affected region, or record the size of a single lesion in each affected region.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from:",
"     <br>",
"      <ol>",
"       <li>",
"        Sartorius, K, Lapins, J, Emtestam, L, Jemec, GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003; 149:211.",
"       </li>",
"       <li>",
"        Mahmoud, BH, Tierney, E, Hexsel, CL, Pui, J, Ozog, DM, Hamzavi, IH. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. J Am Acad Dermatol. 2010; 62:637-45.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26572=[""].join("\n");
var outline_f25_60_26572=null;
var title_f25_60_26573="Framing effects";
var content_f25_60_26573=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F78787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F78787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Framing effects: Variations in the public's attitudes toward euthanasia and physician-assisted suicide depending upon the questions asked",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Survey question",
"       </td>",
"       <td class=\"subtitle1\">",
"        Year",
"       </td>",
"       <td class=\"subtitle1\">",
"        Proportion of public supporting euthanasia or PAS, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        When a person has a disease that cannot be cured, do you think doctors should be allowed to end the patient's life if the patient and his or her family request it?",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        1950",
"       </td>",
"       <td>",
"        34",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1982",
"       </td>",
"       <td>",
"        61",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1991",
"       </td>",
"       <td>",
"        63",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1998",
"       </td>",
"       <td>",
"        59",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        A patient develops metastatic cancer, which invades the bones and causes excruciating pain. Current levels of morphine, nerve blocks, and other treatments are failing to control the pain completely. In this case would it be all right, upon request from the patient, for the doctor to administer intravenous drugs, such as potassium, to intentionally end the patient's life?",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        1993",
"       </td>",
"       <td>",
"        65.6",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        As you may know, physician-assisted suicide involves a doctor giving a terminally ill patient the means to end his or her life. Do you think it should be legal for a doctor to help a terminally ill patient commit suicide?",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td>",
"        1997",
"       </td>",
"       <td>",
"        45",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        If a person has a disease that will ultimately destroy their mind or body and they want to take their own life but cannot do it by themselves, should a doctor be allowed to administer lethal drugs to end the person's life?",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"       <td>",
"        1998",
"       </td>",
"       <td>",
"        47",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Sometimes, terminally ill patients want to die and ask a doctor to help them commit suicide. Should it be legal for doctors to give a lethal dose of drugs to terminally ill patients who ask for it?",
"        <sup>",
"         [5]",
"        </sup>",
"       </td>",
"       <td>",
"        1999",
"       </td>",
"       <td>",
"        54",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        In 1997, the US Supreme Court ruled that individuals do not have a constitutional right to doctor-assisted suicide. Do you agree or disagree with this decision?",
"        <sup>",
"         [6]",
"        </sup>",
"       </td>",
"       <td>",
"        2005",
"       </td>",
"       <td>",
"        35",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Regardless of whether or not you think it should be legal, please tell me whether you personally believe that in general it is morally acceptable or morally wrong. How about doctor assisted suicide?",
"        <sup>",
"         [7]",
"        </sup>",
"       </td>",
"       <td>",
"        2005",
"       </td>",
"       <td>",
"        49",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        All in all, do you strongly favor, favor, oppose, or strongly oppose making it legal for doctors to assist terminally ill patients in committing suicide?",
"        <sup>",
"         [8]",
"        </sup>",
"       </td>",
"       <td>",
"        2005",
"       </td>",
"       <td>",
"        44",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Is doctor-assisted suicide morally acceptable?",
"        <sup>",
"         [9]",
"        </sup>",
"       </td>",
"       <td>",
"        2007",
"       </td>",
"       <td>",
"        49",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        When a person has a disease that cannot be cured and is living in severe pain, do you think doctors should or should not be allowed by law to assist the patient to commit suicide if the patient requests it?",
"        <sup>",
"         [9]",
"        </sup>",
"       </td>",
"       <td>",
"        2007",
"       </td>",
"       <td>",
"        56",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        When a person has a disease that cannot be cured and is living in severe pain, do you think doctors should or should not be allowed by law to end the patient's life by some painless means if the patient and his family request it?",
"        <sup>",
"         [9]",
"        </sup>",
"       </td>",
"       <td>",
"        2007",
"       </td>",
"       <td>",
"        71",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Blendon, RJ, Szalay, US, Knox, RA, JAMA 1992; 267:2658. Gallup Poll June 1998.",
"       </li>",
"       <li>",
"        Emanuel, EJ, Fairclough, DL, Daniels, ER, Clarridge, BR, Lancet 1996; 347:1805.",
"       </li>",
"       <li>",
"        CBS News Poll, November 23-24, 1998.",
"       </li>",
"       <li>",
"        Rasmussen Research, March 30, 1999.",
"       </li>",
"       <li>",
"        Princeton Survey Research Associated for Kaiser Family Foundation and Harvard University, November 5, 1997.",
"       </li>",
"       <li>",
"        Harris Interactive Poll, April 2005; Roper Center, Storrs, CT.",
"       </li>",
"       <li>",
"        Gallup Poll, May 2005; Roper Center, Storrs, CT.",
"       </li>",
"       <li>",
"        Pew Research Center, Pew Forum on Religion and Public Life; Roper Center, Storrs, CT.",
"       </li>",
"       <li>",
"        <a href=\"file://www.gallup.com/poll/27727/public-divided-over-moral-acceptability-doctorassisted-suicide.aspx\" target=\"_blank\">",
"         file://www.gallup.com/poll/27727/public-divided-over-moral-acceptability-doctorassisted-suicide.aspx",
"        </a>",
"        .",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26573=[""].join("\n");
var outline_f25_60_26573=null;
var title_f25_60_26574="Contents: Hospital medicine calculators";
var content_f25_60_26574=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?2/63/3070\">",
"       Hospital Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Hospital medicine calculators",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Hospital medicine calculators",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Clinical criteria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/8/3205\">",
"           Calculator: APACHE II scoring system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/0/33796\">",
"           Calculator: CIWA-Ar Clinical Institute Withdrawal Assessment for Alcohol scale",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/19/14642\">",
"           Calculator: Clinical indicators for malignant hyperthermia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/42/44705\">",
"           Calculator: Community-acquired pneumonia severity index (PSI) for adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/30/1505\">",
"           Calculator: DVT probability: Wells score system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/35/4656\">",
"           Calculator: Diagnosis of endocarditis - Duke criteria for definite endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/36/40513\">",
"           Calculator: Pressure ulcer risk stratification (Braden score)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/35/40496\">",
"           Calculator: Pulmonary embolism Wells score",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/53/28497\">",
"           Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for ST elevation acute myocardial infarction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/34/5665\">",
"           Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for unstable angina or non ST elevation myocardial infarction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/0/34818\">",
"           Calculator: Venous clinical severity score",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Medical equations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/51/31539\">",
"           Calculator: A-a gradient (alveolar-arterial gradient; AaG)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/1/12305\">",
"           Calculator: Absolute neutrophil count",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/34/34337\">",
"           Calculator: Adult burn injury fluid resuscitation (Parkland crystalloid estimate)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/27/4529\">",
"           Calculator: Body Surface Area (Mosteller, square root method)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/41/40593\">",
"           Calculator: Body mass index (BMI; Quetelet's index)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/35/17969\">",
"           Calculator: Calcium correction in hypoalbuminemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/51/15153\">",
"           Calculator: Calcium correction in hypoalbuminemia (SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/62/25570\">",
"           Calculator: Cardiac Output",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/19/42288\">",
"           Calculator: Corticosteroid Medication Dosing Conversions (glucocorticoid effect)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/8/16513\">",
"           Calculator: Creatinine clearance (measured)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/57/30609\">",
"           Calculator: Creatinine clearance estimate by Cockcroft-Gault equation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/22/19809\">",
"           Calculator: Creatinine clearance estimate by Cockcroft-Gault equation (SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/13/25809\">",
"           Calculator: Fractional excretion of sodium",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/28/25025\">",
"           Calculator: Fractional excretion of sodium (SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/40/24193\">",
"           Calculator: Glomerular filtration rate estimate by Schwartz formula",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/61/10194\">",
"           Calculator: Glomerular filtration rate estimate by abbreviated MDRD study equation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/26/29089\">",
"           Calculator: Lean body weight (adult female)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/21/29009\">",
"           Calculator: Lean body weight (adult male)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/7/34928\">",
"           Calculator: Nasal Canula Oxygen Fractional Inspired O2 (FIO2) Estimate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/49/14098\">",
"           Calculator: Oxygenation index",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/9/14481\">",
"           Calculator: Peak Expiratory Flow Prediction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/59/28593\">",
"           Calculator: Pulmonary Vascular Resistance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/48/7937\">",
"           Calculator: QT Interval Correction (EKG)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/45/28370\">",
"           Calculator: Serum osmolal gap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/19/20786\">",
"           Calculator: Serum osmolal gap (SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/56/26497\">",
"           Calculator: Systemic Vascular Resistance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/18/16673\">",
"           Calculator: Urinary protein excretion estimation",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-B676A6C4BA-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f25_60_26574=[""].join("\n");
var outline_f25_60_26574=null;
var title_f25_60_26575="Inflamed tophaceous gout";
var content_f25_60_26575=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F73021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F73021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inflamed tophaceous gout",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three inflamed tophi over the proximal interphalangeal joints in a patient with chronic tophaceous gout. Several of the lesions ruptured spontaneously over the next three days, exuding a pasty material composed of urate crystals and inflammatory cells but no organisms. The inflammation largely subsided over one week after the administration of a nonsteroidal antiinflammatory drug.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael A Becker, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_60_26575=[""].join("\n");
var outline_f25_60_26575=null;
